(anti-sense viral genome	is-a	replicative forms
(purifying	is-a	selection
,	is-a	proteins
-1 PRF	has-property	rates
0.097	in-context	first
0.1	in-context	COVID-19
0.1	is-a	growth rate
0.438	in-context	second
0.5%	in-context	threshold
1.15	in-context	copies
1.36%	in-context	Bat CoV
1.36%	in-context	Human SARS
10-20 fold higher affinity	in-context	binds
100% sensitivity	has-property	mNGS
100% sensitivity	in-context	detection
1000	in-context	steps
1000 steps	in-context	GROMACS
1000 steps	in-context	steepest descent
100ns	in-context	MD
103	in-context	areas
103	in-context	countries
103	in-context	territories
106,893	in-context	cases
106,893	in-place	103
1099	in-context	cases
11	is-a	day
113	in-context	patients
116	in-context	patients
12	in-context	residues
130	in-context	cities
130 cities	in-place	China
133 days	same-as	range 126 -147 days
14 days	in-context	infection
145-289	in-context	residues
18	is-a	day
18%	has-property	maximum
18%	in-context	variation
18kD translocator protein	is-a	microglial-targeted radiotracer
18kD translocator protein	is-a	radiotracer
18kD translocator protein	same-as	TSPO
2-7	in-context	days
2.1 to 4.2	in-context	scenarios
2.1%	has-property	pediatric patients
2.1%	in-context	44,672
2.1%	is-a	patients
2.70%	in-context	SARS-COV-2
20%	in-context	allied health workers
2003 SARS-CoV-1	is-a	virus
2019	has-part	S
2019	in-time	December
2019-nCoV	causes	SARS-CoV-2
2019-nCoV	has-part	S-RBD
2019-nCoV	has-part	genome
2019-nCoV	has-part	number
2019-nCoV	has-part	protease
2019-nCoV	has-part	proteome
2019-nCoV	has-part	regions
2019-nCoV	has-property	contagious
2019-nCoV	has-property	genome
2019-nCoV	has-property	sequence
2019-nCoV	has-property	severe
2019-nCoV	has-property	similar
2019-nCoV	has-property	transmitted
2019-nCoV	in-context	receptor-binding domain
2019-nCoV	is-a	Sarbecovirus
2019-nCoV	is-a	coronaviruses
2019-nCoV	same-as	SARS)-CoV-2
2019-nCoV	same-as	coronavirus
2019-nCoV	same-as	severe acute respiratory syndrome
2019-nCoV testing	in-context	cases
21.1%	in-context	births
21.1%	same-as	births
214 3.2 Å	in-context	distance
23.5%	in-context	births
23.5%	same-as	births
23.9%	same-as	21/88
23.9%	same-as	prevalence
23000	in-context	NP RNA copies
23000	in-context	copies
24	has-property	elevation
24	in-context	patients
268	in-context	cities
29%	has-property	households
293T	in-context	cells
3 weeks	in-context	preceding
3,639	in-context	deaths
3,639	in-place	103
3.25 ≤ R 0 ≤ 3.4	in-context	R0 = 1 + r * Tc
3.25 ≤ R 0 ≤ 3.4	in-context	Tc = 7.5
3.28	is-a	reproductive number
30-50	in-context	years old
30kb	in-context	length
3600	in-context	NP RNA copies
3600	in-context	copies
38.1%	has-property	count
38.1%	in-context	patients
3CL	in-context	2019-nCoV
3CL	in-context	SARS-CoV
3CL	is-a	proteases
3CL proteases	has-property	2019-nCoV
3CL proteases	in-context	SARS-CoV
3D lung mask	in-context	volume
3D model	entails	2019-nCoV
3D model	in-context	2019-nCoV
3a protein	in-context	SARS-CoV
4	in-context	angiotensin converting enzyme 2 (ACE2)
4.32%	in-context	parents
4.9	in-context	days
40%	same-as	12
42-108 46 hpi	has-property	Infected
42-108 46 hpi	is-a	cell
44,672	in-context	cases
44,672	in-place	China
44-84 residues	in-context	Human SARS
44-84 residues	in-context	SARS-CoV-2
48-84 residues	in-context	Bat CoV
4X	in-context	HEK293
4X	is-a	dosage
5	in-context	angiotensin converting enzyme 2 (ACE2)
5.0	in-context	days
5.0%	in-context	2019
5.2%	same-as	fatality
5.7%	same-as	fatality
5.8%	in-context	2020
5.84	in-context	days
50%	in-context	MERS
506	in-context	proteins
507	in-context	proteins
54	in-context	years
554 role	in-context	PL
58.33%	in-context	24
58.33%	in-context	patients
60.61%	in-context	concentrated
67	has-property	male
67	in-context	116
6X	in-context	PC-12
6X	is-a	dosage
7	in-context	mNGS
7 mNGS	has-property	critical
7 mNGS	in-context	settings
70%	in-context	identity
70% cross immunity	entails	virtual elimination
70% cross immunity	same-as	level of cross-immunity
72314	in-context	cases
78%	in-context	HCWs
79%	in-context	SARS-CoV
81.1%	in-context	parents
82%	has-property	remaining
82%	in-context	variation
82.1%	in-context	cases
85	in-context	countries
88%	in-context	bat-SL-CoVZC45
88%	in-context	bat-SL-CoVZXC21
9	in-context	sites
9%	entails	infection fatality risk (IFR)
9%	in-context	infected individuals
9-amino	in-context	acridine
9-amino acridine complex formation	in-context	SE-PGQs
95%	in-context	probability
96.08%	in-context	3CL proteases
99.8%	in-context	COVID-19
99.8%	in-context	illness
99.8%	in-place	UK
9X	in-context	SY5Y
9X	is-a	dosage
<1	in-context	CD4 / CD8
A	is-a	blood group
A	is-a	blood groups
A	is-a	groups
ABO	is-a	blood groups
ACE2	has-part	E329
ACE2	has-property	correlated
ACE2	has-property	human
ACE2	in-context	cells
ACE2	in-context	human
ACE2	in-place	infected
ACE2	is-a	functional receptor
ACE2	is-a	protein
ACE2	is-a	receptor
ADV	is-a	pathogen
AIPs	in-context	Some
ALT	has-property	elevated
AMBER	is-a	force field
AMI	in-place	patients
AN	is-a	motifs
AN	is-a	three conserved sequence motifs
AN	same-as	SARS-CoV
APP	same-as	amyloid precursor protein
APP/PS1dE9	has-part	amyloid precursor protein
APP/PS1dE9	has-part	presenilin-1
ARDS	has-property	critical
ARDS	in-place	admission
ARDS	in-time	few as 2 days
ARDS	is-a	complications
ARG 202	is-a	residues
ARG 459	is-a	residues
ARG 462	is-a	residues
ASFV	is-a	proteins
AST	has-property	elevated
ATP	has-property	bound
ATP	is-a	molecule
Alzheimer's mutations	has-property	familial
Alzheimer's mutations	in-context	APP/PS1dE9
Alzheimer's mutations	in-context	amyloid precursor protein
Analysis	in-context	effects
Analysis	target	effects
Another	in-context	source
April	in-time	2020
B	is-a	blood groups
B	is-a	groups
B CoVs	has-property	lineage
B#59	same-as	naphthyl ring system
BCR	is-a	antibodies
BN	is-a	motifs
BN	is-a	three conserved sequence motifs
Based	entails	conclude
Based	target	findings
Bat CoV	has-part	M proteins
Bat CoV	has-property	PPID score
Bat-CoV,	has-property	sequence similarity
Bat-SARSr-CoV RaTG13	causes	SARS-CoV-2
Bgh pA	has-property	redundant
Bgh pA	is-a	signals
BtCoV	in-context	samples
C	is-a	pathogen
C	is-a	species
C CoVs	has-property	lineage
C-terminal domain of XP	has-property	features
C-terminal domain of XP	in-place	membrane
CA12	entails	drug resistance
CA12	has-property	overexpressed
CA12	in-context	cancer
CCDC	entails	rate
CCDC	is-a	model
CCoV	has-part	S 103 protein
CCoV	is-a	strain A76
CCoV sequences	has-property	serotype
CCoV strain A76	has-property	recombinant S 103 protein
CD147	causes	invasion
CD147	has-part	peptide-9
CD147	has-property	associated
CD147	in-context	host cells
CD147	in-place	host cells
CD147-antagonistic peptide-9	has-property	binding rate
CD147-antagonistic peptide-9	has-property	effect
CD163+ cells	has-property	numbers
CD163+ cells	in-context	per villus
CD4	is-a	cells
CD4 + T	is-a	cells
CD8	has-property	percentage
CD8	is-a	cell
CD8	is-a	cells
CD8 + T	is-a	cells
CD8 + T cells	has-property	account
CFR	has-property	46%
CFR	has-property	true
CFR	in-context	COVID-19
CFR	in-context	failure
CFR	in-place	China
CFR	in-place	Hubei
CFR	same-as	between
CML	is-a	tumor
CMV	causes	pneumonitis
CMV	has-part	genomes
CN	is-a	motifs
CN	is-a	three conserved sequence motifs
COIVD-19	is-a	disease
COVID-19	causes	HCWs
COVID-19	causes	complications
COVID-19	causes	cough
COVID-19	causes	fever
COVID-19	causes	infection
COVID-19	causes	injury
COVID-19	causes	organic injury
COVID-19	causes	pneumonia
COVID-19	causes	symptoms
COVID-19	entails	chest CT imaging
COVID-19	entails	damage
COVID-19	entails	edema
COVID-19	entails	manifestations
COVID-19	entails	morbidity
COVID-19	entails	mortality
COVID-19	entails	require
COVID-19	entails	reverse transcription polymerase chain reaction
COVID-19	has-part	binding
COVID-19	has-part	loops
COVID-19	has-part	residues
COVID-19	has-part	strain
COVID-19	has-property	R0
COVID-19	has-property	contagious
COVID-19	has-property	disease course
COVID-19	has-property	disparity
COVID-19	has-property	duration
COVID-19	has-property	fatality
COVID-19	has-property	incubation period
COVID-19	has-property	infection
COVID-19	has-property	infectivity
COVID-19	has-property	interpersonal transmission capabilities
COVID-19	has-property	mild
COVID-19	has-property	more contagious
COVID-19	has-property	mortality
COVID-19	has-property	patients
COVID-19	has-property	period
COVID-19	has-property	pneumonia
COVID-19	has-property	r
COVID-19	has-property	rare
COVID-19	has-property	rate
COVID-19	has-property	regional disparity
COVID-19	has-property	severe
COVID-19	has-property	severity
COVID-19	has-property	subtype
COVID-19	has-property	transmissibility
COVID-19	in-context	Chongqing
COVID-19	in-context	[0.30, 0.32]
COVID-19	in-context	cases
COVID-19	in-context	failure
COVID-19	in-context	samples
COVID-19	in-place	China
COVID-19	in-place	Chongqing
COVID-19	in-place	UK
COVID-19	in-place	cases
COVID-19	is-a	beta-coronavirus
COVID-19	is-a	concern
COVID-19	is-a	coronavirus
COVID-19	is-a	coronavirus disease
COVID-19	is-a	coronaviruses
COVID-19	is-a	diseas
COVID-19	is-a	disease
COVID-19	is-a	epidemic
COVID-19	is-a	group
COVID-19	is-a	health threat
COVID-19	is-a	infections
COVID-19	is-a	novel coronavirus disease
COVID-19	is-a	pneumonia
COVID-19	is-a	virus
COVID-19 cases	has-property	confirmed
COVID-19 cases	has-property	newly
COVID-19 clusters	has-property	large
COVID-19 clusters	is-a	events
COVID-19 population	has-property	ICU admission
COVID-19 population	has-property	discharge
COVID-19 population	has-property	fatality
COVID-19 population	has-property	shorter incubation time
CP	is-a	pathogen
CT	has-property	pulmonary
CT	in-context	chest
CT	in-context	diagnosis
CT	in-context	method
CT	is-a	key point
CT	is-a	method
CT imaging	has-property	opacity
CT imaging	has-property	shadows
CT imaging	in-place	chest
CT imaging	is-a	Diagnosis criteria
CT scan	has-part	characteristics
CT scan	has-property	COVID-positive
CT scan	in-context	COVID-19
CT volume	in-context	input chest
CT-Mask	has-property	preprocessed
CT-Mask volume	has-property	preprocessed
CT-Mask volume	in-context	patient
CTLV1	is-a	variants
CTLV2	is-a	variants
CTLV3	is-a	variants
CTLV4	is-a	variants
CTT	in-context	WT
CVB3 3C pro	is-a	complex
CVL218	causes	antiviral activities
CVL218	has-property	higher distributions
CVL218	in-context	DMSO control group
CVL218	in-context	lung
CVL218	in-context	tissues
CVL218	is-a	antiviral treatment
CVL218	is-a	inhibitor
Ca 2+	has-property	stoichiometry
Ca 2+	in-context	MERS-CoV
Ca 2+ pools	has-property	extracellular
Ca 2+ pools	has-property	intracellular
Carriage	has-property	dynamic process
Carriage	is-a	process
Cas13d expression	causes	inhibitory activity
Cas13d-based	has-part	genetic
Ce:GAGG	has-property	rod-shaped
Ce:GAGG	is-a	crystals
Ce:GAGG crystals	has-property	rod-shaped
Chemokine signaling	is-a	pathways
Chemokine signaling	is-a	signaling pathways
Children	has-property	chronic kidney disease (CKD)
Children	in-context	chronic kidney disease
Children	is-a	high-risk group
Children	is-a	risk group
China	has-part	Chongqing municipality
China	has-part	Wuhan
Clinical studies	in-context	cases
CoV	has-property	COVID-19-related
CoV	has-property	RBD
CoV	has-property	SARS-related
CoV	in-context	COVID-19
CoV	in-context	SARS
CoVZC45	is-a	strains
CoVZXC21	is-a	strains
CoViD-19	has-property	severe
CoVs	has-property	lineage B
CoVs	has-property	lineage C
Comorbidities	has-property	associated
Comorbidities	in-context	infection
Comparing	subject	2019-nCoV
Comparing	target	MERS
Comparing	target	SARS-CoV
Concern	has-property	International
Concern	in-context	International
Concern	subject	Emergency
Concern	target	International
Considering	subject	complexity
Considering	subject	potentia
Considering	target	suggest
Construction	target	PPI
Coronavirus	causes	COVID-19
Coronavirus	causes	SARS
Coronavirus	in-context	COVID-19
Coronavirus	in-context	SARS
DBP	is-a	actin scavenger
DBP	is-a	protein
DHODHi	has-property	role
DHODHi	in-context	patients
DNA	has-property	viral
DNA	in-context	viral
DNA repair machinery	in-place	DNA damage
DNA sequencing	causes	respiratory infections
DNA sequencing	in-context	another case
DNA viruses	has-part	genomes
DNA viruses	has-property	pulmonary pathogenicity
DNA viruses	in-context	RNA intermediates
DNA viruses	in-context	five
DNA viruses	same-as	same
DPP4	same-as	receptor dipeptidyl peptidase 4
DUB	has-property	negative
DUB	in-context	containing
DUB	is-a	viruses
DUSP1	causes	increase
DUSP1	in-context	dephosphorylation
DeCoV-Net	has-property	trained
December	has-property	early
Diagnosis	has-property	challenging
Diagnosis	in-context	HCT
Diagnosis	in-context	LRTI
Diagnosis	in-context	recipients
Diagnosis	target	LRTI
Domestication	target	sporulation
E	is-a	proteins
E (envelope)	is-a	proteins
E1163	in-place	HR2
EAT density	has-property	low
EAT density	in-context	CT scan
EAT density	is-a	factors
ED	same-as	emergency department
EDS1	is-a	components
EVC	is-a	paralogs
EVC2	is-a	paralogs
EVC3.1	in-context	choanoflagellate
EVC3.1	in-context	sea anenome
EVC3.1	in-context	sea urchin ciliomes
EVC3.1	is-a	paralogs
EVC3.1	same-as	EVC3.2 323
EVC3.1	same-as	paralogs
EVC3.2	in-context	choanoflagellate
EVC3.2	in-context	sea anenome
EVC3.2	in-context	sea urchin ciliomes
EVC3.2	is-a	paralogs
EWS	in-context	COVID-19
Early	in-context	prolonged
Ebola	is-a	epidemic
Ebola	is-a	virus
Emergency	has-property	Public
Emergency	in-context	Concern
Emergency	in-context	Health
Escherichia coli	is-a	bacterial strains
Escherichia coli	is-a	strains
FCS	in-context	coronavirus evolution
FP	in-context	SARS-CoV
FP1	in-context	FP
FP1	in-context	n= 0.92
FP1_2	in-context	FP
FP1_2	in-context	n=1.7
FP2	in-context	FP
FP2	in-context	n= 1.02
Fever	has-property	less
Fudan-CCDC	entails	r
Fudan-CCDC	is-a	model
GFP-MAD2 L13A	has-part	mCherry-Mis12-MAD1 AA
GFP-MAD2 L13A	in-place	kinetochores
GFP-MAD2 L13A	in-place	metaphase kinetochores
GLU 286	is-a	residues
GLY 197	is-a	residues
GROMACS	has-property	version 4.5.7
GROMACS	in-context	4.5.7
GROMACS	in-context	AMBER
GVHD	same-as	graft versus host disease
GZ02	is-a	SARS viral strain
GZ02	same-as	SARS viral strain
Guangdong pangolin	is-a	coronaviruses
Guarani DNA	has-property	mutant
H5N1	is-a	influenza
H5N1	is-a	influenza virus infections
H7N1	is-a	influenza
H7N1	is-a	influenza virus infections
HA-NA	has-property	distributions
HA-NA distributions	has-property	polarized
HA-NA distributions	in-place	viruses
HCOV-229E	in-context	viruses
HCOV-229E	is-a	viruses
HCT	causes	noninfectious inflammatory conditions
HCT	in-context	recipients
HCW	in-context	78%
HCWs	has-property	Chinese
HCoV-HKU1	in-place	them
HCoV-OC43	in-place	them
HCoV-OC43	subject	induces
HEK293	in-place	human
HEK293	is-a	cell lines
HEK293	is-a	cells
HEK293	is-a	lines
HHV-6	causes	pneumonitis
HHV-6	is-a	genomes
HIV-1	has-part	protease
HKU9-1	has-property	ancestor
HKU9-1	in-context	SARS
HKU9-1	in-context	SARS-CoV-2
HRV-A	in-context	viruses
HRV-A	is-a	viruses
HSP90AA1	same-as	heat shock protein 90 alpha family class A member 1
Health	has-property	Public
Hospital-related transmission	in-time	early stages
Hospital-related transmission	is-a	causes for infection
Hubei	is-a	Province
Hubei Province	is-a	areas
Human SARS	has-part	M proteins
Human SARS	has-part	segment
Human SARS	has-property	PPID
Human SARS	has-property	PPID score
Human SARS	has-property	sequence similarity
I	is-a	serotype
IAPP	same-as	NNFGAIL
IAV	in-place	lung
IC values	in-context	processing
ICU	is-a	patients
ICU care	in-time	eventually
ICU care	subject	patients
ICU patients	has-property	respiratory failure
ICU patients	in-context	requiring
ID	has-property	6LU7
IDRs	has-property	polyampholytic
IDRs	in-context	proteome
IFN-I	causes	responding
IFN-β	in-context	mRNAs
II CCoV	in-context	sequences
IL-10	has-property	responsible
IL-10	is-a	cytokines
IL-10	is-a	serum
IL-33	causes	hypersensitivity
IL-33	has-property	levels
IL-33	in-context	elevated
IL-33	in-place	asthmatic
IL-33	in-place	smokers
IL-6	is-a	cytokines
ISG	has-property	transcriptomic signature
ISG	in-context	mRNAs
ISG	same-as	gene
Influenza A	causes	failure
Influenza A	same-as	H1N1
Influenza A (H1N1)	causes	respiratory failure
Initiation	causes	genome
Initiation	subject	replication
Irbesartan	has-part	targets
Isolation	target	cases
January	in-context	late
K(τ) = K(τ)/θ	same-as	proportion
K(τ) = g(τ)	same-as	equivalent
K929	in-place	HR1
KNTC1-null RPE	is-a	cells
Kd	has-part	folds
Kd	is-a	lesser
Kd	subject	estimated
L-A	is-a	proteins
LPS	causes	release
LYS 200	is-a	residues
Longer	entails	have to spent
Longer	target	times
Lower respiratory tract infections	causes	mortality
Lower respiratory tract infections	in-context	hematopoietic cellular transplant
Lower tract infections respiratory	same-as	LRTI
Lymphopenia	is-a	indicator
M	is-a	proteins
M (membrane),	is-a	proteins
M pro	has-part	site
M proteins	has-property	intrinsic disorder
M proteins	in-context	estimated mean PPID
M proteins	in-place	Bat CoV
M proteins	in-place	Human SARS
M proteins	in-place	SARS-COV-2
MAD1	causes	GFP-MAD2 L13A
MAD1	in-place	kinetochores
MCM	has-property	amounts
MCM	has-property	loaded
MD	in-context	simulation trajectory
MERS	in-context	samples
MERS-CoV	has-property	FP
MERS-CoV	is-a	Betacoronavirus genus
MERS-CoV	is-a	coronaviruses
MERS-CoV	is-a	respiratory pathogen
MERS-CoV RBD	has-property	key residues
MERS-Cov	is-a	viruses
MHV	in-context	samples
MP	is-a	pathogen
MRC5	is-a	cells
MSEIR	is-a	model
MSIR	is-a	model
MTase	has-part	region
MTase	has-property	non-functional
MTase region	has-property	non-functional
Measurements	in-context	ACE2
Measurements	in-context	proteins
Measurements	in-context	recombinant ACE2
Measurements	is-a	proteins
Metagenomic next generation sequencing	same-as	mNGS
Metagenomic next-generation sequencing	has-property	diagnostic
Middle East respiratory syndrome	same-as	(MERS)-CoV
Middle East respiratory syndrome	same-as	CoV MERS
Middle Eastern respiratory syndrome	same-as	MERS
Mn 2+	is-a	residues
Murine hepatitis virus	is-a	Betacoronavirus genus
N	is-a	proteins
N (nucleocapsid)	is-a	proteins
N-terminal (1-10 residues)	in-context	predicted disordered segment
N-terminal regions	in-context	S proteins
N8R	in-context	factors
N8R	is-a	factors
NB	same-as	negative binomial
NCP type	has-property	common
NL63	has-property	receptor
NLR	in-context	factors
NLR	in-place	patients
NLR	is-a	factors
NNK	is-a	primers
NNK	same-as	primers
NP-exo	has-part	infectious particle
NP-exo	has-part	particle
NP-exo	in-context	23000
NP-exo	is-a	viruses
NP-exo WT	has-part	infectious particle
NP-exo WT	has-part	particle
NP-exo WT	in-context	3600
NP-exo WT	is-a	viruses
NS2B-NS3pro	in-context	homology
NS2B-NS3pro	is-a	complex
NS2B-NS3pro complex	is-a	homology
NSP7	has-part	bundle
NSP7-NSP8	is-a	structure
NSP8	has-part	head
NTP	is-a	ion
Native Nanopore data	entails	rRNA
Nidovirales	has-part	coronaviruses
Non-ICU	is-a	patients
Nsp8	has-property	long disorder segment
Nsp8	is-a	proteins
O	is-a	blood groups
O	is-a	groups
ODE	has-property	mean-field
ODE	has-property	two-dimensional
ODE	same-as	field
OR	in-context	1.279
OR	same-as	1.279
ORF3b	has-property	Bat-CoV
ORF3b	has-property	Human SARS
ORF3b	has-property	SARS-CoV-2
ORF3b	in-context	Bat-CoV,
ORF3b	in-context	SARS-CoV-2
ORF3b	in-context	not closer
ORF3b	is-a	protein
ORF6	in-place	COVID-19
ORF6	in-place	HCov-HKU1
ORF6	is-a	genes
ORF8	in-place	COVID-19
ORF8	is-a	HCov-HKU1
ORF8	is-a	genes
ORF9b	has-part	N-terminal (1-10 residues)
ORF9b	has-property	N-terminal (1-10 residues) predicted disordered segment
ORF9b	has-property	mean PPID of 10.31%
ORF9b	in-context	PPID of 10.31%
ORF9b	in-context	SARS-CoV-2
ORF9b	is-a	protein
One	in-context	patient
One	in-context	these
Other	in-context	infections
P-type transistor	in-context	NOT gate
PAC-MAN)	is-a	huMAN cells
PAD4	is-a	components
PARP1	has-property	potential
PARP1	is-a	inhibitor
PARP2	in-context	response
PC-12	in-place	rat
PC-12	is-a	cell lines
PC-12	is-a	lines
PCR	in-context	Taq
PCT	is-a	marker
PD-1	has-property	percentage
PD-1	is-a	cell
PD-1	is-a	exhaustion markers
PD-1 + CD8 + T cells	in-context	ICU patients
PDB	has-property	ID
PEDV	causes	mortality
PEDV	is-a	infection
PID	has-property	range
PID range	in-context	occurs
PK	has-property	wellconserved
PK region	has-property	wellconserved
PL	has-property	pro
PL	in-context	suppression
PPI	has-property	most significant
PPI	same-as	Protein-protein interaction
PPI	same-as	interaction
PPID	has-property	mean
PPID score	has-property	mean
PPID score	same-as	1.12%
PPID score	same-as	1.41%
PPID score	same-as	1.85%
PS1dE9	same-as	presenilin-1
PWK/PhJ	has-property	founder
PWK/PhJ	is-a	founder
Patients	has-property	8.65%
People	has-property	blood group A
People	has-property	symptoms
People	in-context	blood group A
People	in-context	diagnosed
People	in-context	non-A blood groups
People	in-context	symptoms
People	is-a	subclinical cases
Phe	is-a	residues
Preventing	is-a	breakthroughs
Preventing	target	recognition
Prior	has-property	analyses
Prophylactic Antiviral CRISPR	has-property	genetic intervention
Prophylactic Antiviral CRISPR	in-context	huMAN cells
Prophylactic Antiviral CRISPR in huMAN cells (PAC-MAN)	is-a	strategy
R	has-property	2.1 to 4.2
R	in-context	COVID-19
R	in-context	HCoV-NL63 M pro
R	in-context	SARS-CoV
R	in-place	Hubei
R	is-a	configuration
R	same-as	number
R configuration	in-context	HCoV-NL63 M pro
R configuration	in-context	SARS-CoV
R genemediated disease resistance	has-part	components
R0	has-property	3.25 ≤ R 0 ≤ 3.4
R0	has-property	above
R0	has-property	comparable
R0	has-property	estimated
R0	in-context	3.25 ≤ R 0 ≤ 3.4
R0	in-context	COVID-19
R0	is-a	reproductive number
R0	same-as	reproductive number
R0 = 1 + r * Tc	in-context	Tc = 7.5
RAS	has-property	significant
RAS	is-a	pathways
RBD	has-part	amino acid
RBD	has-property	form
RBD	in-context	COVID-19-related CoV
RBD	in-context	SARS-related CoV
RBD	is-a	coronaviruses
RBD	is-a	domain
RBD	is-a	protein
RBD	same-as	receptor-binding domain
RBD region	has-property	dN/dS ratio
RBM	is-a	motif
RNA	causes	path
RNA	has-part	NP
RNA	has-part	PK region
RNA	has-part	human telomerase
RNA	has-property	30kb
RNA	has-property	human
RNA	has-property	microbial
RNA	has-property	positive-sense
RNA	has-property	positive-strand
RNA	has-property	satellite
RNA	has-property	singlestranded
RNA	in-context	SARS-CoV-2
RNA	in-context	human
RNA	in-context	microbial
RNA	in-context	positive-strand
RNA	in-context	virus
RNA	in-place	active site
RNA	in-place	virus
RNA extraction operations	in-context	alternative
RNA extraction operations	in-context	time-consuming
RNA markers	has-property	various
RNA molecules	has-property	2 μg
RNA viruses	in-context	10
RPE cells	has-property	KNTC1-nul
RSCs 27	entails	differences
RSCs 27	is-a	stem cells
RSV	is-a	pathogen
RT-LAMP	has-property	large value
RT-LAMP	has-property	positive
RT-LAMP	is-a	assays
RT-LAMP	is-a	reactions
RT-LAMP reactions	entails	specificity
RT-LAMP reactions	has-property	positive
RT-PCR	has-property	positive
RT-PCR	in-context	nasal
RT-PCR	in-context	patients
RT-PCR	in-context	pharyngeal
RT-PCR	in-place	swabs
RT-PCR	same-as	real-time reverse-transcriptase polymerase-chain-reaction
RT-PCR-based	is-a	methods
RXR activation	is-a	pathways
RaTG13	has-property	ancestor
RaTG13	has-property	evolution
RaTG13	in-context	SARS
Renmin	is-a	Hospital
Rgl pA	has-property	redundant
Rgl pA	is-a	signals
S	in-context	CVB3 3C pro
S	in-context	SARS-CoV
S	is-a	configuration
S	is-a	protein
S	is-a	proteins
S 103 protein	has-property	recombinant
S configuration	in-context	CVB3 3C pro complex
S protein	in-place	SARS-CoV
S proteins	has-part	folding pattern
S-29	is-a	protein
S-RBD	in-context	ACE2
S-protein	in-context	2019-30
S1	has-property	organization
S1	is-a	domains
S1	is-a	interfaces
S1-S2	is-a	interfaces
S2	has-property	organization
S2	is-a	domains
S2	is-a	interfaces
S416	has-property	best efficient
S416	is-a	chemical
SAC failure	has-property	severe
SAC failure	subject	RPE cells
SARS	has-part	proteome
SARS	has-property	ancestor
SARS	has-property	other
SARS	is-a	coronaviruses
SARS	same-as	severe acute respiratory syndrome
SARS-2002	has-part	residues
SARS-2002	has-property	loops
SARS-COV-2	has-part	M proteins
SARS-COV-2 infection	causes	liver injury
SARS-CoV	has-part	FP
SARS-CoV	has-part	M pro
SARS-CoV	has-part	NSP7
SARS-CoV	has-part	NSP8
SARS-CoV	has-part	S
SARS-CoV	has-part	S protein
SARS-CoV	has-part	S-RBD
SARS-CoV	has-part	antibodies
SARS-CoV	has-part	domain
SARS-CoV	has-part	genome
SARS-CoV	has-part	life cycle
SARS-CoV	has-part	particles
SARS-CoV	has-part	protease
SARS-CoV	has-part	proteins
SARS-CoV	has-part	titer
SARS-CoV	has-property	3a protein
SARS-CoV	has-property	FP
SARS-CoV	has-property	FP1
SARS-CoV	has-property	FP1_2
SARS-CoV	has-property	FP2
SARS-CoV	has-property	S-RBD structure
SARS-CoV	has-property	antigen staining
SARS-CoV	has-property	main protease
SARS-CoV	has-property	sequence
SARS-CoV	has-property	spike protein
SARS-CoV	has-property	transmissibility
SARS-CoV	in-context	NSP12
SARS-CoV	in-context	human
SARS-CoV	in-place	2003
SARS-CoV	is-a	Betacoronavirus genus
SARS-CoV	is-a	Sarbecovirus
SARS-CoV	is-a	coronavirus
SARS-CoV	is-a	coronaviruses
SARS-CoV	is-a	respiratory pathogen
SARS-CoV	is-a	virus
SARS-CoV NSP12	has-part	elongation complexes
SARS-CoV NSP12	has-part	norovirus 24
SARS-CoV RBD	has-part	R426
SARS-CoV S	has-part	folding pattern
SARS-CoV S	is-a	protein
SARS-CoV S-RBD	has-property	binding strength
SARS-CoV S-RBD	in-context	ACE2
SARS-CoV S-RBD structure	causes	use
SARS-CoV S-RBD structure	in-context	template
SARS-CoV-1	in-time	2003
SARS-CoV-2	causes	COIVD-19
SARS-CoV-2	causes	COVID-19
SARS-CoV-2	causes	death
SARS-CoV-2	causes	deaths
SARS-CoV-2	causes	exponential rise
SARS-CoV-2	causes	immunity against
SARS-CoV-2	causes	infection
SARS-CoV-2	causes	outbreak
SARS-CoV-2	causes	respiratory
SARS-CoV-2	causes	severe respiratory disease
SARS-CoV-2	entails	risk
SARS-CoV-2	has-part	HKU-1
SARS-CoV-2	has-part	OC43
SARS-CoV-2	has-part	ORF9b
SARS-CoV-2	has-part	RBD
SARS-CoV-2	has-part	RNA
SARS-CoV-2	has-part	RNA sequences
SARS-CoV-2	has-part	energy
SARS-CoV-2	has-part	fragments
SARS-CoV-2	has-part	genome
SARS-CoV-2	has-part	infection
SARS-CoV-2	has-part	nucleic acid
SARS-CoV-2	has-part	proteins
SARS-CoV-2	has-part	segment
SARS-CoV-2	has-part	sequence
SARS-CoV-2	has-part	unique capacities
SARS-CoV-2	has-property	148
SARS-CoV-2	has-property	149
SARS-CoV-2	has-property	70% cross immunity
SARS-CoV-2	has-property	PPID
SARS-CoV-2	has-property	PPID score
SARS-CoV-2	has-property	airborne
SARS-CoV-2	has-property	amplitude of seasonal variation
SARS-CoV-2	has-property	ancestor
SARS-CoV-2	has-property	canonical TRS-mediated 144 mechanism
SARS-CoV-2	has-property	evolution
SARS-CoV-2	has-property	genome
SARS-CoV-2	has-property	global spread
SARS-CoV-2	has-property	infection
SARS-CoV-2	has-property	infectious
SARS-CoV-2	has-property	isolate
SARS-CoV-2	has-property	load
SARS-CoV-2	has-property	new
SARS-CoV-2	has-property	pathogenesis
SARS-CoV-2	has-property	prognosis
SARS-CoV-2	has-property	seasonal variation
SARS-CoV-2	has-property	seasonal variation in R0
SARS-CoV-2	has-property	spreading
SARS-CoV-2	has-property	transmissibility
SARS-CoV-2	has-property	transmission
SARS-CoV-2	has-property	transmission route
SARS-CoV-2	in-context	HKU-1
SARS-CoV-2	in-context	OC43
SARS-CoV-2	in-context	R0
SARS-CoV-2	in-context	after
SARS-CoV-2	in-context	generalized circulation
SARS-CoV-2	in-context	infection
SARS-CoV-2	in-context	invade host cells
SARS-CoV-2	in-place	COVID-19 patients
SARS-CoV-2	in-place	Wuhan
SARS-CoV-2	in-place	asymptomatic carriers
SARS-CoV-2	in-time	December 2019
SARS-CoV-2	in-time	stage
SARS-CoV-2	is-a	betacoronaviruses
SARS-CoV-2	is-a	coronavirus
SARS-CoV-2	is-a	coronaviruses
SARS-CoV-2	is-a	infection
SARS-CoV-2	is-a	pathogen
SARS-CoV-2	is-a	pneumonia
SARS-CoV-2	is-a	sequenced coronaviruses
SARS-CoV-2	is-a	viral pathogen
SARS-CoV-2	is-a	virus
SARS-CoV-2	is-a	viruses
SARS-CoV-2	same-as	pathogen
SARS-CoV-2	same-as	syndrome
SARS-CoV-2	subject	have
SARS-CoV-2	subject	interaction
SARS-CoV-2	subject	invasion
SARS-CoV-2	subject	isolate
SARS-CoV-2	subject	originated from
SARS-CoV-2	subject	usage
SARS-CoV-2 234 RBD	has-part	binding energy
SARS-CoV-2 234 RBD	has-part	interface sequence
SARS-CoV-2 3CL pro	has-property	PDB
SARS-CoV-2 3CL pro	has-property	structure
SARS-CoV-2 3CL pro	is-a	coronavirus
SARS-CoV-2 R0	has-part	seasonal variation
SARS-CoV-2 RNA	in-context	clinical recovery
SARS-CoV-2 S	is-a	protein
SARS-CoV-2 WIV04	has-property	RBD region
SARS-CoV-2 infection	causes	COVID-19 outbreak
SARS-CoV-2 infection	causes	breathing difficulty
SARS-CoV-2 infection	causes	dry cough
SARS-CoV-2 infection	causes	fever
SARS-CoV-2 infection	causes	weakness
SARS-CoV-2 infection	in-place	lung
SARS-CoV-2 invasion	in-place	host cells
SARS-CoV-2 viruses	causes	exhaustion
SARS-Cov	causes	human disease
SARS-Cov	has-property	receptor
SARS-Cov	is-a	virus
SARS-Cov	is-a	viruses
SARSr-CoV	in-context	bat
SARSr-CoV	subject	usage
SEIR-PO	has-property	suitable
SEIR-PO	is-a	models
SEIR-QD	has-property	suitable
SEIR-QD	is-a	models
SMM	is-a	algorithm
SNP	has-property	carriers
SP	causes	infection
STLC	causes	attachments
SY5Y	in-place	human
SY5Y	is-a	cell lines
SY5Y	is-a	lines
Sarbecovirus	is-a	subgenus
Sequence	in-context	subunits
Sequence analysis	causes	revealed
Sequence analysis	in-place	Nidovirales
Sequence analysis	target	polymerase subunits
Similar	in-context	outbreak
Staphylococcus	has-property	aureus
Staphylococcus	is-a	strains
Staphylococcus aureus strains	is-a	bacterial strains
Stenotrophomonas maltophilia	in-context	culture-positive
Streptococcus	has-property	pyogenes
Streptococcus	is-a	strains
Streptococcus mitis	causes	bacteremia
Streptococcus mitis	causes	respiratory distress
Streptococcus mitis	has-property	pulmonary pathogen
Streptococcus mitis	is-a	oropharyngeal microbe
Streptococcus mitis	is-a	pulmonary pathogen
Streptococcus pyogenes	is-a	bacterial strains
Superposition	in-place	SARS-CoV
Superposition	target	complexes
T	has-property	percentage
T	is-a	cell
T	is-a	cells
T cell exhaustion	has-property	particularly
T cell exhaustion	subject	SARS-CoV-2
T cell exhaustion	target	patients
T cells	has-property	decreased
T cells	has-property	exhausted
T cells	has-property	total
T cells	in-context	patients
T lymphocyte	has-property	counts
T3	is-a	phage
TCR	is-a	antibodies
TNF-α	is-a	cytokines
TRIM25 KO	is-a	cells
TSPO	same-as	18kD translocator protein
Taq	is-a	polymerase
The World Health Organization	same-as	WHO
These	entails	shifts
These	entails	therapy
These	in-context	cases
These	in-place	subunit structures
These	is-a	changes
These	is-a	results
This	causes	R0 above 2
This	has-property	critical
This	in-place	social network
This	is-a	depletion
This	is-a	goal
This	is-a	technology
This technology	causes	detection
Those	is-a	existing drugs
Tim-3	is-a	exhaustion markers
Trp	is-a	residues
Tyr	is-a	residues
U1	has-part	snRNA
V1691R	is-a	substitution
Vero E6	is-a	cells
Vibrio cholerae	is-a	bacterial strains
Vibrio cholerae	is-a	strains
Virus sequence	in-context	samples
Virus sequence	in-place	blood samples
Virus sequence	in-place	respiratory
Vitamin D	is-a	pathways
WHO	same-as	World Health Organization
WT CTT	has-property	width
Wuhan	in-place	China
Wuhan	is-a	City
Wuhan University	has-part	Renmin
Wuhan University	in-place	Wuhan
Wuhan city	is-a	areas
Wuhan-Hu-1	is-a	earliest sequenced SARS-CoV-2
Wuhan-Hu-1	is-a	the earliest sequenced SARS-CoV-2
ZIKV NS3	has-part	crystal structure
ZIKV NS3	has-part	helicase
ZIKV NS3	in-context	ATP
ZIKV NS3	is-a	helicase
ZIKV group	has-property	higher
Zika NS2B-NS3pro	has-property	pocket
Zika NS2B-NS3pro	has-property	susceptible
ability	in-context	bind
ability	in-context	escape 300
ability	in-context	escape from
ability	in-context	neutralize
ablated	causes	SAC failure
ablated	entails	exhibited
ablated	subject	kinetochore
ablated	subject	nocodazole
ablated	target	kinetochore attachments
abnormality	has-property	obvious
abnormality	in-context	renal function
about transmission approaches	in-context	SARS-CoV-2
above	in-context	2
absence	in-context	DUSP1
absence	in-time	infection
absence	target	DUSP1
absence	target	any
absent	subject	ORF6
absent	subject	ORF8
absent	target	HCov-HKU1
accelerated	subject	RSV
accelerated	target	kinetics
acceptor	in-place	site
accessory features	entails	unique capacities
accessory features	is-a	unique capacities
account	has-property	low
account	in-context	<190/µL
account	in-context	CD8 + T
account	in-context	those
accumulating	target	evidence
accumulation	has-property	higher
accumulation	has-property	hippocampal
accumulation	has-property	in vivo cortical
accumulation	in-context	18kD translocator protein
accumulation	in-context	cases
accumulation	in-context	cortical
accumulation	in-context	hippocampal
accumulation	in-context	in vivo
accumulation	in-context	mice
accumulation	in-time	after
accumulation	in-time	long after
accumulation	subject	cases
accumulation	subject	mice
accumulation	target	18kD translocator protein
acid	has-property	fatty
acid	has-property	nucleic
acidic residues glutamic acid	same-as	E
acquired	target	immunity
acquiring	target	COVID-19
act as	has-property	same way
act as	in-context	SARS
act as	subject	proteins
act as	target	proteins
act same way	subject	proteins
act same way	target	proteins
acting	in-context	positive control
acting	subject	interacts
acting	target	binding assay
acting as	is-a	interacts
acting as	subject	DBP
acting as	target	actin scavenger
acting as	target	control
action	has-property	inflammatory
action	in-place	spike gene
action	in-time	evolution
action	subject	selection
actions	has-property	control
actions	in-context	disease
activating	causes	autophagy
activating	subject	It
activating	target	omegasome pathway
activation	in-context	infection
activation	is-a	signaling pathways
activation	subject	PAD4
activation	subject	genes EDS1
activation	subject	glial cells
activation	target	EDS1
activation	target	PAD4
activation	target	RAS
activation	target	RXR
activation	target	Vitamin D
activation	target	bystander
activation	target	glial cells
activation	target	pathway
activation	target	signaling pathway
activity	causes	leading
activity	has-property	antiviral
activity	has-property	inhibitory
activity	has-property	potent
activity	in-context	2019-nCoV
activity	in-context	against
activity	subject	regimens
activity	target	microbe
acute cardiac injury	is-a	complications
acute respiratory distress syndrome	same-as	ARDS
acuteness	in-context	disease
adaptability	has-property	205
adaptability	target	RNA markers
addition	entails	successful
addition	in-context	control
addition	in-context	time-lapse
addition	target	agents
addition	target	isolation
addition	target	tracing
addition	target	transfection agents
address	subject	has been described
address	target	differences
adenosine	has-property	5'
adjust	has-property	based
adjust	in-context	based
adjust	in-context	paying attention
adjust	subject	4.32%
adjust	target	dosage
adjust	target	medication dosage
administration	has-property	glucocorticoid
administration	has-property	immunoglobulin
administration	is-a	intravenous
admission	in-context	hospital
admission	in-place	ICU
admitted	in-time	before
admitted	in-time	later
admitted	subject	patients
admitted	target	patients
adults	has-property	older
advent	target	multicellularity
adverse outcomes	has-property	consequent
aerosol	has-property	virus-laden
aerosol	in-time	sampling period
affect	in-context	more likely
affect	subject	People
affect	subject	SARS-CoV-2
affect	subject	delay
affect	target	older men
affect	target	patterns
affect	target	process
affect	target	transmission patterns
affected	subject	look-back windows
affected	subject	mothers
affected	target	COVID-19
affected	target	data
affected	target	sites
affected population	in-place	reported
affects	subject	COVID-19
affects	target	elderly
affects	target	patients
affects	target	youth
affinity	has-property	much higher
affinity	in-context	binds
affinity	in-context	than
after	has-part	recovery
after	in-context	11 days
after	in-context	4X
after	in-context	6X
after	in-context	9X
after	in-context	downturns
after	in-context	illness
after	in-context	passages
after	in-time	2-week
against	has-part	SARS-CoV-2
age	has-property	concentrated
age	has-property	increased
age	has-property	median
age	in-context	116
age	in-context	30-50 years old (60.61%)
age	in-context	patients
age	same-as	54
agents	has-property	empiric
agents	has-property	immunosuppressive
agents	has-property	transfection
agents	in-context	infection
agents	in-place	stage
aggregation	has-property	amyloid
aggregation	subject	model amyloidogenic peptide derived from IAPP
aggregation	target	amyloid
agreeing	subject	interacts
agreeing	target	published crystal structure
agreeing with	is-a	interacts
air droplets	has-property	respiratory
air droplets	is-a	transmission route
airway	has-property	deep
algorithm	in-context	binding
alignment	has-part	comparative
all models	entails	increases
all-atom	in-context	AMBER
allied health workers	in-context	20%
allow	has-property	necessary
allow	in-place	locations
allow	subject	resources
allow	target	interventions
allow	target	investment
allow	target	occur
allowing	entails	have even incorporated
allowing	target	detection
along	subject	contraction
along	target	branch
along	target	families
alveolar damage	in-context	COVID-19
amino acid	has-property	evolutionary
amino acid	has-property	similar
amino acid	in-context	58
amino acid sequence	has-property	varied
amino acid sequence	in-context	SARS-CoV-2
amino acid similarity	in-context	2019-nCoV
amino acid similarity	in-context	RBD
amount	in-context	Guarani DNA
amounts	has-property	low
amounts	in-context	MCM
amphiphysin	has-property	Full-length
amplitude	subject	is half
amplitude of seasonal variation	has-property	half
amplitude of seasonal variation	in-context	R0
amplitude of the seasonal variation	in-context	R0
amyloid precursor protein	is-a	protein
analyses	subject	SARS-CoV
analyses	target	revealed
analysis	entails	association
analysis	entails	elevated
analysis	entails	enriched
analysis	entails	similar codon usage
analysis	has-part	alignment
analysis	has-property	Genetic
analysis	has-property	comparative
analysis	has-property	comprehensive
analysis	has-property	recent
analysis	in-context	GZ02
analysis	in-context	HKU9-1
analysis	in-context	IDRs
analysis	in-context	RaTG13
analysis	in-context	SARS-CoV-2
analysis	in-context	Wuhan-Hu-1
analysis	in-context	network proximity
analysis	in-context	other coronaviruses
analysis	in-context	regression
analysis	in-place	order
analysis	target	COVID-19
analysis	target	Sequence
analysis	target	membrane protein
analysis 197	in-context	membrane protein
analysis 197	in-context	pangolin P1E virus
ancestor	has-property	potential
ancestral branch	in-context	CoV
and Bat CoV	is-a	PPID
angiotensin converting enzyme	same-as	ACE2
angiotensin converting enzyme 2 (ACE2)	is-a	cell entry receptor
angiotensin-converting enzyme 2	same-as	ACE2
angular gyrus	is-a	regions
announcement	entails	facilitate
announcement	has-property	transparent
announcement	target	information
antibodies	has-property	RBD-targeted
antibodies	has-property	SARS-CoV-2
antibodies	has-property	monoclonal
antibodies	has-property	non-neutralizing
antibodies	has-property	protective
antibodies	has-property	sensitive
antibodies	has-property	specific
antibodies	in-context	SARS-CoV
antibodies	in-context	SARS-CoV-2
antibody titer	in-context	patients
antibody titer	in-time	first time
antigen distribution	has-property	differences
antigen distribution	in-context	Muc4
antigen distribution	in-context	WT
antigen distribution	in-place	airway
antigen distribution	in-place	parenchymal staining
antigen staining	entails	differences
antiviral	has-part	structure
antiviral activities	has-property	potent
antiviral activities	in-context	Vero E6
antiviral activities	in-time	procedure
antiviral activity	has-property	potent
antiviral activity	in-context	2019-nCoV
antiviral effects	in-context	SARS-CoV-2
antiviral efficacy	has-property	potent
antiviral treatment	has-property	better potential
antiviral treatment	in-context	SARS-CoV-2 infection
anxiety	is-a	mental health problems
any	in-context	interventions
appear	in-place	kinetochores
appear	subject	GFP-MAD2 L13A
appearance	in-context	potential evolution
appearance	subject	subtype
appearance	target	subtype
application	has-property	hampered
application	in-context	control
application	in-context	diagnosis
application	subject	methods
applied	has-property	directly
applied	in-context	COVID-19
applied	in-context	directly
applied	in-context	short time
applied	in-time	short time
applied	subject	Those
applied	subject	drugs
applied	target	treat
apply	has-property	best
apply	in-context	identify
apply	is-a	therapeutic shortcut
apply	target	drug repositioning strategy
approach	in-time	recent
approved	has-property	originally
approved	subject	Gemcitabine
approved	subject	drugs
approved	target	clinical trials
approved	target	clinical use
approved	target	treating
are	in-context	SARS-CoV-2
are	in-context	writing
are	subject	critical key residues
are	subject	genomic data
are	subject	numbers
are	subject	signals
are	target	different
are	target	genes
are	target	genomes
are	target	redundant
are all different	target	SARS-CoV-2 related coronavirus
are conserved	in-context	COVID-19
are conserved	in-place	SARS-2002
are conserved	subject	12
areas	has-property	developed
areas	has-property	epidemic
areas	has-property	lesser developed
areas	has-property	main
areas	has-property	transmission
areas	in-context	Southeast Asia
areas	in-place	Southeast Asia
arose	in-context	recombination
arose	subject	2019-nCoV
arose	target	2019-nCoV
around	in-context	bundle
arthralgia	is-a	symptoms
artifacts	in-context	PCR
ascertained	entails	infection fatality risk (IFR)
ascertained	target	individuals
aspartic acid	is-a	acidic residues
aspartic acid	same-as	D
aspects	causes	82%
aspects	has-property	similar
aspects	has-property	some
aspects	in-context	cultural
aspects	in-context	disease
aspects	in-context	epidemiology
aspects	in-context	setting
aspects	is-a	factors
assay	in-context	LRTI
assay	in-context	single
assay set	has-property	tetraplex qPCR
assays	has-property	RNA binding
assays	has-property	RT-LAMP
assays	has-property	suggested
assays	has-property	usable
assays	in-context	RNA binding
assays	target	qPCR
assembly	in-context	RTC
assess	subject	surveillance
assess	target	situation
assimilate	subject	HCWs
assimilate	subject	doctors
assimilate	target	COVID-19 knowledge
assimilate	target	knowledge
assist	subject	latter
assist	target	invasion
associated	in-context	JIA
associated	in-context	age
associated	in-context	comorbidity
associated	in-context	diseases
associated	in-context	symptoms
associated	in-context	uveitis
associated	in-context	viral pneumonia
associated	is-a	comorbidity
associated	subject	Comorbidities
associated	subject	amino acid positions
associated	subject	number
associated	subject	onset of COVID-19
associated	subject	severity
associated	target	JIA,
associated	target	age
associated	target	cough/sore throat
associated	target	diseases
associated	target	fever
associated	target	infection
associated	target	invasion
associated	target	myalgia/fatigue
associated	target	uveitis
associated	target	viral pneumonia
association	has-property	temporal
association	in-context	COVID-19
association	in-context	interactome
association	in-context	traffic
association	in-place	interactome
association	subject	Irbesartan's targets
association	subject	host proteins
association	subject	proteins
association	subject	targets
association	subject	traffic
association	target	COVID-19
association risks	has-property	different
association risks	in-context	infection
assuming	entails	conclude
assuming	target	change
assumption	target	attack
assumption	target	destroy
asthmatic	is-a	patient
asthmatic	is-a	patients
asymptomatic	has-property	typical
asymptomatic	in-context	cases
asymptomatic	is-a	infections
atent in humans	in-context	time
atom	has-property	additional
atom	has-property	aromatic
atom	has-property	bound nitrogen
atom	has-property	ring-173
atrial fibrillation	has-property	persistent
attachments	causes	SAC failure
attachments	has-property	erroneous
attack	entails	severity
attack	subject	SARS-CoV-2
attack	target	lymphocyte
attacked	causes	Lung injury
attacked	causes	respiratory failure
attacked	subject	SARS-CoV-2
attacked	subject	lung epithelium
attacked	target	SARS-CoV-2
attacked	target	epithelium mainly
attend	has-property	likely
attend	subject	cases
attend	target	gatherings
attenuation element	has-property	-1 PRF
attenuation element	target	-1 PRF
attribute	in-context	viral genomes
authorities	has-property	national
authorities	in-context	health
availability	in-context	sample
availability	is-a	factor
availability	target	sample
available	target	high resolution models
average numbers	in-context	CD163+ cells
average numbers	in-context	ZIKV group
avoid	entails	helpful
avoid	subject	people
avoid	target	anal sex
avoid	target	oral sex
avoid	target	oral/anal sex especially
avoidance	in-context	social
avoiding	target	drugs
awareness	causes	attend
awareness	in-context	COVID-19
babies	has-property	status
bacteremia	in-context	HCT recipients
bacteria	in-context	die
bacterial	is-a	pathogens
bacterial pathogens	has-property	unidentified
bacterial pathogens	in-context	new
bacterial pathogens	in-context	potential
bacterial pathogens	in-context	unidentified
based	in-context	CT findings
based	in-context	cases
based	in-context	experience
based	in-context	knowledge
based	in-context	real numbers
based	subject	confirmation
based	subject	scenarios
based	subject	screening
based	target	different
based	target	experience
based	target	findings
based	target	knowledge
based	target	sources
based	target	viral real-time reverse transcription polymerase chain reaction (RT-PCR) test
bases	entails	cleavage
bases	entails	recognition
bases	in-place	positions
bat	has-part	RSCs 27
bat RSC	has-property	stem cells
bat SARSr-CoV	subject	have
bat-SL-CoVZC45	is-a	coronaviruses
bat-SL-CoVZC45	is-a	severe acute respiratory syndrome
bat-SL-CoVZXC21	is-a	coronaviruses
bat-SL-CoVZXC21	is-a	severe acute respiratory syndrome
batch	has-property	first
batches	has-property	two
be	subject	SARS-CoV-2
be	subject	monkeys with SARS-CoV-2 infection
be	target	atent in humans
be	target	re-infected
be cautious	in-context	sex behavior
be cautious	subject	people
be preserved	subject	interactions
be preserved	target	proteome
be re-infected	in-context	same strain
bead modeling	entails	phases
bead modeling	in-context	ab initio
bead modeling	in-context	low resolution
bead modeling	in-time	available
bead modeling	subject	MONSA
become	has-property	more
become	in-context	increasing
become	subject	landscapes
become	target	rugged
before	in-context	infection
before	in-context	onset
before	in-time	January 23
before	target	January 23
before	target	infection
beginning	in-context	period
begins	subject	Lung injury
begins	target	insult
behavior	has-property	complexity
behavior	has-property	sexual
believed	subject	20%
believed	subject	allied health workers
believed	target	is sufficient
believed	target	vaccine
belong	subject	2019-nCoV
belong	subject	SARS-CoV
belong	subject	sites
belong	target	Sarbecovirus
belong	target	helix
below	in-context	unity
benchmarked	subject	mNGS
benchmarked	target	conventional standard
best efficient	in-context	SARS-CoV-2
best efficient	in-context	against
best efficient	in-place	cellular level
best efficient	in-time	so far
betacoronaviruses	has-property	amplitude of the seasonal variation
betacoronaviruses	has-property	other
betacoronaviruses	has-property	seasonal variation
betacoronaviruses	in-context	human
between	in-context	0.8%
between	in-context	0.9%
between	in-context	CoVZC45
between	in-context	CoVZXC21
between	in-context	ancestral branch
between	in-context	gut dysbiosis
between	in-context	immune disorder
bias	has-property	downward
bias	has-property	strong
bind	in-place	site
bind	subject	antibodies
bind	subject	lopinavir
bind	subject	ritonavir
bind	target	2019-nCoV
binding	causes	defects
binding	has-property	compared
binding	has-property	defects
binding	has-property	similar
binding	in-context	HEK293
binding	subject	CTD 4A
binding	subject	CTD 4E
binding	subject	SARS-CoV
binding	subject	SARS-CoV-2
binding	subject	amino acids
binding	subject	eIF4E
binding	target	C-MAD2
binding	target	MHC-1
binding	target	O-MAD2
binding	target	cap
binding	target	eIF4E
binding energy	has-property	closer
binding rate	has-property	high
binding rate	in-context	HEK293 cells
binding strength	has-property	SARS-CoV S-RBD to ACE2
binding strength	in-context	73%
binding strength	in-context	S-RBD
binding surface	has-part	olaparib
binding surface	has-property	not exactly the same
binding surface	has-property	similar
binding surface	in-context	SARS-CoV-2-N-NTD
binding surface	in-place	SARS-CoV-2-N-NTD
binding to	entails	invade
binding to	has-property	high-affinity
binding to	subject	SARS
binding to	subject	SARS-CoV-2
binding to	target	angiotensin-converting enzyme 2
binding to	target	receptor dipeptidyl peptidase 4
binds	causes	mediate
binds	entails	acting as
binds	entails	have
binds	has-property	10-20 fold higher affinity
binds	has-property	affinity
binds	has-property	higher
binds	in-context	SARS-CoV S
binds	in-context	bridge
binds	in-context	in addition to vitamin D
binds	in-context	vitamin D
binds	in-place	SARS-CoV
binds	subject	ACE2
binds	subject	DBP
binds	subject	K929
binds	subject	SARS-CoV
binds	subject	SARS-CoV-2
binds	subject	SP
binds	target	ACE2 receptors
binds	target	E1163
binds	target	SARS-CoV-2 S
binds	target	actin
binds	target	cellular receptors
binds	target	fatty acids
binds to	in-context	salt bridge
binds to	is-a	interaction
binds to	subject	K929
binds to	target	E1163
biology	in-context	organism
bioterrorism agent	is-a	it
births	has-property	preterm
births	in-context	newborns
blocked	subject	emdoin
blocked	target	interaction
blocking	causes	inhibitory effect
blocking	has-property	inhibitory
blocking	is-a	breakthroughs
blocking	target	CD147
blocking	target	action
blocking	target	occurrence
blood	has-part	lymphocytes
blood group A	is-a	blood group
blood group O	is-a	blood group
blue	in-context	SARS-CoV S
blue	in-context	differences
body	has-part	fluids
body	has-part	secretions
bond energy	in-context	2.00 kcal/mol
both	in-context	two
bound	has-property	upper
branch	has-property	ancestral
branch	in-context	COVID-19-related CoV
branch	in-context	SARS-related CoV
breakpoint	has-property	largest
breakthroughs	has-property	new
breakthroughs	in-context	control
breastfeed	subject	women
breastfeed	target	babies
breastfeeding	in-context	feeding
breastfeeding	in-context	mothers
breastmilk	has-property	expressed
bridge	has-property	214 3.2 Å
bridge	has-property	salt
brings	in-context	inspecting
brings	subject	delay
brings	target	hinder
brings	target	inspecting
broadening	entails	useful
broadening	target	the scope of pathogens
buffer	has-property	200 μL lysis/binding
buffer	has-property	lysis/binding
buffer	in-context	200 μL
bundle	has-property	helical
bundle	in-place	NSP7
calculate	in-context	lowest energy snapshot
calculate	target	root-mean-square fluctuation
calculated	entails	estimated
calculated	in-context	sample
can report	target	dynamics
can spread	subject	persons
can spread	target	COVID-19
cancer	has-part	types
candidates	in-context	drugs
canonical TRS-mediated	causes	produce
canonical TRS-mediated 144 mechanism	has-part	discontinuous transcription
cap	in-context	mRNA
capable	in-time	so far
capable	subject	drugs
capable	target	stemming
capacity	has-property	carrying
capacity	in-time	HCR
capturing	causes	profiling
capturing	subject	mNGS
capturing	target	RNA
care	has-property	enhanced
care	in-context	ICU
care	target	child
care testing	in-time	study enrollment
carrier	target	COVID-19
carriers	causes	aerosol
carriers	causes	reduced
carriers	has-property	asymptomatic
carriers	in-context	COVID-19
carriers	in-context	SNP
carriers	in-context	crowd
carries	in-place	patients
carries	subject	immuno-depletion
carries	target	risk
case	has-part	a little less than one
case	has-property	imported
case	has-property	numbers
case	has-property	onset
case	has-property	suspected
case	in-context	COVID-19
case	in-context	symptom onset
case	is-a	ICU patients
case isolation	has-property	imperfect
cases	causes	illness
cases	has-property	COVID-19 confirmed
cases	has-property	CT-confirmed pneumonia
cases	has-property	asymptomatic
cases	has-property	confirmed
cases	has-property	documented
cases	has-property	hospitalised
cases	has-property	hospitalized
cases	has-property	hundreds to thousands
cases	has-property	infected
cases	has-property	new
cases	has-property	newly
cases	has-property	number
cases	has-property	pediatric
cases	has-property	presymptomatic
cases	has-property	prevented
cases	has-property	published
cases	has-property	reports
cases	has-property	secondary
cases	has-property	severe
cases	has-property	suspect
cases	has-property	symptomatic
cases	has-property	traced
cases	in-context	COVID-19
cases	in-context	SARS-CoV-2
cases	in-context	negative testing
cases	in-context	number
cases	in-context	pneumonia
cases	in-context	testing
cases	in-place	China
cases	in-place	population
cases	in-time	early
cases	is-a	number
cases COVID-19	is-a	disease
catalysis	subject	amino acids
catecholamine	has-property	extracellular
catecholamine dynamics	has-property	extracellular
caused	subject	NOT gate
caused	subject	severe acute respiratory syndrome coronavirus 2
caused	target	die
caused	target	outbreak
caused	target	survive
caused	target	transmission
causes	subject	2019-nCoV
causes	target	disease
causes for infection	in-context	facing
causes for infection	in-context	health-care workers
causes for infection	in-context	lack of knowledge
cell	has-part	membrane
cell	has-property	development
cell	has-property	division
cell	has-property	immune
cell	has-property	innate
cell cycle	has-property	first
cell cycle	in-context	first
cell cycle	subject	cells
cell entry receptor,	in-context	angiotensin converting enzyme
cell foci	has-property	42-108 46 hpi
cell foci	has-property	Infected
cell populations	has-property	adaptive
cell populations	has-property	immune
cell populations	has-property	innate
cells	causes	activating
cells	has-property	host
cells	has-property	infected
cells	in-context	starvation
cells	in-place	SARS-CoV
cells	in-place	human
cells	in-place	tissues
cells	in-time	cell cycle
cellular	in-context	fibromyxoid
cellular pathology	in-context	COVID-19
challenge	has-property	great
challenge	in-context	period
challenging	subject	need
challenging	target	services
chance	in-context	imported
chances	in-context	infected
change	has-property	drastic
change	has-property	rates
change	has-property	seismic
change	in-context	COVID-19
change	in-context	infection rates
change	in-place	R(t)
change	in-time	over time
change	target	R(t)
change	target	biology
changes	causes	antiviral activity
changes	causes	reduced
changes	has-part	introduction
changes	has-part	moving
changes	has-property	Small
changes	has-property	radiological
changes	has-property	small
changes	in-context	lungs
changes	in-place	subunit structures
changes	target	structure
characteristics	has-property	similar
characteristics	has-property	transmission
characteristics	has-property	unique
characteristics	in-context	COVID-19
characteristics	in-context	CT scan
characteristics	in-context	transmission
characterized	subject	presence
characterized	subject	reaction
characterized	target	destruction
characterized	target	expression
chest CT imaging	has-property	ground glass opacity
chest CT imaging	has-property	patchy shadows
child	has-part	one
child	has-property	age 3-12
child	has-property	requires
child	has-property	school-aged
children	has-property	exacerbation
children	in-context	COVID-19
children	in-context	asthma exacerbation
children	in-place	emergency department
children	is-a	least vulnerable
children	is-a	vulnerable
cholesterol homeostasis	has-property	intracellular
chronic kidney disease	same-as	CKD
cilia	has-part	506
ciliated Eukaryotes	has-property	most
ciliomes	in-place	choanoflagellate
ciliomes	in-place	sea anenome
ciliomes	in-place	sea urchin
circle	has-property	vicious
circle	in-context	between
circle	is-a	high risk
circle	target	disorder
circle	target	dysbiosis
circulation	has-property	generalized
circulation	subject	SARS-CoV-2
cities	has-property	other
cities	has-property	≥50%
cities	in-place	China
clash	subject	conformation
clash	subject	second
clash	target	ACE2
clash	target	ACE2 receptor
classification	in-context	Lymphocyte
clear	has-property	completely
clear	target	mechanism
cleavage	entails	improve
cleavage	in-context	proteasomal
cleavage	target	target
cleave	in-context	IAV
cleave	in-context	sequences
clinical manifestation	is-a	fatigue
clinical manifestation	is-a	myalgia
clinical manifestation	is-a	respiratory symptoms
clinical pathways	in-context	prioritise
clinical response	has-property	best
clinical samples	has-part	microbial composition
clinical samples	has-property	microbial composition
clinical significance	in-context	pathogen
clinically negative	in-context	infection
clones	entails	condition
clones	has-property	fewer
clones	in-context	TCR
close	in-context	phylogenetically
close	subject	SARS-CoV
close	subject	SARS-CoV-2
closed	entails	change
closed	target	schools
closed	target	workplaces
closer	in-context	isolates
closer	in-place	Human
closer	in-place	other
closer	subject	cycle
closer	subject	energy
closer	subject	life cycle
closer	subject	sequence
closer	target	isolates
closer	target	yeast
closest	subject	SARS-Cov
closest	target	2019-nCoV
closures	causes	cases
closures	target	school
clustered	subject	SARS-CoV-2
clustered	target	groups of humans in close contact
clustered	target	humans
coexistence	in-time	VDR
combating	subject	BCR
combating	subject	TCR
combating	subject	activation
combating	subject	antibodies
combating	target	infection
combines	subject	approach
combines	target	mutagenesis
combines	target	primers
combines	target	recombination
comorbidities	in-context	older men
comparable	in-context	estimates
comparative	causes	exhibited
comparative	has-property	Further
comparative	target	GZ02
comparative	target	HKU-1
comparative	target	HKU9-1
comparative	target	OC43
comparative	target	RaTG13
comparative	target	Wuhan-Hu-1
compared	in-context	SARS-2002
compared	in-context	calculate
compared	in-context	different
compared	in-context	mock
compared	in-context	original library
compared	in-context	virus
compared	subject	COVID-19
compared	subject	CVL218
compared	subject	expression
compared	subject	remdesivir
compared	subject	rounds
compared	subject	study
compared	target	CVL218
compared	target	DMSO control group
compared	target	SARS-2002
compared	target	SARS-CoV-2
compared	target	arbidol
compared	target	differences
compared	target	mock
compared	target	original
compared	target	third
compared	target	two
comparing	entails	reaches
comparing	subject	values
comparing	target	values
comparison	entails	sanitization
comparison	in-context	batches
comparison	in-context	reference-sequence-based
comparison	subject	two batches
comparison	target	effectiveness
comparison	target	importance
compartments	in-context	replication 301
compel	causes	initiate
compel	subject	concern
compel	target	clinicians
competition	has-property	fierce
competition	target	it
complex	has-property	hetero-hexadecamer
complex	has-property	protein
complex	in-context	9-amino
complex	in-context	protein
complexes	has-property	elongation
complexes	in-context	norovirus
complexes	in-context	poliovirus
complexity	causes	avoid
complexity	causes	be cautious
complexity	in-context	organism
complications	entails	risk
complications	has-property	lethal
complications	has-property	severe
complications	in-context	infection
components	has-property	homology
components	same-as	lipases,
composite plots	in-context	Reb1bound genes
compounds	in-context	30
comprising	subject	P-type transistor
comprising	target	liposomes
concentrated	in-context	30-50
concentration	has-property	crRNA
concentrations	in-context	sugar
concern	causes	initiate
concern	has-property	serious
concern	in-context	GVHD
concern	in-context	health
concern	in-context	patients
concern	target	GVHD
conclude	target	end
condition	has-property	severe
condition	in-context	COVID-19
conditions	has-property	critical
conditions	has-property	severe
confer to	causes	influence
confer to	in-context	properties
confer to	subject	motif
confer to	target	nsp8-9 cleavage site
confirm	subject	results
confirm	target	SARS-CoV-2
confirm	target	interaction
confirmation	in-time	current
confirmation	target	infection
confirmed	causes	showing
confirmed	entails	transmissibility
confirmed	has-property	23.5%
confirmed	in-context	patients
confirmed	in-place	China
confirmed	subject	44,672
confirmed	subject	Measurements
confirmed	subject	cases
confirmed	subject	comparison
confirmed	subject	expressing
confirmed	subject	mothers
confirmed	target	COVID-19
confirmed	target	binding
confirmed	target	carrier
confirmed	target	pneumonia
confirmed	target	this
confirmed cases	in-context	COVID-19
confirmed diagnosis	in-context	COVID-19
confirmed diagnosis	is-a	result
confirming	subject	induced
confirming	target	554 role
confirming	target	role
conformation	has-property	open
conformation	has-property	second
conformation	in-context	DNA
conformation	in-place	compartments
conformation	in-place	replication compartments
conformation	target	DNA
confounded	subject	association
confounded	subject	measures
confounded	target	association
confounded	target	other
congestion	has-property	conjunctival
congestion	in-place	swabs
consensus	subject	Expert
consensus	target	Expert
conserved	in-place	ciliated Eukaryotes
conserved	in-place	humans
conserved	in-place	most ciliated Eukaryotes
conserved	in-place	outside
conserved	in-place	outside of the animal kingdom
conserved	target	506
conserved	target	507
conserved	target	proteins
considering	causes	suggested
considering	target	load
consistent	in-context	findings
consistent	in-context	spreading
contact	causes	infected
contact	causes	survival
contact	causes	transmission
contact	entails	positioning
contact	has-property	close
contact	has-property	direct
contact	has-property	indirect
contact	has-property	initial
contact	in-context	COVID-19
contact	in-context	aerosols
contact	in-context	environments
contact	in-context	human-to-human
contact	is-a	transmission
contact	is-a	transmission mode
contact	subject	loop
contact	target	domain
contact history	has-property	clear
contact rate	in-time	cases
contacting	target	confirmed
contacting	target	suspected
contacting with	causes	depressive symptoms
contacting with	in-time	time
contacting with	subject	HCWs
contacts	has-property	traced
contacts traced	is-a	aspects
contagious	has-property	more
contagious	in-context	SARS
contagious	in-context	others
contagious	in-time	up to 14 days
contain	in-context	interface
contain	subject	interfaces
contain	target	loops
contain	target	nine
contained	target	spread
containing	target	V1691R
containment	has-property	possible
contaminated gloves or hands	is-a	route for SARS-CoV-2
contigs	has-property	proportionally
contigs	in-context	VI
contraction	has-property	antagonistic
contraction	has-property	principle
contraction	in-place	families
contrasts	in-context	distinct
contribute	has-property	maximum
contribute	subject	these
contribute	target	18%
contribute	target	pathogenesis
contribute	target	understanding
contributed	in-time	period
contributed	subject	carriers
contributed	target	source
control	has-property	alone
control	has-property	positive
control	has-property	successful
control	in-context	COVID-19
control	in-context	diseases
control	in-context	reducing
control	subject	diagnosis
control	subject	isolation
control	subject	tracing
control	target	COVID-19
control	target	COVID-19 pneumonia
control	target	epidemic
control	target	other
control	target	outbreak
control	target	outbreaks
control	target	reducing
controlling	in-place	patients
controlling	subject	T cells
controlling	subject	roles
controlling	target	disease severity
controlling	target	severity
controls	has-property	5.0%
controls	has-property	5.8%
controls	has-property	negative
controls	in-context	n=3
convalescent	in-context	plasma
conventional standard	in-context	care testing
convergence	has-property	evolutionary
convergence	subject	protein
coordination	causes	stabilizes
coordination	is-a	functions
coordination	subject	GLU 286
coordination	subject	Mn 2+
coordination	target	GLU 286
coordination	target	Mn 2+
cope	entails	stress response
cope	subject	cells
copies	in-context	RNA
copies	in-context	SARS-CoV-2
copies	in-context	virus
core genomic features	causes	functional
core genomic features	entails	virus
coronavirus	causes	COVID-19
coronavirus	causes	outbreak
coronavirus	has-property	2
coronavirus	has-property	emerging
coronavirus	has-property	infectious
coronavirus	has-property	novel
coronavirus	in-time	2019
coronavirus	same-as	SARS-CoV-2
coronavirus disease	has-property	novel
coronavirus disease-2019	same-as	COVID-19
coronavirus example	in-context	solved structure
coronaviruses	has-part	membrane
coronaviruses	has-part	nucleocapsid
coronaviruses	has-part	proteins
coronaviruses	has-property	Guangdong pangolin
coronaviruses	has-property	Novel
coronaviruses	has-property	emerging
coronaviruses	has-property	novel
coronaviruses	has-property	previous
coronaviruses	has-property	similarities
coronaviruses	has-property	two
coronaviruses	in-context	severe acute respiratory syndrome
coronaviruses	is-a	Nidovirales
correlated	entails	promote
correlated	has-property	negatively
correlated	in-context	DC
correlated	in-context	NK cells
correlated	in-context	Th1 cells
correlated	in-context	Th17 cells
correlated	in-context	Th2 cells
correlated	in-context	neutrophils
correlated	subject	ACE2
correlated	subject	DC
correlated	subject	NK cells
correlated	subject	Th1 cells
correlated	subject	Th17 cells
correlated	subject	Th2 cells
correlated	subject	neutrophils
correlated	subject	numbers
correlated	target	levels
correlated to	entails	cytokines
correlated to	has-property	negatively
correlated to	subject	numbers
correlated to	target	levels
correlation	entails	is the key
correlation	has-property	high
correlation	has-property	inverse
correlation	has-property	positive
correlation	has-property	strong
correlation	in-context	antibody titer
correlation	in-context	clinical severity
correlation	in-context	progression
correlation	in-context	severity
correlation	in-context	values
correlation	in-context	κ-values
correlation	in-place	patients
correlation	in-time	after
correlation	in-time	since 2-week after illness onset
correlation	subject	values
correlation	target	blood lymphocytes
correlation	target	disease progression
correlation	target	lymphocytes
corresponding	subject	breakpoint
corresponding	target	advent
corroborates	target	high adaptability
corroborating	subject	suggests
corroborating	target	effectiveness
cough	is-a	associated
could not	has-part	be re-infected
count	has-property	decreased
count	in-context	lymphocyte
count	in-place	patients
count	target	lymphocyte
counteract	subject	viruses
counteract	target	loss
countermeasures	in-context	Ebola
countermeasures	in-context	epidemic
countries	has-property	multiple
country	has-property	within
counts	has-property	low
counts	in-context	T lymphocyte
counts	in-context	lymphocyte
create	subject	combines
create	target	variation
create variation	causes	combines
create variation	target	specific residues
created	in-context	using
created	subject	We
created	target	NOT gate
criterion	in-context	diagnosis
critical	in-context	development
critical	is-a	conditions
critical key residues	has-property	six
critical key residues	in-context	MERS-CoV RBD
critical key residues	in-context	its receptor
crystal structure	in-context	ATP
culture-positive	in-context	Stenotrophomonas maltophilia
curved	has-property	highly
curves	has-property	epidemiologica
curves	has-property	epidemiological
curves	in-context	COVID-19
curves	in-place	China
cycle	in-context	life
cytokine	has-property	pro-inflammatory
cytokine	has-property	storms
cytokine storms	has-property	fatal
cytokine storms	subject	patients
cytokines	causes	decrease
cytokines	has-property	pro-inflammatory
dN/dS ratio	in-place	RBD region
dN/dS ratio	in-time	3 fold
dNTP	is-a	type
dailyobserved	in-context	numbers
dailyobserved	is-a	numbers
damage	has-part	desquamation
damage	has-part	exudates
damage	has-part	formation
damage	has-property	diffuse
damage	has-property	liver
damage	in-context	alveolar
damage	in-context	myocardial
damage	in-place	liver
damage	is-a	symptom
damage	target	alveolar
damage	target	gyri
damage	target	gyrus
damage	target	hemisphere
damage	target	matter
data	entails	COVID-19
data	has-part	experimental
data	has-property	available
data	has-property	clinical
data	has-property	complementary
data	has-property	experimental
data	has-property	genomic
data	has-property	new
data	has-property	official
data	has-property	valid
data	in-context	SARS
data	in-context	diffusion
data	in-context	influenza
data	in-context	inhibitors
data	in-context	protease inhibitors
data	in-time	Currently
data	is-a	set
day	in-context	hospitalization
death	has-property	cardiovascular
death	has-property	non-accidental
death	has-property	risk
death	in-context	accidental
death	in-context	cardiovascular
death	in-context	respiratory
death	subject	patients
death	target	patients
death rate	has-property	high
deaths	in-context	first
deciding	target	breastfeed
deciphering	target	dynamics
declaration	subject	WHO
declaration	target	Emergency
declared	in-context	emergency
declared	subject	The World Health Organization
declared	subject	WHO
declared	subject	World Health Organization
declared	target	epidemic
declared	target	outbreak
declared	target	this
decrease	has-property	persisting
decrease	in-context	0.097
decrease	in-context	0.097 (0.438)
decrease	in-context	0.438
decrease	in-context	patients
decrease	in-place	COVID-19 patients
decrease	in-time	after
decrease	in-time	first (second) week in the February 2-15
decrease	in-time	following first (second) week
decrease	in-time	future
decrease	is-a	criterion
decrease	is-a	indicator
decrease	subject	Guarani DNA
decrease	subject	T cells
decrease	subject	amount
decrease	subject	infection case
decrease	subject	new infection case
decrease	subject	one new infection case
decrease	subject	treatment
decrease	target	Guarani DNA
decrease	target	T cells
decrease	target	lymphocytes
decrease	target	need
decrease	target	new cases
decrease	target	number
decrease	target	number of infections
decrease	target	number of new cases
decreased	entails	observed
decreased	has-property	significantly
decreased	in-context	3D G64S
decreased	in-context	COVID-19
decreased	in-context	WT
decreased	in-context	patients
decreased	in-place	38.1%
decreased	in-place	patients
decreased	in-time	after
decreased	subject	CD4
decreased	subject	CD8
decreased	subject	expression
decreased	subject	level
decreased	target	T cells
decreased	target	activity
decreased	target	count
decreased	target	fitness
decreased	target	number
decreased	target	overall fitness
decreased	target	patients
decreased	target	transmission
decreases	has-property	226
decreases	in-context	VI
decreases	subject	read length
decreases	target	PID range
decreases	target	range
defects	has-property	functional
defects	in-context	cell populations
deficiency	has-property	lymphocyte
deficiency	in-context	lymphocyte
define	subject	bases
define	target	cleavage
define	target	recognition
defined	has-property	positive
defined	in-context	SARS-Cov
defined	in-place	humans
defined	in-place	imaging
defined	in-place	other species
defined	in-place	species
defined	subject	RT-PCR
defined	subject	patients
defined	target	diagnosis
defined	target	epitopes
defined	target	number
defined	target	pneumonia
defined as	causes	screening
defined as	subject	patients
defined as	target	pneumonia
definition	has-property	strict
definition	in-context	myocardial injury
degraded	in-context	when not required
degraded	in-time	required
degraded	subject	proteasome
degraded	target	PARP2
degraded	target	genomic stability
delay	entails	affect
delay	entails	brings
delay	entails	time
delay	in-context	confirmation
delay	in-context	restricting
delay	target	confirmation
delay	target	risk
delays	subject	temperature
delays	target	spread
deletion	in-place	strain
deletion	same-as	APP/PS1dE9
deletion	target	exon-9
demonstrate	subject	results
demonstrate	target	ORF3b
demonstrated	has-property	now
demonstrated	in-time	infection
demonstrated	subject	We
demonstrated	subject	mNGS
demonstrated	subject	role
demonstrated	subject	structure
demonstrated	subject	study
demonstrated	target	Cas13d-based
demonstrated	target	disparity
demonstrated	target	folds
demonstrated	target	sensitivity
demonstrating	subject	work
demonstrating	target	produce
demonstration	has-property	preliminary
demonstration	target	exhaustion
denaturation	target	urea
dengue	has-property	transmission
density	causes	82%
density	has-property	low
density	in-context	EAT
density	in-context	population
density	is-a	factors
density	is-a	high risk factors
department	has-property	emergency
department	has-property	local
department	same-as	ED
department,	has-property	NCP
depend	in-context	E proteins
depend	in-context	N proteins
depend	in-time	infection
depend	subject	SARS-CoV
depend	subject	formation
depend	target	E
depend	target	M
depend	target	N
depend	target	extracellular
depend	target	intracellular
depend on	causes	infection
depend on	subject	SARS-CoV
depend on	target	Ca 2+ pools
dependent	has-property	greatly
dependent	has-property	totally
dependent	in-context	effectiveness
dependent	in-context	experience
dependent	in-context	proteins
dependent	in-context	replication
dependent	subject	screening
dependent	subject	virus
dependent	target	L-A
dependent	target	experience
depends	has-property	direction
depends	subject	level
depends	subject	relationship
depends on	in-place	locations
depends on	in-time	stage
depends on	subject	effectiveness
depends on	target	aspects
depends on	target	contacts
depends on	target	serial interval
depends on	target	timing
dephosphorylation	in-context	JNK
dephosphorylation	in-context	p38
dephosphorylation	target	JNK
dephosphorylation	target	p38
depletion	has-property	susceptible
depletion	in-place	social network
depressive symptoms	in-context	family
depressive symptoms	is-a	mental health problems
deprivation	entails	stress response
deprivation	target	Serum
derived	has-property	exclusively
derived	in-context	exclusively
derived	in-place	environmental capsids
derived	subject	RNA
derived	subject	peptide
derived	target	IAPP
design	target	probe
design	target	report
designed	in-context	patients
designed	target	programme
desquamation	in-context	pneumocytes
desquamation	target	pneumocytes
destabilize	in-context	cap
destabilize	target	binding
destroy	entails	severity
destroy	subject	SARS-CoV-2
destroy	target	lymphocyte
destruction	target	airway
destruction	target	alveolar
detect	has-property	95%
detect	has-property	better
detect	has-property	simultaneously
detect	in-context	95%
detect	in-context	model
detect	in-context	simultaneously
detect	subject	mNGS
detect	subject	panel
detect	target	1.15
detect	target	COVID-19
detect	target	host response
detect	target	pathogens
detect	target	response
detect	target	viral genomes
detectable	has-part	LRTI assay
detectable	in-context	assay
detectable	in-place	rectal swabs
detectable	in-place	throat
detectable	in-time	remained
detectable	subject	SARS-CoV-2 RNA
detectable	subject	microarray approaches
detectable	target	pathogens
detectable	target	real time RT-20 PCR
detected	causes	corroborates
detected	entails	corroborates
detected	has-property	Positive
detected	has-property	most
detected	has-property	successfully
detected	in-context	receptor
detected	in-context	urea denaturation
detected	in-place	AT1 cells
detected	in-place	airway epithelial cells
detected	in-place	children
detected	in-place	endothelial cells
detected	in-place	fibroblasts
detected	in-place	macrophages
detected	in-time	denaturation
detected	subject	42-108 46 hpi
detected	subject	ACE2
detected	subject	C
detected	subject	RT-PCR
detected	subject	SARS-CoV
detected	subject	SENSR
detected	subject	WU polyoma
detected	subject	WU polyoma virus
detected	subject	mNGS
detected	subject	nucleic acid
detected	subject	protein
detected	target	ACE2
detected	target	AT1 cells
detected	target	DNA sequencing
detected	target	PARP2
detected	target	RT-PCR
detected	target	SARS-CoV
detected	target	SARS-CoV-2 nucleic acid
detected	target	Streptococcus mitis
detected	target	airway epithelial cells
detected	target	endothelial cells
detected	target	fibroblasts
detected	target	macrophages
detected	target	skeletal
detected	target	target RNA
detection	causes	data
detection	causes	number
detection	causes	reduce
detection	causes	screening
detection	entails	screening
detection	entails	window for diagnosis
detection	has-property	Early
detection	has-property	faster
detection	has-property	introducing bias
detection	has-property	mNGS
detection	has-property	missed
detection	has-property	positive
detection	has-property	prolonged
detection	has-property	rapid
detection	has-property	simpler
detection	has-property	simultaneous
detection	in-context	Early
detection	in-context	cases
detection	in-context	prolonged
detection	in-context	simultaneous
detection	in-context	simultaneously
detection	in-context	specimens
detection	in-context	three
detection	in-context	window
detection	in-place	specimens
detection	is-a	differences
detection	is-a	measures
detection	subject	SARS-CoV-2
detection	subject	antibodies
detection	subject	genotyping
detection	subject	mNGS
detection	target	RNA
detection	target	SARS-CoV-2
detection	target	airway microbiome
detection	target	antibodies
detection	target	bacterial
detection	target	cases
detection	target	epidemiologic tracking
detection	target	fungal
detection	target	immunologic response
detection	target	infections
detection	target	microbial
detection	target	microbiome
detection	target	pathogens
detection	target	resistance mutations
detection	target	respiratory pathogens
detection	target	viral
detection	target	viral strains
detergent heads	is-a	phases
detergent tails	is-a	phases
determine	in-context	prediction
determine	subject	SMM
determine	subject	SMM algorithm of MHC-1 binding
determine	subject	efficiency
determine	target	IC 50 values
determine	target	IC values
determined	subject	artifacts
determined	target	dNTP
determined	target	primers
development	causes	apply
development	entails	breakthroughs
development	in-context	pathogenicity
development	in-context	regulation
development	in-place	West Africa
development	in-place	strains
development	in-time	2014-2016
development	in-time	years
development	is-a	breakthroughs
development	is-a	functions
development	target	cell
development	target	countermeasures
development	target	drug
development	target	drugs
development	target	epidemic
development	target	pathogenicity
diagnosed	has-property	unlikely
diagnosed	in-context	particular time
diagnosed	in-context	place
diagnosed	target	People
diagnosis	has-property	accurate
diagnosis	has-property	confirmed
diagnosis	has-property	molecular
diagnosis	has-property	rapid
diagnosis	in-context	COVID-19
diagnosis	in-place	lung
diagnosis	subject	method
diagnosis	subject	window
diagnosis	target	COVID-19
diagnosis	target	SARS-CoV-2
diagnosis	target	infection
diagnosis	target	infections
diagnosis	target	lesions
diagnostic	has-property	enhanced
diagnostic method	has-property	fast
diagnostic method	has-property	reliable
diagnostic method	in-context	SARS-CoV-2
diarrhea	in-place	animals
diarrhea	in-time	Week 2
diarrhea	is-a	symptoms
diarrhea	target	animals
die	in-context	high temperatures
die	subject	bacteria
differ	in-context	dynamics
differ	subject	dynamics
differ	subject	system
differ	target	ODE
differ	target	field
difference	has-property	significant
difference	in-context	distributions
difference	in-context	number
difference	in-context	patients
difference	in-context	these
difference	subject	mild
difference	target	severe
differences	has-property	blue
differences	has-property	fundamental
differences	has-property	noteworthy
differences	has-property	principal
differences	has-property	significant
differences	in-context	COVID-19
differences	in-context	SARS
differences	in-context	amino acid
differences	in-context	clinical pathology
differences	in-context	mammals
differences	in-context	modeled proteins
differences	in-context	pathology
differences	in-place	China
differences	in-place	regions
differences	is-a	bats
differences	subject	29 other mammals
differences	subject	COVID-19
differences	subject	bats
differences	target	SARS
differences	target	amino acid
different	in-context	FP1_2
different	in-context	SARS-CoV
different	in-context	assumptions
different	subject	FP1_2
different	subject	stoichiometry
different	target	each other
differentiating	subject	COVID-19
differentiating	target	SARS
diffusion	subject	SARS-CoV-2
diffusion	target	SARS-CoV-2
dipeptidyl peptidase 4	same-as	DPP4
direction	has-property	opposite
direction	has-property	potential
direction	in-context	expectation
direction	is-a	evolution
discharge	has-property	lower
discharge	in-place	ICU
discovered	in-context	in silico drug repurposing framewor
discovered	in-context	sequencing
discovered	in-place	strain
discovered	subject	CVL218
discovered	subject	sequencing comparative
discovered	target	PARP1
discovered	target	deletion
discovered	target	insertion
discovered	target	mutations
discovered	target	our
disease	has-part	parameters
disease	has-property	(COVID-19)
disease	has-property	2019
disease	has-property	acuteness
disease	has-property	cardiovascular
disease	has-property	chronic
disease	has-property	coronavirus
disease	has-property	kidney
disease	has-property	limited
disease	has-property	outcomes
disease	has-property	severe
disease	in-context	COVID-19
disease	in-context	cardiovascular
disease	in-context	coronavirus
disease	in-place	eye
disease	in-place	human
disease	same-as	CKD
disease	subject	patients
disease course	has-property	unknown
disease course	in-context	COVID-19
disease course	in-place	carriers
disease resistance	has-part	PAD4
disease resistance	has-part	genes EDS1
disease resistance	has-property	R genemediated
diseases	has-property	autoimmune
diseases	has-property	infectious
diseases	in-context	autoimmune
disorder	has-property	immune
disorder	has-property	intrinsic
disorder	in-context	M proteins
disorder	in-context	mean PPID
disorder	in-place	M proteins
disorder segment	has-property	long
disorder segment	in-context	44-84 residues
disorder segment	in-context	48-84 residues
disparities	in-context	susceptibility
disparity	is-a	regional
dispersion parameter	in-context	k
display	subject	N-terminal regions
display	target	differences
displayed	in-context	infection
displayed	subject	82.1%
displayed	subject	A
displayed	subject	B
displayed	subject	O
displayed	target	association risks
displayed	target	counts
displayed	target	risks
displaying	entails	IL-10
displaying	subject	patients
displaying	target	levels
disrupts	in-context	interferon
disrupts	subject	IFITMs
disrupts	target	cholesterol homeostasis
disrupts	target	homeostasis
distance	in-context	arrays
distance	in-context	barrier Reb1
distancing	has-property	Social
distress	has-property	acute
distress	in-context	respiratory
distributed	has-property	heterogeneously
distributed	in-place	age groups
distributed	subject	morbidity
distributed	subject	mortality
distributed	target	groups
distribution	has-part	dispersion parameter
distribution	has-part	mean
distribution	has-property	generation-interval
distribution	has-property	intrinsic
distribution	has-property	negative binomial
distribution	has-property	peripheral
distribution	has-property	resulting
distribution	has-property	specific
distribution	in-context	mean
distribution	in-context	parameter
distribution	same-as	distribution
distribution	target	risk
distributions	has-property	polarized
distributions	in-context	viruses
division	target	cell
domain	has-part	residues
domain	has-part	residues 306-575
domain	has-property	C-terminal
domain	has-property	involved
domain	has-property	receptor binding
domain	has-property	small
domain	in-context	XP
domain	in-context	head
domain	in-context	thumb
domain	in-place	S protein
dominance	in-context	capacity
dominance	in-context	carrying capacity
dominance	in-time	HCR
dominance	target	host
dominate	subject	viral 112 transcripts
dominate	target	transcriptome
dosage	causes	decreased
dosage	has-property	medication
dosage	in-place	cell lines
downturns	in-context	spread
downturns	subject	spread
drawn	entails	correlation
drawn	in-context	proteome
drawn	subject	IDRs
drive	in-time	episodes
drive	subject	factors
drive	target	inflammation
drive	target	severity
driver	has-property	main
driver	in-place	lung
driver	subject	PWK/PhJ
driver	target	titer
droplets	has-property	respiratory
droplets	is-a	transmission
drug	has-property	new
drug development	has-property	target
drug repositioning strategy	is-a	strategy
drug repositioning strategy	same-as	finding
drug resistance	in-context	cancer
drug resistance	subject	CA12
drugs	has-property	antiviral effects
drugs	has-property	antiviral efficacy
drugs	has-property	nephrotoxic
drugs	has-property	new
drugs	has-property	old
drugs	in-context	30
drugs	in-context	M pro
drugs	in-context	multiple
ductal	has-part	human liver
due	subject	COVID-19
due	subject	coronavirus disease
due	target	inhibitory effect
duration	has-property	unknown
duration	in-context	viral existence
duration	in-place	carriers
dynamic	has-property	real
dynamic	in-context	epidemic
dynamic	in-context	numbers
dynamic	is-a	numbers
dynamic model	is-a	tools
dynamics	causes	spread
dynamics	has-property	complicate
dynamics	has-property	fidelity
dynamics	in-context	binding
dynamics	in-context	development
dynamics	in-context	division
dynamics	in-context	protein
dynamics	in-context	spread
dynamics	in-place	structures
dynamics	in-place	within
dynamics	is-a	contraction
dynamics	target	catecholamine
dysbiosis	has-property	gut
early stage	in-context	COVID-19
early stages	has-property	especially
early stages	in-context	COVID-19 epidemic
early stages	in-time	knowledge
edema	has-property	inflammatory
edema	has-property	pulmonary
edema	in-context	COVID-19
edema	target	pulmonary
effect	has-property	1.5-fold greater
effect	has-property	good
effect	has-property	inhibitory
effect	in-context	1.5-fold greater
effect	in-context	SARS-CoV
effect	in-context	other pA sequences
effect	in-context	prevention
effect	in-context	treatment
effect	subject	maintenance
effect	subject	peptide-9
effect	subject	promotion
effect	subject	protection
effect	target	SARS-CoV
effect	target	expression
effect	target	prevention
effect	target	treatment
effective	in-context	lockdown
effective	subject	lockdown
effective	target	reduction
effectiveness	has-property	limited
effectiveness	in-context	China's large-scale
effectiveness	in-context	monitoring
effectiveness	in-context	quarantine
effectiveness	in-context	sanitization
effects	has-property	60
effects	in-context	allele 60
effects	subject	DTR
effects	target	mortality
efficacy	has-property	stronger
efficiency	has-property	improved
efficiency	in-context	cleavage
efficiency	in-context	proteasomal cleavage
efficiency	in-context	silencing
efficiency	in-context	transport
efficiency	subject	siRNA silencing
efforts	in-context	around the world
efforts	in-context	from around the world
efforts	subject	to provide
elevated	in-context	that
elevated	in-place	TRIM25 KO
elevated	in-place	type
elevated	target	signal
elevated	target	synonymous mutations
elevated IL-33 levels	in-context	asthmatic
elevated IL-33 levels	in-context	smokers
elevation	in-context	levels
elevation	in-place	levels
elevation	is-a	factors
elevation	is-a	high risk factors
elevation	subject	TnI
elevation	target	TnI
eliminated	in-context	evolution
eliminated	in-place	plasmids
eliminated	in-time	evolution
eliminated	subject	region
eliminated	target	MTase region
elongation complexes	has-part	norovirus 24
elongation complexes	has-part	poliovirus 23
emerge	target	data
emerged	causes	rise
emerged	causes	tens of thousands
emerged	in-time	2019
emerged	in-time	late 2019
emerged	subject	SARS-CoV-2
emergence	in-place	Wuhan
emergence	in-time	December
emergence	subject	coronavirus
emergence	target	caused
emergency	has-property	global
emergency	in-context	health
empirical estimation	entails	effectiveness
empirical estimation	entails	infection
empirical estimation	has-property	based
empirical estimation	in-context	subsample
enable	subject	attribute
enable	target	detection of resistance mutations
enable	target	epidemiologic tracking
enable	target	genotyping
encoded	in-context	U1
encoded	in-context	U2
encoded	subject	U1
encoded	subject	U2
encoded	subject	pGKL
encoded	subject	pGKL plasmids
encoded	target	proteins
encoded	target	toxin
encouragement	has-property	needed
encouragement	in-context	health authorities
encouragement	subject	authorities
end	in-time	April
end	in-time	April 2020
end	subject	epidemic
energy	has-property	binding
energy minimized	in-context	1000 steps
energy minimized	target	NS2B-NS3pro complex
energy snapshot	has-property	lowest
enhance	in-context	interactions
enhance	in-place	membrane
enhance	subject	proteins
enhance	subject	understanding
enhance	target	control
enhance	target	mortality
enhance	target	prevention
enhance	target	viral pathogenicity
enriched	in-context	T:C transition
enriched	target	mutations
enriched	target	nucleotide mutations
enrichment	has-property	compared
enrichment	in-context	acidic residues glutamic acid
enrichment	in-context	aspartic acid
enrichment	in-context	compared
enrichment	in-context	glycine
enrichment	in-context	serine
enrichment	target	aspartic acid
enrichment	target	glutamic acid
enrichment	target	glycine
enrichment	target	serine
entered	has-property	amounts
entered	in-context	amounts
entered	in-context	uniformly
entered	subject	cells
entered	target	S phase
entered	target	phase
entered	target	quiescence
entering	subject	virus
entering	target	cell
entering	target	host cell
entry	has-property	Analogous
entry	has-property	Receptor-dependent
entry	has-property	protease-enhanced
entry	has-property	viral
entry	in-context	C CoVs
entry	same-as	step
entry	subject	B CoVs
entry	subject	CoVs
entry	subject	lineage B
environmental factors	causes	survival
environmental factors	causes	transmission
environments	has-property	contaminated
enzymes	in-context	myocardial
epidemic	has-property	strength
epidemic	in-context	COVID-19
epidemic	in-context	Ebola virus
epidemic	in-place	West Africa
epidemic	in-time	2014-2016
epidemic	is-a	health emergency
epidemic	subject	COVID-19
epidemic information	causes	psychological treatment
epidemiologic tracking	in-context	disease outbreaks
epidemiology	has-part	aspects
epithelial	has-part	cell cultures
epitopes	has-property	SARS-CoV
epitopes	in-context	MHC-I molecules
equal	in-context	1.96%
equivalent	subject	distribution
equivalent	target	distribution
escape 300	in-place	repression
escape from	target	repression
essential	in-context	deciphering
essential	in-context	life cycle
establish	in-context	transmission
establish	subject	COVID-19
establish	subject	virus
establish	target	transmission
establish	target	virus
established	subject	model
establishment	has-property	key
establishment	subject	hospital
establishment	target	NCP department
establishment	target	department,
estimate	subject	We
estimate	subject	approach
estimate	target	abundance
estimate	target	rates of overdispersion
estimated	entails	interaction
estimated	has-property	alone
estimated	in-context	147 3 folds lesser
estimated	in-context	SARS-CoV-2
estimated	in-context	cases
estimated	in-context	symptomatic cases
estimated	subject	CCDC
estimated	subject	model
estimated	target	0.1
estimated	target	detect
estimated	target	incubation period
estimated mean PPID	has-property	1.36%
estimated mean PPID	has-property	2.70%
estimates	has-property	current
estimates	in-context	COVID-19
estimates	in-context	SARS data
estimates	target	serial intervals
estimation	has-property	empirical
estimation	in-context	COVID-19 cases
events	in-context	transfer
evidence	has-property	significant
evidence	has-property	statistically significant
evidence	in-context	existence
evidence	in-context	many
evidence	in-context	selection
evidence	in-place	branch
evidence	subject	phylogenetic uniting
evidence	subject	uniting
evidence	target	similarity
evidences	causes	2019-nCoV
evidences	in-context	rapid human-tohuman transmission
evolution	entails	amino acid similarity
evolution	entails	similarity
evolution	has-property	accelerated
evolution	has-property	convergent
evolution	has-property	recent
evolution	has-property	related
evolution	has-property	selectively-mediated
evolution	in-context	selectively-mediated
evolution	subject	RBD
evolution	subject	RaTG13
evolution	subject	SARS-CoV-2
evolution	subject	pathogen
evolution	target	RBD
evolution	target	pathogen
evolutionary	has-property	convergent
evolutionary convergence	in-context	protein
evolutionary convergence	subject	branch
evolutionary convergence	target	branch
evolve	has-property	gradually
evolve	subject	SARS-CoV-2
evolve	target	virus
evolve	target	virus similar to influenza
exacerbate	causes	disease
exacerbate	has-property	inadvertently
exacerbate	in-context	infection
exacerbate	subject	Other
exacerbate	subject	agents
exacerbate	subject	infections
exacerbate	target	COVID-19
exacerbate	target	disease
exacerbated	subject	death rate
exacerbated	subject	rate
exacerbated	subject	transmission
exacerbated	target	risk
exacerbated	target	worsen
exacerbation	target	asthma
exacerbations	has-property	virus-induced
exacerbations	in-context	COPD
examination	causes	detected
examination	entails	detected
examination	in-context	post-mortem
examination	in-time	post-mortem
examination	target	skeletal muscle
examined	entails	found
examined	in-context	this
examined	in-place	Renmin
examined	subject	We
examined	target	environmental factors
examined	target	patients
examining	target	SARS-CoV antigen staining
example	entails	most studied
example	has-property	most studied
example	in-context	plasmids
example	in-context	unique world
exceed	in-time	kicks in
exceed	subject	concentrations
exceed	target	0.5%
exceed	target	threshold
excessive synthesis of IL-6	entails	virus
exchange	has-property	fluid
exhausted	in-context	patients
exhausted	target	T cells
exhaustion	in-context	T cell
exhaustion	in-context	infection
exhaustion	in-place	COVID-19 patients
exhaustion	in-place	those
exhaustion	in-time	infection
exhaustion	target	T cell
exhaustion markers	in-context	PD-1
exhaustion markers	in-context	Tim-3
exhaustion markers	in-place	T cells
exhibited	in-context	echo
exhibited	in-context	study
exhibited	in-place	echo
exhibited	subject	58.33%
exhibited	subject	78%
exhibited	subject	Construction
exhibited	subject	FCS
exhibited	subject	KNTC1-null RPE
exhibited	subject	patients
exhibited	subject	proteins
exhibited	target	ARF
exhibited	target	LV dysfunction
exhibited	target	PPI
exhibited	target	SAC failure
exhibited	target	clear sequence
exhibited	target	perception
exhibited	target	rule
exhibited	target	sequence and rule
exhibiting	in-place	China
exhibiting	in-time	currently
exhibiting	subject	COVID-19
exhibiting	target	transmission
exhibits	causes	hypothesize
exhibits	subject	genome
exhibits	subject	method
exhibits	target	potential
exhibits	target	similarity
existence	causes	need
existence	has-property	non-neutralizing
existence	has-property	potential
existence	target	asymptomatic
existence	target	presymptomatic
existence	target	protective antibodies
existing drugs	has-property	antiviral efficacy
expect	has-property	reasonable
expect	subject	aspects
expect	target	similar
expected	subject	transitions
expected	target	differ
experience	has-property	medical
experience	in-context	physician
experience	in-context	physician's
experience	in-time	previous
experienced	has-property	fatal
experienced	subject	patients
experienced	target	"cytokine storms"
experiencing	subject	features
experiencing	target	recovery
experiments	entails	influence
experiments	has-property	simulated
explain	subject	binding
explain	subject	depletion
explain	subject	participates
explain	target	change
explain	target	detected
explain	target	transmissibility
explaining	subject	SARS-CoV-2
explaining	target	spread
explaining	target	virulence
exponential rise	target	cases COVID-19
exposed	in-context	antimicrobial therapy
exposed	in-context	therapy
exposed	target	patients
exposed	target	these
exposure	in-context	situations
exposure	is-a	measures
exposure	subject	patient
exposure	target	patient
exposure	target	situations
exposure route	target	SARS-CoV-2
expressed	causes	attacked
expressed	entails	attacked
expressed	in-place	AT2 cells
expressed	in-place	lungs
expressed	subject	ACE2
expressed	target	ACE2
expressed	target	AT2 cells
expressed	target	lungs
expressing	subject	Measurements
expressing	subject	recombinant ACE2
expressing	target	293T
expressing	target	293T cells
expression	has-property	Cas13d
expression	has-property	differential
expression	has-property	increased
expression	has-property	suppressed
expression	in-context	airway microbial diversity
expression	in-context	host gene
expression	in-context	host immune response genes
expression	in-context	two
expression	in-place	patients
expression	in-place	two
expression of fibrinogen	in-place	lung
extracellular	in-context	pools
exudates	in-context	cellular
exudates	in-context	fibromyxoid
facilitate	subject	characteristics
facilitate	subject	epidemic information
facilitate	subject	intervention
facilitate	target	control
facilitate	target	psychological treatment
facilitate	target	spread
facilitate	target	treatment
facilitating	in-place	host cells
facilitating	subject	CD147
facilitating	target	SARS-CoV-2
facilitating	target	SARS-CoV-2 invasion
facilitating	target	invasion
facing	causes	response
facing	has-property	period
facing	in-context	phase
facing	subject	HCWs
facing	target	shortage of protective materials
facing	target	situation
factor	has-property	limiting
factor	target	two
factors	causes	inflammation
factors	causes	severity
factors	has-property	high risk
factors	has-property	powerful
factors	has-property	prognostic
factors	has-property	understood
factors	in-context	identification
factors	in-context	injury
factors	in-context	patients
factors	in-context	prognostic
fail	has-property	usually
fail	in-context	maintain
fail	subject	metapopulations
fail	subject	those
failure	entails	ventilation
failure	has-part	acute
failure	has-property	respiratory
failure	in-context	heart
failure	subject	treatment
failure	target	heart
fall	has-property	0.8%
fall	has-property	0.9%
fall	subject	CFR
families	has-part	fibers
families	has-property	perpendicularly oriented
families	in-context	HCW
families	in-context	HCWs
families	in-context	fibers
families	in-context	oriented
family	has-part	members
family	in-context	HCWs
fasciculus	has-property	fronto-occipital
fasciculus	has-property	inferior
fasciculus	has-property	longitudinal
fasciculus	has-property	superior
faster	in-context	RT-PCR
faster	in-context	SARS
fatality	has-property	lower
fatality	has-property	lower-case
fatality	in-context	cases
fatality	in-context	patients
fatality	in-place	ICU
fatality	same-as	5.2%
fatality	same-as	5.7%
fatigue	has-property	insidious
fatigue	has-property	prominent
fatigue	is-a	associated
fatigue	is-a	manifestations
fatigue	is-a	symptoms
fatty acid	has-property	role
fatty acid	in-place	S1
fatty acid	in-place	S2
fatty acid	is-a	ligands
favorable	causes	isolate
feature	has-property	common
feature	has-property	crucial
feature	in-context	infection
features	has-property	NCP type
features	has-property	harbours
features	has-property	key
features	has-property	pathological
features	in-context	pneumonia
features	in-context	viroporin
feeding	target	infant
female	in-context	patients
fermentation	has-property	kicks
fermentation	target	sugar
fever	has-property	insidious
fever	has-property	prominent
fever	is-a	associated
fever	is-a	symptoms
fewer	entails	more
fewer	target	clones
fiber	in-context	T3
fiber	in-context	tail
fibrillation	has-property	atrial
fibrillation	has-property	persistent
fibromyxoid	has-property	cellular
fibrous lesion	has-property	specific
fidelity	has-property	spatial
fidelity	has-property	temporal
field	has-property	mean
field	has-property	two-dimensional
field	in-context	all-atom
field	in-context	force
filter	in-context	given position
finally	in-context	followed
finally	target	targeting
financial	in-context	99.8%
financial	is-a	implications
finding	target	uses
findings	entails	end
findings	entails	reduces
findings	has-property	atypical
findings	has-property	previous
findings	in-context	change
findings	in-context	imaging
findings	in-context	patients
findings	in-place	some
findings	subject	imaging
findings	target	CT
findings	target	some
first	has-property	following
first	in-context	energy
first	is-a	week
first deaths	entails	hundreds to thousands of cases
fission	has-property	curved
fission products	has-property	curved
fitness	has-property	host-specific
fitness	has-property	overall
five	in-context	these same
fixed-target PCR	causes	bias
fluctuations	target	species
fluctuations	target	strains
fluid exchange	in-context	time-lapse
focus	in-context	impact
folding pattern	has-property	similar
folds	has-property	147 3
folds	has-property	around
folds	in-place	around
folds	in-place	bundle
folds	subject	domain
folds	subject	head domain
followed	in-context	scenario
followed	subject	interventions
followed	subject	replication
followed	target	interventions
followed	target	protect
followed	target	switch
following	in-context	infection
following	subject	patients
following	subject	up to 14 days
following	target	infection
following	target	start
following first (second) week	in-context	February 2-15 subsample
follows	in-context	case
follows	subject	number
follows	target	distribution
foot and mouth disease	is-a	virus
foot and mouth disease virus	is-a	viruses
force field	has-property	all-atom
forcing	subject	isolation
forcing	subject	surveillance
forcing	target	R below one
form	has-property	bound
form	in-context	ligand
form	in-place	ligand
formation	entails	stop
formation	in-context	SE-PGQs
formation	in-context	hyaline membrane
formation	in-place	packing
formation	subject	PCR artifacts
formation	subject	complex
formation	target	artifacts
formation	target	complex
formation	target	membrane
formation	target	particles
former	has-property	required
found	causes	decreased
found	has-property	at the same time
found	in-context	A
found	in-context	B
found	in-context	O
found	in-context	approach
found	in-context	horizontal gene transmission
found	in-context	lineages
found	in-place	COVID-19
found	in-place	Wuhan
found	in-place	along
found	in-place	four
found	in-time	December 2019
found	subject	ORF6
found	subject	ORF8
found	subject	We
found	subject	pathogenic mutations
found	subject	protein
found	subject	r-selected K276R substitution
found	target	COVID-19
found	target	PK region
found	target	congestion
found	target	evidence
found	target	positive
found	target	relative
found	target	trend
four	in-context	patients
fraction	in-context	residues
framework	in-context	repurposing
fredox	causes	complexity
fredox	has-property	robustness
from	target	December 8, 2019
from	target	areas
full system	has-property	dynamics
function	has-property	elucidated
function	has-property	kidney
function	in-context	proteins
function(s)	target	proteins
functional	subject	virus
functional receptor	in-context	SARS-CoV-2
functions	has-property	novel
functions	in-place	crystal structure
fungal	is-a	pathogens
future research	has-property	focus
gas	has-property	antiviral activity
gene	has-property	interferon-stimulated
gene	has-property	unique
gene	in-context	Phage-mediated
generate	subject	set
generate	target	inhibitors
generation	target	COVID-19
genes	has-property	New
genes	has-property	expression
genes EDS1	is-a	components
genetic	has-part	targeting
genome	has-part	2002 SARS-CoV
genome	has-property	SARS-CoV-2
genome	has-property	infectious
genome	has-property	length
genome	has-property	phylogenetically close
genome	has-property	sequence identity
genome	has-property	size
genome	in-context	2019-nCoV
genome	in-context	276
genome	in-context	SARS-CoV-2
genome	in-place	2002 SARS-CoV
genome size	in-context	increases
genomes	has-property	diploid
genomes	has-property	fully assembled
genomes	has-property	normal
genomes	has-property	partially assembled
genomes	is-a	majority
genomic	in-context	COVID-19
genomic data	has-property	available
genomic data	has-property	majority
genomic data	in-context	COVID-19
genotyping	target	mNGS
given	in-context	scenario
given	subject	priority
given	target	protect
gloves	has-property	contaminated
gloves	subject	exposure route
glutamic acid	is-a	acidic residues
glycan	has-property	role
glycan	in-place	S1
glycan	in-place	S2
glycan	is-a	ligands
glycine	same-as	G
graft versus host disease	causes	fever
graft versus host disease	causes	mimic infection
graft versus host disease	causes	pulmonary inflammation
graft versus host disease	is-a	noninfectious inflammatory conditions
graft versus host disease	same-as	GVHD
greater	in-context	Middle Eastern respiratory syndrome
greater	in-context	severe acute respiratory syndrome
greater	target	infectivity
greatest	in-context	need
grids	has-part	holes
grids	has-property	cryoEM
ground-truth	in-context	CT scan
ground-truth	same-as	0
ground-truth	same-as	1
ground-truth label	has-property	1
group	has-property	ZIKV
group	has-property	n=5
group	in-context	COVID-19
group	in-context	failure
groups	has-property	blood
groups	has-property	risk
groups	in-context	age
groups	in-context	blood
growth	has-property	early
growth	has-property	further
growth	has-property	rate
growth	has-property	viral
growth	in-context	epidemic
growth	in-context	further
growth performance	has-property	decreased
growth performance	in-context	pigs
gyri	has-property	inferior
gyri	has-property	middle
gyri	has-property	temporal
gyrus	has-property	angular
had	entails	indicating
had	entails	require
had	has-property	more
had	in-context	group
had	subject	BtCoV
had	subject	COVID-19
had	subject	MERS
had	subject	MHV
had	subject	case
had	subject	group
had	subject	our cases
had	subject	pangolin P1E virus
had	subject	pneumonia
had	subject	~15%
had	target	<1
had	target	CFR
had	target	RT-LAMP
had	target	account
had	target	disease
had	target	illness
had	target	similar codon usage
had	target	ventilation
had been facing	causes	response
had been facing	in-time	phase
had been facing	subject	HCWs
had been facing	target	situation
half	in-context	patients
hands	has-property	contaminated
hands	subject	exposure route
harbored	subject	strains
harbored	target	9
harbors	subject	it
harbors	target	attenuation element
has	in-time	before
has	subject	One
has	subject	RT-LAMP
has	subject	patient
has	subject	simian virus 40 (SV40) pA
has	target	atrial fibrillation
has	target	effect
has	target	fibrillation
has	target	value
has been associated	subject	virus
has been associated	target	respiratory infections
has been characterized	target	changes
has been described	target	detection
has been verified	in-place	clinical trials
has been verified	target	safety
has declared	in-context	global public health emergency
has declared	subject	WHO
has declared	target	COVID-19
has spread	in-context	from
has spread	in-context	to
has spread	subject	COVID-19
have	has-property	more likely
have	has-property	similar
have	has-property	similar 58 amino acid
have	in-context	MERS
have	in-context	SARS
have	in-place	populations
have	in-time	admission
have	subject	130 cities
have	subject	29%
have	subject	COVID-19
have	subject	CVL218
have	subject	both diseases
have	subject	half
have	subject	households
have	subject	patients
have	subject	proteins
have	subject	ritonavir
have	subject	some
have	target	COVID-19
have	target	GGO
have	target	child
have	target	defects
have	target	efficacy
have	target	fever
have	target	genetic similarity
have	target	greater
have	target	history
have	target	impact
have	target	lower
have	target	milieu
have	target	potential
have	target	septal thickening
have	target	severe
have	target	spectrum of severity
have	target	≥50% chance
have been associated	subject	CMV
have been associated	subject	HHV-6
have been associated	target	pneumonitis
have been observed	in-context	CT scan
have been observed	in-place	patients
have been observed	subject	high risk factors
have established	in-context	RNA viruses
have established	target	RNA intermediates
have established	target	pathogenicity
have even incorporated	subject	microarrays
have even incorporated	target	sequences
have found	subject	Researchers
have found	target	invade
have reduced	subject	carriers
have reduced	target	inflammation
have shown	subject	studies
have shown	target	ACE2
have to spent	entails	increase
have to spent	has-property	more
have to spent	subject	HCWs
have to spent	target	contacting
having	in-place	Wuhan
having	in-time	3 weeks
having	subject	130 cities
having	subject	ORF3b
having	target	case
having	target	sequence similarity
having re-acquired	subject	these
having re-acquired	target	cycle
head	has-property	C-terminal
head domain	in-context	NSP8 C-terminal
health	has-property	public
health	in-context	99.8%
health	in-context	mental
health	is-a	implications
health	is-a	measures
health emergency	has-property	global
health emergency	has-property	public
health threat	has-property	acute
health threat	in-place	world
healthy	is-a	patients
heart failure	is-a	group
heart failure	subject	patients
heat map	has-part	patterns
heat shock protein 90 alpha family class A member 1	is-a	AIPs
heat shock protein 90 alpha family class A member 1	is-a	drugs
heat shock protein 90 alpha family class A member 1	same-as	HSP90AA1
helicase	has-property	crystal structure
helix	has-property	short
help	subject	This
help	target	explain
helped	subject	3D lung mask
helped	subject	lung mask
helped	target	detect
helped	target	reduce
helpful	in-context	prevent
helps	subject	linked
helps	target	counteract
hematopoietic cellular transplant	same-as	HCT
hemisphere	has-property	left
hemisphere	has-property	posterior
hemisphere	has-property	superior
hemodynamic support	has-property	adequate
hepatitis virus strain-3 infection	has-property	murine
heterozygosity	has-property	not uniform
heterozygosity	has-property	uniform
heterozygosity	in-context	genome
heterozygosity	in-context	genomes
heterozygosity	in-context	normal diploid genomes
heterozygosity	in-place	276 the genome
high	entails	designed
high	entails	serious
high	has-property	correlation
high	in-context	migrants
high	subject	prevalence
high	target	levels
high	target	migrants
high adaptability	in-context	205
high rates	causes	challenging
high rates	in-context	noninfectious inflammatory conditions
high risk	in-context	pneumonia
high risk factors	in-context	injury
high temperatures	in-context	die
high-affinity binding	target	angiotensin-converting enzyme 2 (ACE2)
higher	causes	decrease
higher	in-context	Non-ICU
higher	in-context	Non-ICU cases
higher	in-context	SARS-CoV
higher	in-context	accumulation
higher	in-context	acquiring
higher	in-context	binds
higher	in-context	group
higher	in-context	healthy
higher	in-context	healthy controls
higher	in-context	negative controls
higher	in-context	risk
higher	in-context	wt
higher	in-time	2003
higher	subject	People
higher	subject	confirmed
higher	subject	suspected
higher	subject	wind speeds
higher	target	People
higher	target	affinity
higher	target	controls
higher	target	non-A blood groups
highlights	subject	existence
highlights	target	need
hinder	has-property	direct
history	has-property	clear
history	has-property	past
history	in-context	CKD
history	in-context	chronic kidney disease
history	in-context	contact
history	in-context	disease
history	in-context	eye disease
history	in-place	areas
homeostasis	has-property	intracellular
homeostasis	subject	cholesterol
homology	causes	detected
homology	has-property	red
homology	has-property	solvated
homology	in-context	SARS-CoV S
homology	in-context	SARS-CoV-2
homology	in-context	Zika
homology	in-context	amino acid
homology	in-context	lipases
homology	in-context	modeled proteins
homology	subject	Virus sequence
homology	target	SARS-CoV
homology	target	proteins
homology	target	sequence
hospitalization	in-context	COVID-19
hospitalization	subject	LRTI
hospitalization	subject	Lower respiratory tract infections
hospitalization	target	recipients
host	causes	pathogenesis
host	has-property	dominance
host	has-property	overexuberant
host	in-context	immunity
host proteins	has-property	HCoV-associated
host response	in-context	patients
households	has-part	29%
households	in-context	healthcare worker
households	in-context	worker
households	in-place	US
human	has-part	HEK293
human	has-part	SY5Y
human	has-part	interactome
human	has-part	proteome
human	has-property	interactome
human	in-context	other
human cells	in-place	target tissues
human disease	in-context	lethal outcomes
human immunodeficiency virus	is-a	virus
human immunodeficiency virus	is-a	viruses
human immunodeficiency virus	same-as	HIV
human telomerase RNA	has-part	PK
human to human transmission	subject	makes
human-tohuman transmission	entails	contagious
humans	in-context	close contact
humans	is-a	ciliated Eukaryotes
humans	is-a	most ciliated Eukaryotes
humidity	entails	relationship
humidity	has-property	lower
humidity	in-context	Absolute
humidity	in-time	winter
hydrolysis	target	NTP
hygiene	in-context	respiratory
hypersensitivity	has-property	type 1 inflammatory cues
hypersensitivity	is-a	type 1 inflammatory cues
hypothesize	subject	we
hypothesize	target	be preserved
hypoxemia	has-property	refractory
identical	in-context	50%
identical	in-context	79%
identical	in-context	88%
identical	subject	MERS
identical	subject	SARS-CoV
identical	subject	bat-SL-CoVZC45
identical	subject	bat-SL-CoVZXC21
identical	subject	genome
identical	target	50%
identical	target	79%
identical	target	88%
identification	causes	reducing
identification	has-property	early
identification	in-context	simultaneously
identification	in-context	subjects
identification	in-context	two
identification	in-place	subjects
identification	subject	factors
identification	target	bacterial pathogens
identification	target	cases
identification	target	infection
identification	target	infections
identification	target	viral
identification	target	viral pathogens
identified	in-context	cases
identified	in-context	drugs
identified	in-place	ciliomes
identified	in-time	soon
identified	subject	DNAseq
identified	subject	RNAseq
identified	subject	domain
identified	subject	mNGS
identified	subject	predict
identified	subject	we
identified	target	DNA viruses
identified	target	EVC3.1
identified	target	EVC3.2 323
identified	target	RNA viruses
identified	target	candidates
identified	target	cases
identified	target	domain
identified	target	genomes
identified	target	lopinavir
identified	target	microbes transcriptionally
identified	target	patients
identified	target	ritonavir
identified,	has-property	soon
identified,	target	cases
identify	has-property	challenge
identify	in-context	contact
identify	in-context	patients
identify	in-time	contact
identify	in-time	epidemic period
identify	subject	doctors
identify	target	antiviral effects
identify	target	pneumonia
identifying	target	areas
identity	has-property	70%
identity	has-property	79%
identity	has-property	sequence
identity	in-context	S-protein
identity	in-context	whole-genome level 5
identity	subject	sequence
identity	target	S
ike	subject	particles
ike	target	SARS-CoV
ill	has-property	critically
illness	has-property	severe
illness	in-context	respiratory
illnesses	has-property	acute
illnesses	in-context	respiratory
imaging	causes	screening
imaging	has-property	atypical
immune	has-property	adaptive
immune	in-context	human
immune response	causes	organ injury
immune response	causes	pathogenesis
immune response	has-property	overexuberant
immune response	in-context	SARS-CoV-2 infection
immune response	in-context	acquired
immune response	in-context	host
immune response	in-context	innate
immune response	subject	host
immunity	has-property	innate
immunity	target	population
immunity against	target	HCoV-HKU1
immunity against	target	HCoV-OC43
immuno-depletion	entails	risk
immunocompromised patients	is-a	pathogen
immunodepletion	in-context	hypoxemia
immunodepletion	in-context	refractory hypoxemia
immunodepletion	is-a	subtype
immunologic response	has-part	host's
immunosuppressed	has-property	patients
impact	has-property	further
impact	in-context	patients'
impact	subject	COVID-19
impact	subject	environmental factors
impact	subject	human-to-human contact
impact	subject	population mobility
impact	target	droplet transmission
impact	target	function
impact	target	kidney function
impact	target	survival
impact	target	symptoms
impairment	in-context	kidney
implanted	causes	activation
implanted	in-place	brain
implanted	in-time	four weeks
implanted	subject	Ce:GAGG
implanted	target	Ce:GAGG crystals
implementation	causes	identified
implementation	entails	attend
implementation	entails	identified,
implementation	has-property	high-quality
implementation	in-context	disease control actions
implementation	target	actions
implementation	target	interventions
implemented	entails	levels of prevented cases
implemented	in-context	COVID-19
implemented	in-context	earlier
implemented	in-time	COVID-19 outbreaks
implemented	in-time	place
implemented	subject	lead
implemented	target	Isolation
implemented	target	contact tracing
implemented	target	management
implemented	target	school closures
implemented	target	tracing
implemented	target	treatment
importance	in-context	sanitization
important	in-context	identification
important	in-context	reducing
important	in-time	viral infection
important	is-a	work
important	subject	dynamics
important	target	development
important	target	division
imported	in-place	Wuhan
imposed	causes	decreased
imposed	target	health
imposed	target	public
improve	causes	prioritise
improve	in-context	treatment
improve	subject	avoiding
improve	subject	hospitals
improve	subject	iNO gas
improve	subject	impairment
improve	subject	including
improve	subject	preference
improve	subject	treatment
improve	target	clinical pathways
improve	target	efficiency
improve	target	oxygenation
improve	target	pathways
improve	target	patients' prognosis
improve	target	prognosis
improved	in-context	use
improved	target	efficiency
improved	target	sensitivity
improves	subject	best clinical response
in comparison	in-context	full spike region
incapacity	has-property	lymphocyte
incapacity	in-context	lymphocyte
incidence	in-context	confirmed
include	subject	manifestations of SARS-CoV-2
include	target	breathing difficulty
include	target	cough
include	target	dry
include	target	fever
include	target	weakness
included	in-place	study
included	subject	age
included	subject	cases
included	subject	regions
included	subject	symptoms
included	target	COVID-19 EWS
included	target	arthralgia
included	target	damage
included	target	myalgia
included	target	shortness of breath
including	in-context	belong
including	subject	monitoring
including	subject	others
including	target	CMV
including	target	HHV-6
including	target	changes
including	target	support
including	target	ultrasound
increase	causes	improve
increase	causes	ration
increase	entails	improve
increase	entails	ration
increase	has-property	marked
increase	in-context	COVID-19
increase	in-context	absence
increase	in-context	role
increase	in-time	infection
increase	subject	NLR
increase	subject	contacting with
increase	subject	number
increase	subject	treatment
increase	target	JNK
increase	target	chances
increase	target	have
increase	target	mortality
increase	target	numbe
increase	target	p38 phosphorylation
increase	target	patients
increase	target	phosphorylation
increase	target	survival
increased	causes	These
increased	entails	selection
increased	in-context	3 fold
increased	in-context	DTR values
increased	in-context	OR
increased	in-context	dose-dependent
increased	in-context	dose-dependent manner
increased	in-context	in comparison
increased	in-context	patients
increased	in-context	population
increased	in-context	values
increased	in-place	Tabriz
increased	in-place	blood group A
increased	in-place	patients
increased	in-time	cold season
increased	in-time	season
increased	is-a	measures
increased	same-as	release
increased	subject	LPS treatment
increased	subject	SARS-CoV-2 WIV04
increased	subject	rates
increased	subject	risk
increased	subject	secretion
increased	target	ATG5
increased	target	LC3B-II
increased	target	dN/dS ratio
increased	target	risk
increased	target	self-quarantine
increased	target	synonymous substitution
increased expression	target	host immune response genes
increases	entails	delays
increases	entails	potential
increases	in-context	genome
increases	subject	substitutions
increases	subject	temperature
increases	target	doubling time
increases	target	number
increasing	entails	become
increasing	target	D
increasing	target	κ
incubating	in-context	buffer
incubating	in-place	buffer
incubating	is-a	assays
incubating	target	20 μg pcMNPs
incubating	target	RNA molecules
incubating	target	molecules
incubating	target	pcMNPs
incubation	in-context	COVID-19
incubation	in-context	symptoms
incubation	in-time	2-7
incubation	subject	COVID-19
incubation period	causes	spread
incubation period	causes	time delay
incubation period	has-property	estimated
incubation period	has-property	long
incubation period	has-property	mean
incubation period	in-context	COVID-19
incubation period	in-context	infections
incubation period	same-as	4.9
incubation period	same-as	4.9 days
incubation time	has-property	shorter
index	has-part	loop
index	has-property	loop
index	is-a	finger
indicate	in-context	assumption
indicate	subject	severity
indicate	target	severity
indicated	subject	CVL218
indicated	subject	Logistic regression analysis
indicated	subject	analysis
indicated	subject	data
indicated	target	COVID-19
indicated	target	pharmacokinetic profile of CVL218
indicated	target	risk factor
indicated	target	severity
indicates	subject	Superposition
indicates	subject	X
indicates	subject	limited data
indicates	subject	seasonality factor
indicates	target	SARS-CoV-2
indicates	target	amino acids
indicates	target	cases
indicates	target	involved
indicates	target	spread
indicating	subject	reads
indicating	subject	show
indicating	target	ARDS
indicating	target	acute respiratory distress syndrome
indicating	target	dominate
indicating	target	specificity
indicating	target	suppressed
indicator	has-property	effective
indicator	has-property	reliable
indicator	in-context	COVID-19
indicator	in-context	disease
indicator	in-context	patients
indicator	subject	decrease
indicator	subject	lymphopenia
indicator	target	COVID-19
indicator	target	disease
indicator	target	hospitalization
indicator	target	severity
individual	causes	cases
individuals	has-property	infected
individuals	has-property	uninfected
induced	entails	confirming
induced	has-property	higher
induced	subject	DUB
induced	subject	SARS-CoV-2
induced	subject	activation
induced	subject	hemagglutinin
induced	subject	inflammation
induced	subject	viruses
induced	target	70% cross immunity
induced	target	bystander activation
induced	target	inflammation
induced	target	levels
induced	target	lysis
induces	target	HCoV-HKU1
inefficient	in-context	computationally
infect	subject	patients
infect	target	others
infected	has-part	9%
infected	has-property	disease severity
infected	has-property	easily
infected	has-property	severely
infected	in-context	COVID-19
infected	in-context	MERS-CoV
infected	in-context	SARS-CoV
infected	in-context	asymptomatic
infected	in-context	close contact
infected	in-context	more
infected	in-context	protection
infected	subject	COVID-19
infected	subject	Middle East respiratory syndrome
infected	subject	SARS-CoV
infected	target	HCWs
infected	target	cells
infected	target	males
infected	target	patients
infected	target	people
infected individuals	has-property	ascertained
infected individuals	has-property	reported
infection	causes	ARDS
infection	causes	complications
infection	causes	contagious
infection	causes	decrease
infection	causes	growth performance
infection	entails	COVID-19
infection	entails	outbreak
infection	has-property	Diagnosis criteria
infection	has-property	asymptomatic
infection	has-property	bacterial
infection	has-property	cases
infection	has-property	cross
infection	has-property	fatal
infection	has-property	new
infection	has-property	risk
infection	has-property	severity
infection	has-property	successful
infection	has-property	unrecognized
infection	has-property	viral
infection	in-context	COVID-19
infection	in-context	H1N1
infection	in-context	RSV
infection	in-context	SARS-CoV
infection	in-context	SARS-CoV-2
infection	in-context	SeV
infection	in-context	health-care workers
infection	in-context	one
infection	in-context	severe
infection	in-place	China
infection	in-time	December 2019
infection	in-time	early stages
infection	in-time	shortage
infection	subject	COVID-19
infection	subject	PEDV
infection	subject	SARS-CoV-2
infection	subject	bacterial
infection	subject	entry
infection	target	SARS-CoV-2
infection	target	cells
infection	target	host cells
infection	target	nodes
infection	target	pigs
infection fatality risk (IFR)	has-property	0.5% to 0.8%.
infection fatality risk (IFR)	has-property	order
infection fatality risk (IFR)	same-as	the risk
infections	causes	mean generation interval
infections	has-property	asymptomatic
infections	has-property	mix
infections	has-property	more
infections	has-property	number
infections	has-property	symptomatic
infections	in-context	COVID-19
infections	in-context	subspecies
infections	subject	COVID-19
infectious	causes	differentiating
infectious	entails	differentiating
infectious	has-property	highly
infectious	in-time	incubation period
infectious	in-time	period
infectious period	has-part	beginning
infectiousness	has-property	high
infectiousness	in-context	contact
infectiousness	in-context	droplets
infectives	has-property	asymptomatic
infectivity	has-property	greater
inferior temporal gyri	is-a	regions
inflammation	causes	destruction
inflammation	has-property	TLR4-mediated
inflammation	has-property	hyper
inflammation	has-property	mediated
inflammation	in-context	TLR4
influence	has-property	considerable
influence	in-context	RTC assembly
influence	in-context	processing order
influence	subject	length
influence	target	VI
influence	target	assembly
influence	target	processing order
influenza	has-property	pandemic
influenza	in-context	infections
influenza	in-context	virus
influenza	is-a	pandemic
influenza	is-a	pathogen
influenza	is-a	respiratory pathogen
influenza	is-a	viruses
influenza A (H1N1)	has-property	severe
inform	subject	data
inform	target	clinical significance
inform	target	data
inform	target	significance
information	has-property	SARS-CoV
information	has-property	available
information	has-property	background
information	in-context	epidemic
infrared	has-property	near
inhibited	subject	emdoin
inhibited	target	3a protein
inhibition	has-property	sensitive
inhibition	in-context	crRNA
inhibition	subject	SARS-CoV-2
inhibition	target	SARS-CoV-2
inhibition	target	sensitive
inhibitor	subject	remdesivir
inhibitor	target	2019-nCov
inhibitor	target	PARP1
inhibitors	has-property	new
inhibitors	in-context	protease
inhibitory	has-property	therapeutic effect
inhibitory	in-context	SARS-CoV-2
inhibitory	subject	darunavir
inhibitory	subject	lopinavir
inhibitory	subject	ritonavir
inhibitory	target	CEP_C30
inhibitory	target	PLVP
inhibitory activity	has-property	moderately
inhibitory effect	in-context	PLVP
inhibitory effect	in-context	SARS-CoV-2
inhibitory effect	in-place	CEP_C30
inhibitory effect of darunavir	causes	inhibitory effect
inhibitory effect of darunavir	has-property	potential therapeutic effect
inhibitory effect of darunavir	in-context	SARS-CoV-2
initiate	subject	clinicians
initiate	target	agents
initiate	target	exacerbate
injury	has-property	COVID-19 -related
injury	has-property	cardiac
injury	has-property	liver
injury	has-property	multiple
injury	has-property	serious
injury	in-context	cardiac
injury	in-context	organic
injury	in-place	liver
injury	in-time	initial stage
injury	subject	host
injury	subject	viral load
injury	target	organ
input	in-context	CT
insertion	in-place	strain
insidious	in-context	admitted
insidious	subject	fatigue
insidious	subject	fever
insidious	subject	myalgia
insidious	subject	sputum
insidious	target	patients
insight	has-property	n
insight	in-context	presence
insight	in-context	type
inspecting	in-context	number
inspecting	target	number
instructed	entails	financial
instructed	entails	health
instructed	in-context	results
instructed	in-context	symptoms
instructed	subject	Patients
instructed	target	selfisolate
insult	has-part	lung epithelium
interact	has-property	predicted
interact	subject	proteins
interact	target	ASFV
interact	target	proteins
interacted	subject	proteins
interacted	target	hits
interacting	entails	playing
interacting	subject	residues
interacting	target	nucleotides
interaction	causes	invade
interaction	has-property	Protein-protein
interaction	has-property	favorable
interaction	in-context	ACE2
interaction	in-context	CD147
interaction	in-context	SARS-CoV spike protein
interaction	in-context	SP
interaction	in-context	binds
interaction	in-context	pig 146 ACE2
interaction	in-place	receptor binding domain
interaction	subject	ACE2
interaction	subject	CD147
interaction	subject	SARS-CoV
interaction	subject	receptor binding motif
interaction	target	ACE2
interaction	target	SP
interaction	target	pig 146 ACE2
interactions	causes	stabilize
interactions	entails	depend
interactions	has-property	many
interactions	has-property	protein-protein
interactions	in-context	role
interactions	in-place	SARS proteome
interactions	subject	Ca 2+
interactions	subject	acid
interactions	subject	fatty acid
interactions	subject	glycan
interactions	target	FP
interactions with	causes	depend on
interactions with	subject	Ca 2+
interactions with	target	FP
interactive	has-property	tightly
interactive	in-context	each other
interacts	in-context	lane 3
interacts	subject	CTD
interacts	target	CTD
interface	in-context	ACE2
interface sequence	has-property	closer
interfaces	in-context	COVID-19
interfaces	in-context	SARS-2002
interferon	causes	disrupts
interferon	causes	entering
interleukin-6	has-property	important
interleukin-6	is-a	cytokines
interleukin-6	same-as	IL-6
interleukin-6 (IL-6)	is-a	cytokines
intermediate compartment	has-property	endoplasmic
intermediates	causes	evolution
intermediates	has-property	phylogenetic
interval	has-property	mean
interval	in-context	generation
intervention	causes	psychological treatment
intervention	entails	facilitate
intervention	has-property	aggressive
intervention	has-property	constant-strength
intervention	has-property	early
intervention	has-property	required
intervention	has-property	strength
intervention	in-context	patients
intervention	in-context	strength
intervention	target	VT
intervention	target	patients
intervention	target	stress
interventions	has-property	high-quality
interventions	has-property	priority
interventions	has-property	targeting
interventions	in-context	contact tracing
interventions	in-context	least vulnerable
interventions	in-context	population
interventions	in-context	protect
interventions	in-context	scenario
interventions	in-context	tracing
intracellular	in-context	pools
intracellular origin	subject	viral RNA
introducing	subject	This
introducing	target	bias
introducing bias	has-part	fixed-target PCR
introducing bias	has-part	serologic
introduction	is-a	changes
introduction	target	atom
introduction	target	nitrogen atom
invade	has-property	symptoms
invade	in-context	high-affinity binding
invade	subject	SARS
invade	subject	SARS coronaviruses
invade	subject	SARS-CoV-2
invade	subject	SARS-CoV-2 coronaviruses
invade	target	cells
invade	target	digestive system
invade	target	hematological system
invade	target	host cells
invade	target	human cells
invade	target	respiratory system
invade	target	urinary system
invasion	has-property	SARS-CoV-2
invasion	in-context	SARS-CoV
invasion	in-place	cells
invasion	subject	SARS-CoV
invasion	subject	viruses
invasion	target	cells
invasion	target	host cells
investigate	causes	performed
investigate	in-context	PCR
investigate	in-context	Taq polymerase PCR stop assay
investigate	target	dynamics
investigate	target	formation
investigate	target	stop
investigation	has-property	further
investigation	in-place	hospital
investment	in-context	implementation
involved	in-context	features
involved	in-context	membrane permeabilization
involved	subject	T925
involved	subject	amino acids
involved	subject	mechanism
involved	target	binding
involved	target	binds to
involved	target	catalysis
involved	target	improved
involved	target	interaction
involving	subject	Carriage
involving	target	fluctuations
ion NTP hydrolysis	has-property	key role
ion NTP hydrolysis	in-context	nucleotides
ion NTP hydrolysis	subject	residues
is	subject	amplitude
is	subject	mortality
is	subject	process
is	subject	protein
is	target	half the amplitude
is	target	lower
is	target	protein
is	target	reaction
is due	subject	number
is due	target	less
is due	target	milder
is half	subject	amplitude
is half	target	amplitude
is sufficient	subject	flu vaccine
is sufficient	target	COVID-19 prevention
is the key	subject	deficiency
is the key	subject	incapacity
is the key	target	pathology
isolated	entails	implemented
isolated	in-place	body fluids
isolated	in-place	fluids
isolated	in-place	secretions
isolated	target	coronaviruses
isolated	target	pathogen
isolated	target	respiratory pathogen
isolates	has-property	domesticated
isolates	has-property	related
isolates	has-property	unclassified
isolates	is-a	yeasts
isolation	causes	reduce
isolation	has-property	imperfect
isolation	has-property	rapid
isolation	in-context	people
isolation	target	cases
isolation	target	infections
isolation	target	people
isopropyl ether 172	has-property	substituent
it	has-property	potential
it	has-property	related
it	is-a	bioterrorism agent
it	same-as	SARS-CoV
it	same-as	mRNA pseudoknot
its	same-as	viral RNA
its receptor	has-property	dipeptidyl peptidase 4
itself	same-as	SARS-CoV-2
justification	has-property	biological
keep	subject	authorities
keep	target	contained
key	in-context	management
key	in-context	treatment
key point	in-context	patients
key point for	subject	CT
key point for	target	patients
key residues	has-property	critical
key residues	has-property	six
key residues	in-place	SARS-CoV
key residues	subject	are all different
key residues	subject	binding to
key role	in-context	hydrolysis
key to	subject	establishment
key to	target	success
kicks in	subject	fermentation
kidney disease	has-property	basic
kidney disease	subject	patients
kidney function	in-context	patients
kinetics	in-context	aggregation
kinetochores	has-property	last
kinetochores	has-property	unattached
knowledge	has-property	COVID-19-related
knowledge	has-property	medical
knowledge	has-property	previous
knowledge	in-context	transmission approaches
knowledge	in-time	previous
laborious	in-context	processing steps
lack of knowledge	in-context	about transmission approaches
lack of treatment	subject	makes
landscapes	has-property	energy
landscapes	has-property	rugged
landscapes	in-context	CTLV1
landscapes	in-context	CTLV2
landscapes	in-context	CTLV3
landscapes	in-context	CTLV4
landscapes	in-context	CTT sequences
landscapes	in-context	increasing
landscapes	in-context	sequences
landscapes	in-context	variants
large value	in-context	screening
large value	in-context	testing
larger	in-context	0.1
late	in-context	January
latent	in-place	humans
latent	in-time	long time
later	in-time	January 23
later	target	January 23
law	in-context	development
law	in-context	epidemic development
lead	target	levels of prevented cases
leading	subject	branch
leading	subject	complications
leading	subject	spreading
leading	target	COVID-19
leading	target	adverse outcomes
leading	target	death
leading	target	declaration
leading	target	disease progression
leading	target	treatment failure
leading to	subject	branch
leading to	target	COVID-19
leads	subject	expressed
leads	target	learning
leads	target	respiratory failure
learn	has-property	biological justification
learn	has-property	justification
learn	has-property	possible
learn	in-context	position
learn	subject	filter
learn	target	only negative weights
learn	target	weights
learning	has-property	efficient
learning	has-property	fast
learning	in-context	sequences
learning	target	sequences
led	has-property	administratively
led	has-property	directly
led	subject	department,
led	target	president
left hemisphere posterior superior	is-a	regions
length	causes	contigs
length	has-property	30kb
length	has-property	longer
lengths	in-context	linker
lesion	has-property	fibrous
lesions	in-place	lung
less	has-property	little
less	in-context	MERS-CoV
less	in-context	SARS-CoV
less	in-context	susceptibility
less	in-context	widespread
less	subject	estimate
less	subject	infected
less	target	COVID-19
less	target	infected
less	target	series
less	target	widespread
lesser	in-context	compared
level	has-property	individuals'
level	in-context	exercise
level	in-context	expression
level of cross-immunity	in-context	HCoV-OC43
level of exercise	causes	relationship
levels	entails	injury
levels	entails	pneumonia
levels	has-property	decreased
levels	has-property	elevated
levels	has-property	high
levels	has-property	higher
levels	has-property	increased
levels	has-property	very high
levels	in-context	ALT
levels	in-context	AST
levels	in-context	IFN-β
levels	in-context	IL-10
levels	in-context	IL-6
levels	in-context	ISG
levels	in-context	LDH
levels	in-context	PCT
levels	in-context	PD-1
levels	in-context	TNF-α
levels	in-context	Tim-3
levels	in-context	enzymes
levels	in-context	exhaustion markers
levels	in-context	lymphocyte
levels	in-context	marker
levels	in-context	markers
levels	in-context	meet
levels	in-context	myocardial enzymes
levels	in-context	patients
levels	in-context	prealbumin
levels	in-context	serum IL-10
levels	in-place	T cells
levels	in-place	half
levels	in-place	one-third
levels	in-time	on admission
levels	is-a	marker
levels of LDH	has-property	increased
levels of prealbumin	has-property	decreased
library	has-property	original
life cycle	in-context	yeast
life cycle	subject	SARS-CoV
ligand	in-context	RBD
ligands	entails	role
ligands	in-context	acid
ligands	in-context	glycan
ligands	in-place	S1-S2
like	subject	parameters
like	target	CoVID-19
limit	subject	Social distancing
limit	subject	closures
limit	subject	distancing
limit	subject	school closures
limit	target	COVID-19 cases
limit	target	cases
limited	entails	change
limited	in-context	groups
limited	target	travel
lineages	has-property	3D G64S
lineages	in-context	158
lines	has-property	cell
linked	entails	counteract
linked	subject	ability
linked	target	conformation
liposomes	has-property	ampicillin-loaded
liposomes	has-property	heat-triggered
liposomes,	has-property	ampicillin-loaded
liposomes,	has-property	heat-triggered
lived	in-place	epidemic areas
lived	subject	people
liver	in-context	human
liver	in-place	ductal organoid
liver injury	in-place	one-third
living	in-place	Spain
load	has-property	high
load	has-property	viral
load	in-context	early stage
load	in-time	after symptom onset
load	subject	SARS-CoV-2
localized	in-place	cell membrane
localized	in-place	endoplasmic reticulum-Golgi intermediate compartment
localized	subject	GFP-MAD2 L13A
localized	subject	accessory proteins
localized	subject	yeast cytoplasmically
localized	target	linear double-stranded DNA plasmids
localized	target	metaphase kinetochores
locations	has-property	allow
locations	in-context	early stage
long after	in-context	downturns
long disorder segment	has-property	44-84 residues
long disorder segment	has-property	48-84 residues
longer	entails	decreases
longer	entails	more
longer	in-context	estimated
longer	subject	225 genome length
longer	subject	interval
longer	subject	read length
longer	target	cases
look-back windows	has-property	smaller
loops	has-property	flexible
loops	has-property	long
lopinavir	has-property	therapeutic effect
lopinavir	is-a	HIV-1 protease inhibitors
lopinavir	is-a	candidates
lopinavir	is-a	inhibitors
loss	has-property	decay-induced
loss	has-property	transcript
loss	has-property	viral
loss	target	transcript
low	in-context	<190/µL
low temperatures	in-context	survive
lower	has-property	effectively
lower	in-context	acquiring
lower	in-context	population
lower	in-context	risk
lower	in-time	winter
lower	subject	blood group O
lower	subject	mobility reduction
lower	subject	reduction
lower	target	airway microbial diversity
lower	target	fatality rate
lower	target	humidity
lower	target	incidence rate
lower	target	non-O blood groups
lower-case	in-context	Middle Eastern respiratory syndrome
lower-case	in-context	severe acute respiratory syndrome
lowest energy snapshot	in-context	trajectory
lung	has-part	epithelial
lung	has-part	epithelial cells
lung macrophage	has-property	population
lung mask	has-property	3D
lung mask	in-context	CT volume
lungs	in-context	COVID-19
lymphocyte	causes	cellular pathology
lymphocyte	has-property	circulating
lymphocyte	has-property	targetedly
lymphocytopenia	has-property	peripheral
lymphocytopenia	is-a	feature
lymphopenia	is-a	indicator
lysis	has-property	hemagglutinin-induced
mNGS	causes	identification
mNGS	entails	diagnostic
mNGS	in-context	bacterial pathogens
mNGS	in-context	clinical testing
mNGS	in-context	simultaneous
mNGS	same-as	Metagenomic next-generation sequencing
mRNA pseudoknot	has-property	three-stemmed
machinery	has-property	replication
main protease	has-property	essential
main protease	in-context	SARS-CoV
main protease	is-a	target
maintain	target	populations
maintains	subject	PARP2
maintains	target	genomic stability
maintenance	causes	effect
maintenance	target	levels
maintenance	target	lymphocyte levels
majority	entails	exacerbated
majority	entails	worsen
majority	has-property	elderly
majority	in-context	data
majority	in-context	parents
makes	subject	human to human transmission
makes	subject	mutation rate
makes	subject	survival time
makes	target	it
malaria	has-property	transmission
male	has-property	susceptible
male	in-context	patients
mammals	has-property	other
managed	causes	exposed
managed	has-property	pragmatically
managed	target	patients
managed	target	these
managemen	has-property	standardized
managemen	subject	obtain
managemen	subject	prognosis
managemen	subject	reduces
management	has-property	related
management	subject	respiratory pathogen
management	target	patients
manifestations	has-property	clinical
manifestations	has-property	neurological
manifestations	has-property	reported
manifestations	in-context	patients
many	in-context	cases
marker	has-property	suggesting
marker	in-context	cardiac
marker	in-context	corresponding
marker	target	complexity
marker levels	has-property	cardiac
marker levels	has-property	elevated
marker levels	in-context	half
markers	in-context	damage
markers	in-context	myocardial damage
matches	entails	equivalent
matches	subject	strength
matches	target	strength
matter	has-part	fasciculus
matter	has-property	underlying
matter	has-property	white
may be	has-part	latent
mean	has-property	5.84
mean	has-property	Reff(t)
mean	has-property	equal
mean	in-context	COVID-19
mean	in-context	Reff(t)
mean	in-context	incubation
mean	same-as	5.84
mean PPID	has-property	equal
mean PPID	in-context	Bat CoV
mean PPID	in-context	Human SARS
mean PPID	in-context	SARS-CoV-2
mean generation interval	has-property	longer
mean generation interval	in-context	COVID-19
measure	has-property	difficult
measure	target	occur
measurement	in-context	comprehensive
measurement	in-context	culture independent
measurement	target	microbial composition
measures	causes	82%
measures	causes	decreased
measures	causes	delay
measures	causes	reduce
measures	causes	reduction
measures	causes	transmission
measures	entails	reduction
measures	has-property	comprehensive
measures	has-property	containment
measures	has-property	control
measures	has-property	cost-effective
measures	has-property	enhanced
measures	has-property	important
measures	has-property	imposed
measures	has-property	preventive
measures	has-property	stringent
measures	in-context	control
measures	in-context	hygiene
measures	in-context	public health
measures	in-time	January
measures	is-a	factors
measures	is-a	measures
mechanism	has-property	overall
mechanism	in-context	efficiency
mechanism	in-context	sensitivity
mechanisms	causes	exacerbations
mechanisms	has-property	understood
median	has-property	133 days
median	has-property	5.0
median	in-context	COVID-19
median	in-context	incubation
median	same-as	5.0
mediate	has-property	directly
mediate	subject	latter
mediate	subject	residues 424-494
mediate	target	infection
mediate	target	interaction
mediate	target	invasion
meet	subject	features
meet	subject	markers
meet	target	definition
meets	entails	has
meets	subject	RT-LAMP
meets	target	these
members	has-property	cohabiting
members	in-context	cohabiting
members	in-context	family
membrane	has-property	hyaline
membrane	in-context	permeabilization
mental health problems	in-context	HCWs
merging	causes	leads
merging	causes	learning
merging	target	prediction results
merging	target	results
metapopulations	has-property	efficient
metapopulations	is-a	models
method	has-property	excellent performances
method	has-property	high adaptability
method	has-property	important
method	has-property	objective
method	has-property	pcMNPs-based
method	has-property	robustness
method	in-context	RNA markers
method	is-a	simplicity
methods	has-property	RT-PCR-based
mice	has-property	Aged
mice	has-property	Alzheimer's mutations
mice	has-property	aged
mice	has-property	deletion
mice	has-property	presenilin-1
mice	has-property	transgenic
mice	has-property	wildtype
mice	has-property	young Tg
mice	in-context	Aged transgenic
mice	in-context	Alzheimer's mutations
mice	in-context	aged wildtype
mice	in-context	young Tg
microarray approaches	has-property	useful
microarrays	causes	detection
microbe	has-property	underlying
microbe	in-context	underlying
microbes	has-property	respiratory pathogenicity
microbes	has-property	transcriptionally active
microbes transcriptionally	has-property	respiratory pathogenicity
microbes transcriptionally	in-context	active
microbial composition	has-property	measurement
microbiome	has-part	airway
microglial-targeted radiotracer	in-context	activated
middle temporal gyri	is-a	regions
migrants	in-place	Spain
mild	is-a	patients
milder	in-context	presentation
milieu	has-property	proinflammatory
minimized	has-property	first
minimized	in-context	1000
minimized	in-context	using
minimized	target	NS2B-NS3pro
missing	subject	salt-bridge
missing	target	SARS-CoV-2 RBD
model	has-property	SARS-CoV-2
model	has-property	dynamic
model	has-property	effective
model	has-property	infection
model	has-property	mathematical
model	has-property	mouse
model	has-property	outputs
model	has-property	useful
model	in-context	identifying
model	is-a	one
model amyloidogenic peptide derived from IAPP	same-as	NNFGAIL
model outputs	has-property	useful
modeling	subject	SEIR-PO
modeling	subject	SEIR-QD
modeling	target	COVID-10 epidemics
models	has-property	computationally inefficient
models	has-property	high resolution
models	has-property	network based
modulating	target	S1
modulating	target	S2
modulating	target	interfaces
molecular diagnosis	in-context	potential
molecular diagnosis	subject	pcMNPs-based method
molecular diagnosis	target	SARS-CoV-2
molecule	has-property	ATP
molecules	causes	Zika NS2B-NS3pro
molecules	causes	pocket
molecules	has-property	RNA
molecules	has-property	different scaffols
molecules	has-property	many
molecules	has-property	small
molecules	in-context	2 μg
molecules	in-context	scaffols
monitoring	has-property	active
monitoring	has-property	fetal
monitoring	in-context	women
monitoring	target	fetal
monkeys	in-context	SARS-CoV-2
monkeys with SARS-CoV-2 infection	in-context	recovery
morbidity	has-property	significant
morbidity	in-context	outbreak
more	causes	decrease
more	in-context	70%
more	in-context	infections
more	in-context	managed
more	in-context	persistent
more	in-context	symptomatic
more	in-context	time
more	subject	precipitation
more	subject	these
more	target	contigs
more	target	patients
more	target	severe
more contagious	in-context	SARS
morphology	has-property	rounded
morphology	has-property	specific
mortality	has-part	effects
mortality	has-property	lower
mortality	has-property	related
mortality	has-property	significant
mortality	in-context	COVID-19
mortality	in-context	infection
mortality	in-context	outbreak
mortality	subject	LRTI
mortality	subject	SARS-CoV-2
mortality	target	recipients
most	has-property	NCP type
most	in-context	24
mothers	in-context	COVID-19
mothers	in-context	pneumonia
motif	entails	properties
motif	has-property	receptor binding
motifs	in-context	sequence
motivates	subject	This
motivates	subject	goal
motivates	target	design
motor	has-property	antagonistic
mouse model	has-property	effective
mouse model	in-context	SARS-CoV-2 infection
movement	in-context	machinery
movement	subject	polymerase replication machinery
moving	in-place	naphthyl ring system
moving	is-a	changes
moving	target	isopropyl ether 172
muscle	in-place	skeletal
mutagenesis	in-context	PCR
mutagenesis	subject	PCR
mutation rate	has-property	High
mutation rate	subject	makes
mutations	has-property	nucleotide
mutations	has-property	pathogenic
mutations	has-property	synonymous
mutations	in-context	RaTG13
mutations	in-context	SARS-CoV-2
mutations	in-context	human telomerase RNA
mutations	in-place	PK
mutations	in-place	strain
myalgia	has-property	insidious
myalgia	has-property	prominent
myalgia	is-a	associated
myalgia	is-a	manifestations
myalgia	is-a	symptoms
nasal	is-a	swab
nasal symptoms	is-a	symptoms
nasopharyngeal	is-a	swab
ndividuals	has-property	level of exercise
necessary	entails	to achieve
necessary	target	to occur
need	entails	exposed
need	has-property	model
need	in-context	managed
need	in-context	mouse model
need	in-context	patients
need	in-context	ventilatory support
need	subject	triggers
need	target	investigation
need	target	more
need	target	provision
need	target	ventilatory support
needed	in-context	assimilate
needed	in-context	mothers
needed	subject	breastfeeding
needed	subject	deciding
needed	subject	encouragement
needed	subject	use
needed	target	consensus
negative	is-a	selection
negative testing	in-context	clinical
network based	has-property	inefficient
network based	is-a	models
network proximity analysis	entails	association
neutralize	subject	antibodies
neutralize	target	2019-nCoV
newborns	in-context	mothers
niches	has-property	wild
nine	in-context	residues
nitrogen atom	has-property	additional
nitrogen atom	has-property	aromatic
nitrogen atom	has-property	bound
nitrogen atom	has-property	ring-173
nitrogen atom	same-as	B#57
normal diploid genomes	same-as	not inbred lab strains
normal diploid genomes	same-as	wild strains
not	same-as	found
not closer	in-context	ORF3b
not exactly the same	in-context	that
not targeted	has-part	specifically
not targeted	target	SARS-CoV-2
notably reduced	has-property	but still high
notably reduced	subject	protein
notably reduced	target	genetic similarity
noted	in-context	examining
noted	in-place	106 parenchymal staining
noted	in-place	airway
noted	in-place	antigen distribution
noted	in-place	identity scale
noted	in-place	models
noted	subject	differences
noted	target	Muc4
noted	target	WT
noted	target	differences
noted	target	homology
nsp8-9	is-a	cleavage site
nucleic acid	has-property	Positive
nucleic acid	in-place	blood samples
nucleic acid	in-place	respiratory
nucleocapsid	same-as	N
nucleocapsid (N) protein	is-a	protein
nucleotides	in-context	adenosine
nucleotides	in-context	state
numbe	in-context	cases
number	has-part	epitopes
number	has-property	associated
number	has-property	bound
number	has-property	effective
number	has-property	large
number	has-property	limited
number	has-property	low
number	has-property	real
number	has-property	reproductive
number	has-property	significant
number	in-context	COVID-19
number	in-context	HLA types
number	in-context	T
number	in-context	T cell
number	in-context	amino acid positions
number	in-context	cases
number	in-context	patients
number	in-context	reproduction
number	in-context	substitutions
number	in-context	types
number of cases	has-property	traced
number of cases	has-property	upper bound
numbers	has-property	average
numbers	has-property	higher
numbers	has-property	off-diagonal
numbers	in-context	CD4 + T
numbers	in-context	CD4 + T cells
numbers	in-context	CD8 + T
numbers	in-context	T cells
numbers	in-context	off-diagonal
numbers	is-a	genes
n°1	causes	detection
n°1	causes	identification
n°1	is-a	assay set
observed	in-place	proteome
observed	subject	interactions
observed	target	difference
obtain	target	clinical response
occur	entails	population immunity
occur	has-property	reported
occur	has-property	some
occur	in-context	isolation
occur	in-context	surveillance
occur	in-time	before
occur	subject	beginning
occur	subject	infections
occur	target	COVID-19 clusters
occur	target	onset
occurred	in-place	China
occurred	in-time	late-December 2019
occurred	subject	SARS-CoV-2 infection
occurrence	target	action
occurs	subject	VI
olaparib	has-property	binding surface
one	has-property	best-known
one	has-property	oldest
one	in-context	particle
one	in-context	tools
one	is-a	compounds
one	is-a	drugs
one	same-as	remdesivir
one of whom	has-property	culture-positive
one of whom	in-context	patients
one pair	has-property	bond energy
one-third	in-context	patients
one-third	in-context	pneumonia
onset	has-property	associated
onset	in-context	COVID-19
onset	in-context	symptoms
onset	subject	symptom
onset	subject	symptoms
onset	target	t-th day
opacity	has-property	ground glass
operations	has-property	extraction
operations	has-property	time-consuming
operations	has-property	viral
operations	in-context	RNA
optic fibers	causes	activation
optic fibers	has-property	biocompatible
order	has-part	0.5%
order	has-part	0.8%
order	in-context	Nidovirales
organic injury	has-property	multiple
organism	has-property	biology
organisms	is-a	Coronavirus
organization	has-property	uniform
organoid cultures	has-part	ductal
oriI locus	in-time	after
oriented	has-property	perpendicularly
origin	has-property	intracellular
origin	in-context	pathogen
origin	subject	viral RNA
origin	target	pathogen
originated from	target	Bat-SARSr-CoV RaTG13
origins	in-context	proteins
origins	is-a	Another
other	has-part	Coronavirus
other	in-context	COVID-19
other	in-context	Hubei Province
other	in-context	SARS-CoV-2
other	in-context	Wuhan city
other	in-context	cities
other	in-context	clades
other	in-context	diseases
other	in-context	measures
other	in-context	provinces
other	in-context	species
other	in-context	viruses
other betacoronaviruses	has-property	seasonal variation
other betacoronaviruses	has-property	seasonal variation in R0
other coronavirus strains	has-property	that
other coronavirus strains	in-context	mutations
other pA sequences	has-property	effect
others	in-context	coronaviruses
others	in-context	five
our	in-context	framework
outbreak	has-property	current
outbreak	has-property	over time
outbreak	has-property	severe
outbreak	in-context	COVID-19
outbreak	in-context	CoViD-19
outbreak	in-context	coronavirus disease-2019
outbreak	in-context	coronavirus example
outbreak	in-context	novel coronavirus disease
outbreak	in-time	2002/2003
outbreak	in-time	current
outbreak	is-a	public health concern
outbreak	is-a	threat
outbreak	subject	COVID-19
outbreak	subject	SARS
outbreak	subject	coronavirus
outbreak	target	emergency
outbreaks	causes	106,893
outbreaks	causes	3,639
outbreaks	causes	closures
outbreaks	in-context	COVID-19
outbreaks	in-context	SARS-CoV-2
outbreaks	in-time	earlier
outbreaks	subject	SARS-CoV-2
outcomes	has-property	adverse
outcomes	has-property	lethal
outcomes	has-property	long-term
output	subject	DeCoV-Net
output	target	probability
outside	in-context	animal kingdom
over 1,000	has-part	deaths
over 90%	in-context	genetic similarity
over time	has-property	from
over time	has-property	to
overall fitness	in-context	3D G64S (0.55 ± 0.03, p=0.005 vs. 3D G64S , t-test)
overall fitness	in-context	WT (0.92 ± 159 0.03, p=0.0031 vs. WT, t-test)
overdispersion	has-property	high
overestimation	in-context	reproduction number
overestimation	target	reproduction number
overexpressed	in-context	FLC
overexpressed	subject	CA12
overwhelm	subject	COVID-19 clusters
overwhelm	subject	events
overwhelm	subject	overdispersion
overwhelm	target	surveillance system
oxygenation	target	cases
pA	has-property	effect
pA	is-a	signal
pGKL	is-a	plasmids
packing	has-property	crystal
packing	in-context	NSP7-NSP8
packing	in-context	NSP7-NSP8 structure
packing	target	crystal
paid attention	target	effects
panel	has-property	SARS-CoV-2-designed
panel	has-property	designed
panel	in-context	SARS-CoV-2
pangolin P1E virus	has-property	membrane protein
pangolin P1E virus	has-property	similar codon usage
parainfluenza	is-a	pathogen
parainfluenza	is-a	respiratory pathogen
parainfluenza	is-a	viruses
parameter	has-property	dispersion
parameter	in-context	k
parameters	has-property	CoVID-19-like
parents	in-context	HCWs
participates	subject	PARP2
participates	target	stress response
particle	has-property	infectious
particle	in-context	23000
particle	in-context	3600
particles	has-property	virus-like
particularly	in-context	ICU
passages	causes	decrease
passages	has-property	several
passages	in-context	Tupanvirus
past	in-context	site
path	has-property	past
path	in-context	RNA
pathogen	has-property	causative
pathogen	has-property	common
pathogen	has-property	detected
pathogen	has-property	frequent
pathogen	has-property	respiratory
pathogen	has-property	viral
pathogen	in-context	COVID-19
pathogen	in-context	children
pathogenesis	has-property	COVID-19
pathogenesis	in-context	COVID-19
pathogenicity	in-place	bacterial strains
pathogenicity	in-place	lungs
pathogenicity	subject	DNA viruses
pathogenicity	subject	RNA viruses
pathogenicity	subject	SARS-CoV-2
pathogenicity	target	lungs
pathogenicity	target	pulmonary
pathogens	causes	pneumonia
pathogens	has-property	other
pathology	has-property	cellular
pathology	has-property	clinical
pathology	in-context	COVID-19
pathway	has-property	cap-independent
pathway	has-property	signaling
pathway	in-context	interferon-MAPK
pathway	is-a	response
pathways	has-property	signaling
pathways	in-context	C3
patient	has-property	82 years old
patient	has-property	contagious
patient	has-property	male
patient	in-context	one
patient	in-time	14 days
patients	entails	≤19 years of age
patients	has-part	COVID-19
patients	has-part	non-severe
patients	has-part	respiratory illnesses
patients	has-part	severe
patients	has-part	swab
patients	has-property	113
patients	has-property	54
patients	has-property	COVID-19
patients	has-property	HCT
patients	has-property	LRTI pathogens
patients	has-property	abnormality
patients	has-property	account
patients	has-property	age
patients	has-property	basic kidney disease
patients	has-property	body
patients	has-property	body fluids
patients	has-property	clinical need
patients	has-property	confirmed
patients	has-property	confirmed COVID-19
patients	has-property	critical
patients	has-property	critically
patients	has-property	defects
patients	has-property	differences
patients	has-property	dysfunction
patients	has-property	elevation
patients	has-property	failure
patients	has-property	features
patients	has-property	first
patients	has-property	greatest
patients	has-property	half
patients	has-property	heart failure
patients	has-property	history
patients	has-property	ill
patients	has-property	illness
patients	has-property	immunosuppressed
patients	has-property	infected
patients	has-property	infection
patients	has-property	influenza A (H1N1)
patients	has-property	levels
patients	has-property	mainly concentrated
patients	has-property	male
patients	has-property	many
patients	has-property	microbes
patients	has-property	mild
patients	has-property	milieu
patients	has-property	more
patients	has-property	multi-organ damage
patients	has-property	need
patients	has-property	neurological manifestations
patients	has-property	number
patients	has-property	older
patients	has-property	pediatric
patients	has-property	respiratory syndrome
patients	has-property	secretions
patients	has-property	severe
patients	has-property	suspected
patients	has-property	suspected COVID-19
patients	has-property	suspected of COVID-19
patients	has-property	symptoms
patients	has-property	transplant
patients	has-property	wide-range
patients	has-property	≥65
patients	in-context	309
patients	in-context	CKD
patients	in-context	COVID-19
patients	in-context	COVID-19-confirmed
patients	in-context	COVID-2019
patients	in-context	HCT
patients	in-context	SARS-CoV
patients	in-context	SARS-CoV-2
patients	in-context	a proportion
patients	in-context	care
patients	in-context	case
patients	in-context	contact history
patients	in-context	counts
patients	in-context	cytokine storms
patients	in-context	half
patients	in-context	heart failure
patients	in-context	history
patients	in-context	hospitalization
patients	in-context	illnesses
patients	in-context	infection
patients	in-context	one-third
patients	in-context	risk
patients	in-context	severe acute respiratory syndrome coronavirus 2
patients	in-context	six
patients	in-context	symptoms
patients	in-context	three
patients	in-context	transplant
patients	in-context	two
patients	in-place	ICU
patients	in-time	following
patients	is-a	patients
pattern	has-property	folding
patterns	in-context	Reb1bound genes
patterns	in-place	heat map
paying attention	in-context	survey
paying attention	subject	81.1%
paying attention	subject	parents
paying attention	target	CKD
paying attention	target	COVID-19
paying attention	target	epidemic
pcMNPs	in-context	20 μg
pcMNPs-based method	has-property	excellent performances
pcMNPs-based method	has-property	robustness
peak	has-property	infectious
peak	in-context	infectious
pediatric patients	has-property	≤19 years of age
pending	subject	results
people	has-property	history
people	has-property	infected
people	has-property	tourism history
people	in-context	protection
people	in-context	who lived
peptide	has-property	amyloidogenic
peptide	has-property	model
peptide-9	has-property	antagonistic
peptide-9	has-property	rate
peptides	has-property	antigenic
percentage	causes	SARS-CoV-2 viruses
percentage	has-property	higher
percentage	in-context	ICU
percentage	in-context	PD-1 + CD8 + T cells
perception	has-property	positive
perception	in-context	COVID-19
perception	subject	HCW
perception	target	COVID-19
performed	entails	phases
performed	in-context	incubating
performed	in-context	models
performed	subject	MONSA
performed	target	ab initio low resolution bead modeling
performed	target	assays
perfusion	has-property	system
perfusion system	causes	addition
perfusion system	causes	exchange
period	causes	time delay
period	has-property	2-7
period	has-property	accurate
period	has-property	epidemic
period	has-property	incubation
period	has-property	infectious
period	has-property	long
period	has-property	sampling
period	has-property	symptoms
period	in-context	COVID-19
period	in-context	circulation
period	in-context	incubation
period	in-context	shown
peripheral lymphocytopenia	is-a	feature
permits	subject	This
permits	subject	mNGS
permits	target	detection
permits	target	profiling
persistence	subject	viruses
persistent	entails	longer
persistent	has-property	more
persistent	subject	asymptomatic
persons	has-property	clinically negative
persons	has-property	symptoms
persons	in-context	symptoms
perturbation	causes	pathogenesis
perturbation	subject	contribute
perturbation	target	immune system
pharmacokinetic profile of CVL218	has-property	superior
pharyngeal	is-a	swab
phase	has-property	early
phase	in-context	COVID-19
phase	in-context	S
phase	in-context	epidemic
phase 1	in-context	protein
phase 1	is-a	phases
phase 2	in-context	detergent tails
phase 2	is-a	phases
phase 3	in-context	detergent heads
phase 3	is-a	phases
phases	has-property	contrasts
phases	in-context	distinct contrasts
phosphorylation	in-context	absence
phosphorylation	target	JNK
phosphorylation	target	p38
phylogenetic uniting	is-a	CoV
phylogenetic uniting	subject	CoV
phylogenetically close	in-context	SARS-CoV
pigs	has-property	older
place	has-property	first
planned	in-context	survey
planned	subject	4.32%
planned	target	adjust
plasmids	has-property	linear double-stranded DNA
plasmids	in-context	yeast cytoplasmically localized
playing	is-a	functions
playing	subject	residues
playing	target	key role
plays	in-context	facilitating
plays	subject	CD147
plays	target	role
pneumonia	has-property	CT-confirmed
pneumonia	has-property	characteristics
pneumonia	has-property	confirmed
pneumonia	has-property	fatal
pneumonia	has-property	infectiousness
pneumonia	has-property	one-third
pneumonia	has-property	severe
pneumonia	has-property	suspected
pneumonia	has-property	viral
pneumonia	has-property	viral-mediated
pneumonia	in-context	COVID-19
pneumonia	in-context	SARS-CoV-2
pneumonia	in-context	imaging
pneumonia	in-context	patients
pneumonia	in-context	suggested
pneumonia	subject	patients
pneumonia	subject	those
pocket	has-property	susceptible
pocket	in-context	allosteric inhibition
points	subject	bionformatic
points	subject	use
points	target	regions
polarized	in-place	virus poles
policies	causes	82%
policies	has-property	general
policies	in-context	health
policies	in-context	quarantine
policies	is-a	factors
policy	has-property	effectiveness
policy	has-property	large-scale
policy	has-property	quarantine
policy	in-place	China's
polymerase	has-part	subunits
polymerases	in-context	RNA
polymerases	in-place	RNA
pools	in-context	Ca 2+
poor immunity	causes	susceptible
poor substrate	has-property	properties
population	has-property	general
population	has-property	high-risk
population	has-property	increased
population	has-property	incubation time
population	has-property	rate
population	in-context	COVID-19
population	in-context	MRES-COV
population	in-context	affected
population	in-context	high-risk
population	in-context	lung macrophage
population	in-context	patients
population mobility	causes	survival
population mobility	causes	transmission
populations	has-property	WT
populations	has-property	exposed
populations	has-property	human
populations	has-property	initial
populations	has-property	not
populations	has-property	potentially exposed
populations	has-property	vulnerable
populations	in-context	patches
populations	in-place	cell
position	has-property	earlier
position	has-property	given
position	has-property	higher
position	in-context	peak
positioning	has-property	beneath
positioning	subject	loop
positioning	target	loop
positions	has-property	particular
positive	entails	ground-truth label
positive	in-context	COVID
positive	in-context	RT-PCR
positive	in-place	swabs
positive	target	scan
possible	subject	receptor assay results
possible	target	arose
potentia	in-context	infectives
potential	causes	avoid
potential	causes	be cautious
potential	has-property	therapeutic
potential	in-context	diagnosis
potential	in-context	infect
potential	in-context	infectives
potential	in-context	reduction
potential	in-context	transmission
potential	in-context	treatment
preceding	in-context	quarantine
precipitation	causes	decrease
predict	has-property	accurately
predict	has-property	precisely
predict	in-context	S-RBD structure
predict	in-context	probability
predict	subject	high-resolution homology modeling
predict	subject	model
predict	subject	proposed
predict	target	3D model
predict	target	drugs
predict	target	infection
predict	target	infection nodes
predicted	subject	Nsp8
predicted	target	disorder segment
prediction	in-context	epitopes
prediction	in-context	generated subsequences
prediction	subject	MHC-I molecules
prediction results	in-context	generated subsequences
predictions	has-property	bionformatic
predicts	in-context	MSEIR
predicts	in-context	MSEIR mode
predicts	subject	MSIR
predicts	subject	MSIR model
predicts	target	position
preference	in-context	sequence
preference	target	Nucleotide sequence
presence	causes	appear
presence	entails	derived
presence	entails	increased expression
presence	entails	intracellular origin
presence	entails	lower
presence	entails	secretion
presence	in-context	infection
presence	in-context	respiratory pathogens
presence	in-place	kinetochores
presence	subject	endogenous MAD1
presence	subject	infection
presence	subject	replicative forms
presence	subject	respiratory pathogens
presence	target	suggests
presenilin-1	in-context	exon-9
present	causes	accumulation
present	in-time	initially
present	subject	RSCs 27
present	subject	children
present	subject	increased
present	subject	patients
present	target	department
present	target	patients
present	target	symptoms
present	target	time
present	target	unique interferon-stimulated 28 gene (ISG) transcriptomic signature
presentation	causes	detection
presentation	has-property	milder
presented between	subject	salt-bridge
presented between	target	E329
presented between	target	RBD
presenting as	subject	COVID-19
presenting as	target	pneumonia
presents	subject	Novel coronaviruses (COVID-19)
presents	target	public health threat
preserved	in-context	affected
preserved	in-context	organoid cultures
preserved	in-place	proteome
preserved	is-a	liver
preserved	subject	interactions
preserved	target	ACE2+ cholangiocytes
president	in-context	hospital
presymptomatic	in-context	cases
presymptomatic transmission	has-property	serial interval
presymptomatic transmission	has-property	timing
prevalence	has-property	high
prevalence	in-context	COVID-19
prevalence of COVID-19	in-place	cases
prevent	has-property	easily
prevent	in-context	spreading
prevent	subject	avoid
prevent	subject	be cautious
prevent	subject	reduction
prevent	subject	transmissibility reduction
prevent	target	spreading
prevent	target	transmission
prevention	has-part	avoiding
prevention	has-part	hemodynamic support
prevention	has-property	early
prevention	has-property	important
prevention	in-context	COVID-19
prevention	in-context	diseases
prevention	in-context	impairment
prevention	in-context	treatment
prevention	target	COVID-19
prevention	target	kidney impairment
prevention	target	other
prevents	in-place	interferon
prevents	subject	IFITMs
prevents	target	entering
previous	in-context	studies
primers	has-property	degenerate
primers	has-property	flap
primers	has-property	tailed
primers	in-context	recombination
principle	has-property	similar
principle	in-context	contraction
prioritise	target	patients
priority	has-property	highest
probability	in-context	COVID-negative
probability	in-context	COVID-positive
probe	has-property	can report
probe	has-property	optical
problems	has-property	HCW
problems	has-property	health
problems	has-property	mental health
problems	has-property	psychological
problems	has-property	similar
problems	in-context	HCWs
procedure	has-part	full-time
procedure	in-context	SARS-CoV-2 infection
procedure	in-place	Vero E6 cells
process	has-property	dynamic
process	has-property	pathological
process	in-context	infecting
process	in-context	pneumonia
process	is-a	inflammation
processing	target	prediction
processing order	in-context	RTC
processing steps	in-context	sample
produce	in-time	hepatitis virus strain-3 infection
produce	in-time	infection
produce	subject	SARS-CoV-2
produce	subject	discontinuous transcription
produce	subject	macrophages
produce	subject	monocytes
produce	target	cytokine
produce	target	sgRNAs
produced	subject	BCR
produced	subject	TCR
produced	target	antibodies
produces	subject	amphiphysin
produces	target	fission products
produces	target	products
producing	entails	differences
producing	subject	RSCs 27
producing	subject	stem cells
producing	target	IFN-I
products	has-property	fission
profile	has-property	spectral
profile	has-property	unique
profiling	has-property	simultaneous
profiling	has-property	transcriptional
profiling	target	host immunologic response
profiling	target	response
prognosis	in-context	treatment
prognosis	target	those
programme	has-property	screening
progress	has-property	rapidly
progress	in-context	hospital admission
progress	in-time	2 days
progress	subject	infection
progress	subject	investigation
progress	target	ARDS
progress	target	hospital
progresses to	causes	death
progresses to	has-property	rapidly
progresses to	is-a	complications
progresses to	subject	COVID-19
progression	in-context	outbreak
progression	in-time	over time
progression	subject	COVID-19
progression	subject	disease
progression	target	COVID-19
progression	target	disease
prominent	in-context	admitted
prominent	subject	myalgia
prominent	target	patients
promote	subject	IL-10
promote	subject	IL-6
promote	subject	TNF-α
promote	target	appearance
promote	target	decrease
promotion	causes	effect
promotion	target	levels
promotion	target	lymphocyte levels
properties	entails	influence
properties	subject	substrate
properties	target	nsp8-9
proportion	has-property	constant
proposed	target	model
protease	in-context	2019-nCoV
protease inhibitors	in-context	SARS-CoV
proteasomal cleavage	in-context	transporter
protect	target	populations
protection	causes	effect
protection	target	levels
protection	target	lymphocyte levels
protective antibodies	has-property	neutralizing
protective antibodies	in-context	SARS-CoV-2
protein	has-property	antagonistic
protein	has-property	dynamics
protein	has-property	hetero-hexadecamer
protein	has-property	motor
protein	has-property	multifunctional
protein	has-property	spike
protein	has-property	viral
protein	in-context	Human SARS
protein	in-place	between
protein	in-place	nucleocapsid
protein	in-place	viral
protein	is-a	phases
protein	is-a	protein
protein-protein interactions	causes	mortality
protein-protein interactions	causes	pathogenicity
protein-protein interactions	in-place	cell membrane
proteins	causes	cilia
proteins	causes	interact
proteins	has-property	ASFV
proteins	has-property	S
proteins	has-property	accessory
proteins	has-property	encoded
proteins	has-property	envelope
proteins	has-property	host
proteins	has-property	interacting
proteins	has-property	interactive
proteins	has-property	metazoan
proteins	has-property	metazoan signaling
proteins	has-property	modeled
proteins	has-property	other
proteins	has-property	sequence similarities
proteins	has-property	signaling
proteins	has-property	spike
proteins	has-property	structural
proteins	has-property	swine
proteins	in-context	HCoV
proteins	in-context	SARS
proteins	in-context	SARS-CoV
proteins	in-context	SARS-CoV-2
proteins	in-context	each other
proteins	in-context	interacting
proteins	in-context	recombinant SARS-CoV-2
proteins	in-place	intermediate compartment
proteins	in-place	membrane
proteins	is-a	accessory proteins
proteome	has-part	2002 SARS-CoV
proteome	in-context	2019-nCoV
proteome	in-context	human
proteome	in-place	2002 SARS-CoV
proved	in-context	settings
proved	in-context	was
proved	subject	7
proved	subject	both
proved	subject	microarray approaches
proved	target	controlling
proved	target	critical
proved	target	reluctant
provide	subject	pcMNPs-based method
provide	subject	profiling
provide	subject	results
provide	target	RNA extraction operations
provide	target	data
provide	target	demonstration
provide	target	insight
providing	subject	Metagenomic next-generation sequencing
providing	subject	mNGS
providing	target	measurement
providing	target	microbial composition
provinces	has-property	other
provision	target	monitoring
provokes	subject	elevated IL-33 levels
provokes	target	hypersensitivity
pseudoknot	has-property	mRNA
pseudoknot	has-property	structurally unique
pseudoknot	has-property	three-stemmed
psychological treatment	in-context	COV
public health concern	has-property	serious
public health threat	has-property	acute
public health threat	target	whole world
pulmonary pathogen	in-context	patient
pulmonary pathogen	in-context	potential
pursued	subject	yeasts
pursued	target	sporulation strategy
pxMNPs	has-property	RNA binding
pxMNPs	has-property	RNA binding property
pxMNPs	has-property	prepared
qPCR	in-context	TaqMan
quarantine	causes	decreased
quarantine	causes	reduce
quarantine	has-property	administratively-imposed
quarantine	has-property	effective
quarantine	has-property	individual
quarantine	has-property	only
quarantine	has-property	stringent
quarantine	in-context	cases
quarantine	in-time	January
quarantine	is-a	measures
quarantine	is-a	way
quarantine	subject	individual
quarantine	subject	reduce
quarantine	target	individual
quiescence	has-property	uniformly
quiescence	subject	isolates
r	has-property	[0.30, 0.32]
r	has-property	larger
r	in-context	CCDC
r	in-context	COVID-19
r	is-a	growth rate
r-selected K276R substitution	in-context	158 3D G64S lineages (4/5)
r-selected K276R substitution	in-context	WT populations
rRNA	has-property	modified
rRNA	in-context	Pyrococcus
radiotracer	has-property	activated
radiotracer	has-property	microglial-targeted
range	in-context	2.1
range	in-context	4.2
range 126 -147 days	same-as	median
rare	has-property	relative
rare	in-place	niches
rare	subject	sugar
rare	target	niches
rat	has-part	PC-12
rate	has-property	binding
rate	has-property	high
rate	has-property	lower
rate	in-context	0.1
rate	in-context	COVID-19
rate	in-context	admission
rate	in-context	death
rate	same-as	r
rates	causes	have
rates	has-property	co-infection
rates	has-property	high
rates	has-property	increased
rates	has-property	infection
rates	in-context	bacteria
rates	in-context	co-infection
rates	in-context	fungus
rates	in-context	growth
rates	in-context	other
rates of overdispersion	in-context	cases
ration	subject	hospitals
ration	target	resources
re-acquired	subject	strains
re-acquired	target	life cycle
re-infected	in-context	same strain
reaches	entails	contact
reaches	has-property	over
reaches	subject	2019-nCoV S-RBD
reaches	subject	S-RBD
reaches	subject	loop
reaches	target	SARS-CoV S-RBD
reaches	target	binding strength
reaches	target	site
reaches over	in-place	positive-strand
reaches over	subject	loop
reaches over	target	site
reaction	has-property	inflammation
reaction	has-property	specificity
reaction	in-context	COVID-19
read	has-property	length
read length	has-property	longer
reads	causes	viral 112 transcripts
reads	in-context	SARS-CoV-2
real-time reverse transcription polymerase chain reaction	causes	confirmation
real-time reverse transcription polymerase chain reaction	in-context	viral
real-time reverse transcription polymerase chain reaction	same-as	RT-PCR
real-time reverse-transcriptase polymerase-chain-reaction	same-as	RT-PCR
reason	subject	SARS-COV-2
reason	target	liver injury
received	subject	patients
received	target	administration
received	target	glucocorticoid
received	target	intravenous immunoglobulin
receptor	has-property	same
receptor	in-context	NL63
receptor	in-context	SARS-Cov
receptor	same-as	ACE2
receptor binding domain	same-as	RBD
receptor binding domain	same-as	domain
receptor binding motif	same-as	RBM
receptor-binding domain	in-context	SARS-CoV
receptor-binding domain	in-context	domain
receptor-binding domain	same-as	RBD
receptors	has-property	cellular
receptors	subject	infection
recipients	has-property	hematopoietic cellular transplant
recipients	in-context	HCT
recognition	entails	improve
recognition	target	action
recognition	target	target
recognized	subject	2019-nCoV
recognized	subject	responses
recognized	target	human immune responses
recognized	target	regions
recombinant ACE2	is-a	protein
recombinant S 103 protein	is-a	product
recombinant SARS-CoV-2	has-part	proteins
recombination	causes	2019-nCoV
recombination	causes	S 103 protein
recombination	causes	arose
recombination	entails	similarity
recombination	has-property	product
recombination	in-place	in-cell
recombination	subject	clade 1
recombination	subject	other
recombination	target	CCoV sequences
recombination	target	in-cell
recombination	target	other clades
recombination	target	sequences
recovery	entails	could not
recovery	has-property	quick
recovery	subject	most
recruiting	causes	maintains
recruiting	in-place	sites of DNA damage
recruiting	subject	PARP2
recruiting	target	DNA repair machinery
rectal swabs	in-time	18
recurrence	in-context	COVID-19 virus
recurrence	subject	COVID-19
red	in-context	homology
reduce	entails	detect
reduce	in-context	restricting
reduce	subject	avoidance
reduce	subject	contact rate
reduce	subject	detection
reduce	subject	people
reduce	subject	policies
reduce	target	contact rate
reduce	target	growth
reduce	target	information
reduce	target	quarantine
reduce	target	risk
reduced	in-context	patients
reduced	in-place	patients
reduced	subject	activity
reduced	subject	treatment
reduced	target	inflammation
reduced	target	mortality
reduced	target	stay
reduces	has-property	proportion
reduces	in-time	matches
reduces	subject	best clinical response
reduces	subject	intervention
reduces	target	density
reduces	target	risk
reducing	causes	outbreak
reducing	in-context	below
reducing	in-context	risk areas
reducing	in-context	unity
reducing	target	SARS-CoV-2
reducing	target	number
reducing	target	reproduction number
reducing	target	risk
reducing the airborne	in-context	SARS-CoV-2
reducing the airborne	in-place	risk areas
reduction	has-property	significant
reduction	in-context	50%
reduction	in-context	fitness
reduction	in-place	china
reduction	in-time	after about 11 days
reduction	subject	cases
reduction	subject	substitutions
reduction	target	cases
reduction	target	confirmed cases
reduction	target	host-specific fitness
reduction	target	incidence
reduction	target	mobility
reduction	target	transmissibility
reference-sequence-based	has-property	straightforward
reflects	same-as	present
reflects	subject	delay
reflects	target	time
refractory metabolic acidosis	is-a	complications
regimens	causes	failure
regimens	causes	outcomes
regimens	causes	progression
regimens	has-property	empiric
regimens	in-context	microbe
regimens	in-context	situations
regions	has-property	N-terminal
regions	has-property	multiple
regions	has-property	specific
regions	in-context	2019-nCoV
regions	in-context	S
regression	has-property	Logistic
regulate	in-place	lung epithelial cells
regulate	subject	SARS-CoV 3a protein
regulate	target	expression of fibrinogen
regulation	has-property	immune
related	has-property	closely
related	has-property	distantly
related	has-property	positively
related	has-property	sequence identity
related	in-context	SARS-CoV
related	in-context	humidity
related	in-context	induced
related	in-context	intermediates
related	in-context	organisms
related	in-context	response
related	subject	2019-nCoV
related	subject	82%
related	subject	COVID-19
related	subject	SARS
related	subject	SARS-CoV
related	subject	SARS-Cov
related	subject	increase
related	subject	injury
related	subject	isolates
related	subject	virus
related	target	2019-nCoV
related	target	COVID-19
related	target	CoV
related	target	SARS-CoV
related	target	aspects
related	target	density
related	target	lower
related	target	measures
related	target	other Coronavirus organism
related	target	policies
related	target	severity
related	target	transportation
related to	subject	NLR
related to	subject	it
related to	target	activation
related to	target	disease severity
related to	target	response
relationship	has-property	negative
relationship	has-property	positive
relationship	in-context	negative
relationship	in-context	positive
relationship	subject	severity
relationship	target	life satisfaction
relationship	target	satisfaction
relationship	target	severity
relative	has-property	translated
relative	in-context	structural
relative	target	proteins
release	in-context	dose-dependent
release	in-context	dose-dependent manner
release	subject	macrophages
release	subject	monocytes
release	target	COVID-19 patients
release	target	cytokine
release	target	cytokines
release	target	pro-inflammatory cytokines
reluctant	target	spread
remained detectable	in-context	hospitalization
remained detectable	in-place	rectal swabs
remained detectable	in-place	throat
remained detectable	in-time	until day 11 and 18
remained detectable	subject	real time RT-20 PCR
remained detectable	target	SARS-CoV-2 RNA
remains	in-time	Currently
remains	subject	COVID-19
remains	subject	interpersonal transmission capabilities
remains	target	unknown
remdesivir	causes	antiviral activities
remdesivir	has-property	inhibitor
remdesivir	has-property	potential
remdesivir	in-context	2019-nCov
remdesivir	in-context	DMSO control group
replacement	has-property	early
replacement	in-context	renal
replication	causes	genome
replication	in-context	donor
replication	in-context	polymerase
replication	subject	virus
replication	target	donor
replicative forms	entails	derived
replicative forms	entails	origin
replicative forms	same-as	anti-sense viral genome
report	entails	secretion
report	has-property	high spatial fidelity
report	has-property	temporal fidelity
report	in-place	spectral profile
report	in-time	incubation period
report	subject	optical probe
report	subject	studies
report	target	catecholamine dynamics
report	target	values
reported	entails	cases
reported	in-context	patients
reported	in-context	period
reported	subject	deaths
reported	subject	four
reported	subject	patients
reported	subject	studies
reported	target	change
reported	target	date
reported	target	deaths
reported	target	experienced
reported	target	first deaths
reported	target	history
reported	target	neurological manifestations
reported	target	occur
reported	target	patients
reported findings	subject	Guan et al 4
reported findings	target	SARS-CoV-2
reported,	entails	infection fatality risk (IFR)
reported,	target	individuals
reports	has-part	batch
reports	has-part	data
represents	subject	Domestication
represents	subject	seasonality factor
represents	subject	sporulation
represents	target	change
represents	target	seasonal variation
repression	has-property	transcriptional
reproduction number	has-property	basic
reproduction number	in-context	COVID-19
reproductive number	has-property	effective
reproductive number	in-context	COVID-19
reproductive number	in-place	Hubei
reproductive number	same-as	R
reproductive number	same-as	range
repurposing	in-place	silico
repurposing	target	drug
require	has-property	rare
require	in-place	UK
require	subject	case
require	subject	patients
require	target	care
required	in-context	H5N1
required	in-context	H7N1
required	in-context	lysis
required	same-as	8.65%
required	subject	Patients
required	subject	former
required	target	H5N1
required	target	H7N1
required	target	ICU
required	target	ICU care
required	target	intervention
requires	subject	child
requires	target	care
requires	target	child care
requiring	subject	failure
requiring	subject	those
requiring	target	ICU care
requiring	target	ventilation
resemble	subject	features
resemble	target	MERS
resemble	target	SARS
resident T cells	is-a	T cells
residues	has-property	12
residues	has-property	P-loop
residues	has-property	aromatic
residues	has-property	charged
residues	has-property	conserved
residues	has-property	functions
residues	has-property	motif VI
residues	has-property	specific
residues	in-context	168-289
residues	in-context	P-loop
residues	in-context	SARS-2002
residues	in-context	crystal structure
residues	in-context	motif VI
residues	in-place	interface
residues	same-as	40%
residues 424-494	in-place	domain
residues 424-494	same-as	motif
resolved	subject	symptoms
resources	has-property	limited
respiratory	has-property	severe
respiratory	is-a	disease
respiratory air droplets	is-a	transmission route
respiratory distress	has-property	acute
respiratory distress	in-context	HCT recipients
respiratory distress	in-context	acute
respiratory distress	in-place	HCT recipients
respiratory droplets	in-context	COVID-19
respiratory droplets	is-a	transmission mode
respiratory illnesses	has-property	acute
respiratory infections	in-context	immunocompromised patients
respiratory infections	in-place	immunocompromised patients
respiratory pathogen	in-context	common
respiratory pathogenicity	has-property	recognized
respiratory symptoms	has-property	lower
respiratory syndrome	has-property	acute
respiratory syndrome	has-property	severe
respiratory syndrome	in-context	COVID-19
responding	entails	differences
responding	subject	RSCs 27
responding	subject	stem cells
responding	target	IFN-I
response	causes	cope
response	causes	deprivation
response	entails	activating
response	has-property	blood immune
response	has-property	delayed
response	has-property	extreme
response	has-property	immune
response	has-property	immunologic
response	has-property	psychological
response	in-context	infection
response	in-context	patients
response	in-context	stress
response	subject	blood
response	subject	cells
response	subject	host
response	target	infection
response	target	starvation
responses	in-context	immune
responsible	in-context	mechanistically
responsible of	subject	SARS-CoV-2
responsible of	target	COIVD-19
restricting	target	exposure
result	has-property	positive
result	in-context	RT-PCR
result	subject	infection
result	target	growth performance
resulted	in-place	103
resulted	in-time	07 March 2020
resulted	subject	outbreaks
resulted	target	106,893
resulted	target	3,639
resulting	has-property	thiohemiketal
resulting	in-place	R
resulting	in-place	S
resulting	subject	reduces
resulting	target	equivalent
results	causes	route
results	entails	contribute
results	entails	demonstration
results	entails	depends
results	entails	intervention
results	entails	mean
results	entails	mortality
results	entails	paid attention
results	has-property	consistent
results	has-property	experimental
results	has-property	pending
results	in-context	MSA
results	in-context	prediction
retain	subject	landscapes
retain	target	width
retaining	subject	strains
retaining	subject	these
retaining	target	cycle
retaining	target	life cycle
retains	subject	iNO gas
retains	target	activity
reticulum-Golgi	has-part	intermediate compartment
revealed	in-place	region
revealed	subject	Analysis
revealed	subject	analysis
revealed	subject	our study
revealed	subject	reports
revealed	subject	study
revealed	subject	value
revealed	target	SARS-CoV-2
revealed	target	correlation
revealed	target	driver
revealed	target	it
revealed	target	motifs
revealed	target	similar
revealed	target	storms
revealed	target	three conserved sequence motifs
reveals	subject	Superposition
reveals	target	path
reverse transcription polymerase chain reaction	same-as	RT-PCR
rhinovirus	has-property	species C
rhinovirus	is-a	pathogen
rhinovirus	is-a	rhinovirus
rhinovirus	same-as	RV
ring	has-part	loop
ring	in-context	structures
ring-finger	has-property	loop
rise	has-property	exponential
rise	target	cases
risk	entails	results
risk	has-property	areas
risk	has-property	cumulative
risk	has-property	high
risk	has-property	higher
risk	has-property	increased
risk	has-property	relative
risk	in-context	A
risk	in-context	COVID-19
risk	in-context	OR
risk	in-context	acquiring
risk	in-context	death
risk	in-context	infection
risk	in-context	problems
risk	subject	circle
risk	subject	patients
risk	target	complications
risk	target	pneumonia
risk areas	has-property	high
risk distribution trend	has-property	similar
risk distribution trend	in-context	ABO
risk distribution trend	in-context	infection
risk distribution trend	in-place	113
risk factor	in-context	AMI
risk factor	in-place	patients
risk factor	subject	severity
risk factor	target	AMI
risk group	has-property	susceptible
risks	has-property	association
risks	has-property	different
ritonavir	has-property	therapeutic effect
ritonavir	is-a	HIV-1 protease inhibitors
ritonavir	is-a	candidates
ritonavir	is-a	inhibitors
robustness	in-context	marker
role	has-property	functional
role	has-property	gender
role	has-property	immune-regulating
role	has-property	lacking
role	has-property	similar
role	in-context	DHODHi
role	in-context	DUSP1
role	in-context	PL
role	in-context	immune-regulating
role	in-context	modulating
role	in-context	pathogen
role	in-context	virus
role	subject	ligands
role	target	modulating
roles	in-context	T
root-mean-square fluctuation	in-context	100ns
root-mean-square fluctuation	in-context	energy snapshot
root-mean-square fluctuation	in-place	residue
root-mean-square fluctuation	same-as	RMSF
route	in-context	SARS-CoV-2
rule	in-context	coronavirus evolution
s not closer	is-a	ORF3b
s not closer	target	ORF3b
safety	in-context	Those
safety	in-context	drugs
salt-bridge	has-property	strong
salt-bridge	in-context	ACE2
salt-bridge	in-context	SARS-CoV RBD
sample	entails	decrease
sample	has-property	big
sample	has-property	period
sample	in-context	data
sample processing steps	causes	application
sample processing steps	has-property	laborious
sample processing steps	has-property	time-consuming
samples	has-property	BtCoV
samples	has-property	COVID-19
samples	has-property	MERS
samples	has-property	MHV
samples	has-property	Only
samples	has-property	RT-LAMP reactions
samples	has-property	batches
samples	in-context	blood
samples	in-context	respiratory
sanitization	causes	reducing
sanitization	has-property	effectiveness
sanitization	in-context	reducing the airborne
sanitization	is-a	measures
sanitization	target	hand
satellite	in-context	L-A
satellite RNA	in-context	L-A
satisfaction	in-context	life
scaffols	has-property	different
scale	has-property	identity
scale	in-context	SARS-CoV S
scale	in-context	modeled proteins
scan	in-context	CT
scenario	has-property	necessary
scenario	has-property	possible
scenario	in-context	allow
scenario	in-context	containment
score PPID	in-context	mean
score PPID	subject	Bat CoV
score PPID	subject	Human SARS
score PPID	subject	SARS-CoV-2
score PPID	target	1.12%
score PPID	target	1.41%
score PPID	target	1.85%
scored	subject	genome
scored	subject	plaque assay
scored	target	genome
scored	target	plaque assay
screening	causes	identification
screening	has-property	based
screening	has-property	dependent
screening	has-property	effectiveness
screening	has-property	important
screening	has-property	rapid
screening	in-context	COVID-19
screening	in-context	population
screening	in-context	populations
screening	in-place	population
screening	target	cases
screening	target	patients
screening	target	populations
screening	target	suspect cases
screening	target	temperature
season	has-property	cold
seasonal variation	has-property	amplitude
seasonal variation	has-property	half the amplitude
seasonal variation	in-context	R0
seasonal variation	in-context	amount
seasonal variation	in-context	betacoronaviruses
seasonal variation in R0	has-property	amplitude
seasonality factor	entails	half the amplitude
seasonality factor	entails	is half
seasonality factor	has-property	0.5
seasonality factor	in-context	0.5
seasonality factor	same-as	variation
second	has-property	following
second	in-context	conformation
second	is-a	week
secretion	in-context	cytokines
secretion	in-context	patients
secretion	in-place	jelly
secretion	subject	cytokines
secretion	subject	its
secretion	subject	viral RNA
segment	has-part	residues
segment	has-property	disordered
segment	has-property	unstructured
segment	in-place	145-289 residues
segment	in-place	168-289 residues
selected	in-context	only
selected	target	one pair
selection	has-property	diversifying
selection	has-property	negative
selection	has-property	positive
selection	has-property	positive diversifying
selection	has-property	purifying
selection	has-property	stronger
selection	in-context	evolution
selection	in-context	spike gene
selection	target	genome
self-isolation	is-a	measures
self-production	in-context	self-isolation
self-production	is-a	measures
self-quarantine	has-property	increased
self-quarantine	is-a	measures
selfisolate	causes	financial and health implications
selfisolate	in-time	pending
selfisolate	in-time	resolved
selfisolate	subject	Patients
sensitive	in-context	crRNA concentration
sensitive	in-place	our samples
sensitivity	has-property	improved
sensitivity	in-context	100%
sensitivity	in-context	microbial detection
septic shock	is-a	complications
sequence	has-property	conserved
sequence	has-property	identity
sequence	has-property	interface
sequence	in-context	Nucleotide
sequence	in-context	S
sequence	in-context	S-29
sequence	in-context	SARS-CoV
sequence identity	has-property	96.08%
sequence identity	in-context	79%
sequence identity	in-context	79.6%
sequence identity	in-context	whole-genome level
sequence identity	target	3CL
sequence similarities	in-context	90%
sequence similarity	has-part	59.09%
sequence similarity	has-property	54.55%
sequence similarity	in-context	54.55%
sequence similarity	in-context	59.09%
sequences	has-part	all known viruses
sequences	has-property	RNA
sequences	has-property	conserved
sequences	has-property	long
sequences	has-property	microarrays
sequences	in-context	CTT
sequences	in-context	RBD
sequences	in-context	SARS-CoV-2
sequencing	causes	understanding
sequencing	has-property	comparative
sequencing	has-property	ongoing
sequencing	in-place	areas
sequencing	subject	7
sequencing	target	cases
serial interval	has-property	assumed
serial interval	is-a	aspects
serial intervals estimates	causes	overestimation
serial intervals estimates	in-context	data
serial ultrasound	in-context	women
serial ultrasound	is-a	monitoring
series	has-part	patients
series	has-property	one case
serine	same-as	S
serious	in-time	initial
serologic	causes	bias
serotype I	in-context	sequences
services	has-property	maternity
set	has-property	training
settings	has-property	field
severe	has-property	more
severe	in-context	COVID-19
severe	in-context	MERS-CoV
severe	in-context	SARS-CoV
severe	in-context	condition
severe	is-a	conditions
severe	is-a	patients
severe acute respiratory syndrome	has-property	bat-derived
severe acute respiratory syndrome	is-a	coronaviruses
severe acute respiratory syndrome	same-as	SARS
severe acute respiratory syndrome -CoV-2	same-as	(2019-nCoV
severe acute respiratory syndrome -CoV-2	same-as	SARS -CoV-2
severe acute respiratory syndrome -CoV-2	same-as	coronavirus
severe acute respiratory syndrome coronavirus	same-as	SARS-CoV
severe acute respiratory syndrome coronavirus 2	causes	outbreak
severe acute respiratory syndrome coronavirus 2	has-property	novel
severe acute respiratory syndrome coronavirus 2	same-as	SARS-CoV-2
severe influenza A	same-as	H1N1
severe respiratory disease	entails	death
severity	entails	severity
severity	has-property	Similar
severity	has-property	associated
severity	has-property	clinical
severity	has-property	wide spectrum
severity	in-context	COVID-19
severity	in-context	NCP
severity	in-context	clinical
severity	in-context	disease
severity	in-context	lymphocytopenia
severity	in-context	patients
severity	in-place	location
severity	in-time	first time
severity	same-as	risk factor
severity	target	COVID-19
severity	target	lymphocytopenia
sex	has-property	vaginal
sexual behavior	has-property	complexity
shadows	has-property	patchy
shares	subject	Virus sequence
shares	subject	sequence
shares	target	homology
shares	target	more
shifts	has-property	larger
shifts	in-context	hexamer
shifts	in-place	hexamer
shortage	in-context	protective materials
shorter	in-context	population
shortness of breath	is-a	symptoms
should be	subject	people
should be	target	very cautious
should be observed	in-context	study
should be observed	target	outcomes
show	entails	indicating
show	has-property	damage
show	in-context	exudates
show	subject	Clinical studies
show	subject	features
show	target	associated
show	target	damage
show	target	desquamation
show	target	formation
showed	in-context	MERS-Cov
showed	in-context	SARS-Cov
showed	in-context	reduction
showed	in-context	study
showed	in-place	china
showed	in-time	To-date
showed	in-time	after
showed	in-time	hospitalization
showed	subject	Blood routine
showed	subject	CVL218
showed	subject	Construction
showed	subject	McLaellen
showed	subject	S1
showed	subject	S2
showed	subject	analysis
showed	subject	classification
showed	subject	colleges
showed	subject	curves
showed	subject	human populations
showed	subject	patients
showed	subject	populations
showed	subject	remdesivir
showed	subject	results
showed	subject	statistics
showed	subject	treatment
showed	target	ACE2
showed	target	abnormality
showed	target	antiviral activities
showed	target	correlation
showed	target	decrease
showed	target	decreased
showed	target	disparities
showed	target	effective
showed	target	exhibited
showed	target	had
showed	target	increase
showed	target	levels of LDH
showed	target	multi-organ damage
showed	target	multi-organ dysfunction
showed	target	organization
showed	target	progression
showed	target	proteins
showed	target	susceptibility
showing	target	,
showing	target	E
showing	target	N
shown	in-time	incubation period
shown	subject	antibodies
shown	subject	patients
shown	subject	studies
shown	target	ability
shown	target	belong
shown	target	regulate
shown	target	symptoms
shows	subject	COVID-19 spread
shows	target	can spread
signal	has-property	elevated
signal	in-context	ubiquitin
signal	in-place	TRIM25 KO cells
signaling pathway	in-context	interferon-MAPK
signaling pathway	is-a	response
signaling pathways	in-place	C3
significance	has-property	clinical
significance	has-property	statistical
significance	in-context	role
significance	target	pathogen
significant	same-as	~7%
silencing	target	siRNA
simian virus 40	has-property	pA
simian virus 40	same-as	SV40
similar	causes	expect
similar	entails	expect
similar	entails	facilitate
similar	has-property	genetically
similar	has-property	highly
similar	has-property	sufficiently
similar	in-context	ACE2
similar	in-context	FP1
similar	in-context	FP2
similar	in-context	S proteins
similar	in-context	SARS-CoV
similar	in-context	SARS-CoV S
similar	in-context	aspects
similar	in-context	form
similar	in-context	genetically
similar	in-context	influenza
similar	in-context	severe acute respiratory syndrome coronavirus
similar	in-context	that
similar	in-context	virus
similar	subject	2019-nCoV
similar	subject	COVID-19
similar	subject	FP1
similar	subject	FP2
similar	subject	One
similar	subject	One of these conformations
similar	subject	characteristics
similar	subject	proteins
similar	subject	stoichiometry
similar	subject	virus
similar	target	2003 SARS-CoV-1
similar	target	S
similar	target	form
similar	target	influenza
similar	target	receptor-binding domain
similar	target	severe acute respiratory syndrome coronavirus
similar	target	that
similar codon usage	has-part	SARS-CoV-2 198
similar codon usage	in-context	SARS-CoV-2
similar codon usage	in-context	other viruses
similar codon usage	in-context	pangolin P1E virus
similarities	entails	retains
similarities	has-property	90%
similarities	has-property	sequence
similarities	in-context	Coronavirus
similarity	entails	preserved
similarity	has-property	genetic
similarity	has-property	reduced
similarity	in-context	amino acid
similarity	in-context	genome
similarity	in-context	proteome
similarity	in-context	sequences
similarity	same-as	90%
similarity	subject	2019-nCoV
similarity	subject	Guangdong pangolin
similarity	subject	RBD protein sequences
similarity	subject	genome
similarity	subject	proteins
similarity	target	genome
similarity	target	proteins
similarity	target	proteome
simpler	in-context	RT-PCR
singlestranded	has-part	length
sister	in-context	COVID-19-related CoV
site	has-property	active
site	in-context	oriI locus
sites	has-property	binding
sites	has-property	two
sites	in-context	amino acid
situation	causes	mental health problems
situation	has-property	severe
situation	in-context	COVID-19
situations	has-property	transmission
situations	in-context	transmission
six of 15	same-as	40%
smokers	is-a	patient
smokers	is-a	patients
snRNA	has-property	level
social avoidance	causes	reduce
social network	has-property	local
solve	causes	exhibits
solve	subject	method
solve	target	operations
solved structure	in-context	SARS-CoV-2 3CL pro (PDB ID: 6LU7)
solved structure	in-time	recently
some	in-context	patients
sore throat	is-a	associated
sore throat	is-a	symptoms
source	in-context	aerosol
source	in-context	variation
source	is-a	origins
sources	in-context	data
species	has-property	other
species	in-context	fluctuations
species	in-context	rhinovirus
specific	has-property	relatively
specific	in-context	COVID-19
specific	in-context	have
specific	in-place	COVID-19
specific	target	distribution
specific	target	lesion
specific residues	in-place	tail fiber
specificity	in-context	reaction
specimens	has-property	clinical
specimens	in-context	swab
specimens	in-context	tract
specimens	in-place	upper respiratory tract
spectral profile	has-property	near-infrared
spectral profile	has-property	unique
spectrum of severity	has-property	wide
speeds	causes	decrease
spike	has-property	viral
splitting	causes	leads
splitting	causes	learning
splitting	in-context	original virus genome sequence
splitting	target	virus genome sequence
sporulation	has-property	Domestication impairing
sporulation	in-context	yeast
sporulation	subject	yeast
sporulation	subject	yeasts
sporulation strategy	same-as	entered
spread	entails	spread
spread	has-property	currently
spread	has-property	dynamics
spread	has-property	faster
spread	has-property	global
spread	has-property	quickly
spread	has-property	rapid
spread	has-property	rapidly
spread	has-property	unique capacities
spread	in-context	COVID-19
spread	in-context	SARS-CoV-2
spread	in-context	community
spread	in-context	contact
spread	in-context	incubation
spread	in-context	period
spread	in-context	person to person
spread	in-context	quickly
spread	in-place	Hubei Province
spread	in-place	Wuhan
spread	in-place	Wuhan city
spread	in-place	cities
spread	in-place	community
spread	in-place	holes
spread	in-place	provinces
spread	in-time	currently
spread	subject	COVID-19
spread	subject	SARS-CoV-2
spread	subject	epidemic
spread	subject	events
spread	subject	persons
spread	subject	virus
spread	target	85
spread	target	COVID-19
spread	target	development
spread	target	functions
spread	target	individuals
spread	target	others
spread	target	person to person
spread	target	to
spread	target	worldwide
spreading	causes	transmissibility
spreading	has-property	currently
spreading	has-property	further
spreading	has-property	rapid
spreading	in-context	Covid-19
spreading	in-place	268
spreading	in-place	Wuhan
spreading	in-place	countries
spreading	in-place	regions
spreading	subject	2019-nCoV
spreading	subject	COVID-19
spreading	subject	Covid-19
spreading	subject	SARS-CoV-2
spreading	subject	epidemics
spreading	subject	virus
spreading	target	cities
spreading	target	countries
spreading	target	epidemics
spreading	target	regions
spreads	causes	reduce
spreads	entails	reduce
spreads	in-context	human
spreads	in-context	human to human
spreads	subject	COVID-19
spreads	target	human
sputum	has-property	insidious
sputum	has-property	prominent
sputum	is-a	symptoms
stabilize	target	viral spike
stabilizes	subject	coordination
stabilizes	target	ATP
stabilizes	target	molecule
stage	has-property	early
stage	has-property	initial
stage	in-context	COVID-19
stage	in-context	onset
stage	in-time	time-lapse
standardized management	causes	best clinical response
start	subject	transmission
start	target	transmission
starvation	causes	pursued
starvation	causes	sporulation
starvation	has-property	extreme
state	has-property	transition
statistical analysis	causes	percentage
statistical analysis	entails	percentage
statistics	has-property	daily
status	has-property	unknown
stay	has-property	10 days
stay	has-property	median
stay	in-context	hospital
stay	in-context	median
stay	in-place	hospital
stay	in-time	10 days
stay	subject	patients
stay	target	patients
steepest	has-property	descent
stem cells	has-property	transcriptomic signature
stemming	in-time	so far
stemming	target	drugs
stemming	target	growth
stemming	target	viral growth
steps	in-context	steepest
stimulate	subject	SARS-CoV
stimulate	subject	mRNA pseudoknot
stimulate	target	-1 PRF
stimulate	target	rates
stoichiometry	has-property	different
stoichiometry	has-property	similar
stoichiometry	in-context	Ca 2+
stoichiometry	in-context	MERS-CoV
stop	subject	9-amino acridine complex formation
stop	target	movement
storms	in-place	patients
strain	in-context	COVID-19
strains	has-property	evolutionarily convergent
strains	has-property	inbred
strains	has-property	lab
strains	has-property	sister
strains	has-property	wild
strains	in-context	bacterial
strains	in-context	coronavirus
strains	in-context	fluctuations
strains	is-a	genomes
strategy	in-context	genetic intervention
strength	has-property	constant
strength	in-context	epidemic
strength	in-context	intervention
stress	has-property	psychological
stress	in-context	GP
stress	in-context	staff
stress	is-a	mental health problems
stretch	entails	destabilize
stretch	has-property	homopolymeric
stretch	has-property	short
stretch	target	nucleotides
strongyloidiasis	has-property	prevalence
structural biology	has-part	studies
structurally	has-property	unique
structure	has-property	co-crystal
structure	has-property	crystal
structure	has-property	published
structure	has-property	solved
structure	in-context	NSP7
structure	in-context	SARS-CoV NSP7
structure	in-context	SARS-CoV NSP8
structures	has-property	contractile
structures	has-property	ring
studies	causes	ACE2
studies	entails	lower
studies	entails	prevent
studies	has-property	Phylogenetic
studies	has-property	Previous
studies	has-property	in vitro
studies	in-context	structural biology
studies	in-context	viral genomics
study	causes	SARS-CoV-2
study	causes	main protease
study	has-property	data
study	has-property	population
study	has-property	recent
study	in-time	Previous
study	in-time	future
study	subject	tools
study	target	law
sub-cellualr	in-context	level
subclinical cases	causes	affect
subclinical cases	same-as	People
subjects	has-property	testing
subjects	in-context	40%
subjects	in-context	negative testing
subjects	in-context	six of 15 (40%)
subsample	in-time	February 2-15
subspecies	has-property	simultaneously
subspecies	in-context	two to three
substituent	has-property	isopropyl ether 172
substituent	target	naphthyl ring system
substitution	causes	decreased
substitution	has-part	RaTG13 strain
substitution	has-part	SARS-CoV-2
substitution	has-property	K276R
substitution	has-property	found
substitution	has-property	r-selected
substitution	has-property	synonymous
substrate	has-property	poor
subtype	has-part	COVID-19
subtype	has-property	high risk
subtype	has-property	mild
subtype	has-property	potentia
subtype	has-property	potential
subtype	has-property	risk
subtype	in-context	COVID-2019
success	in-context	management
success	in-context	treatment
suffer	in-context	COVID-19
suffer	in-time	epidemic
suffer	subject	data
suffer	subject	families
suffer	target	bias
suffer	target	problems
suffered	subject	patients
suffered	target	levels of prealbumin
suffered	target	liver injury
sufficient	in-context	prevention
sugar	has-property	concentrated
sugar	has-property	concentrations
sugar	has-property	fermentation
sugar	has-property	rare
sugar	same-as	it
suggest	subject	results
suggest	target	high
suggest	target	people
suggest	target	required
suggested	in-context	SARS-CoV-2
suggested	subject	Liu
suggested	subject	composite plots
suggested	subject	correlation
suggested	subject	patterns
suggested	subject	results
suggested	target	cellular pathology
suggested	target	monkeys
suggested	target	remdesivir
suggested	target	selection
suggested	target	varied
suggesting	subject	data
suggesting	subject	levels
suggesting	subject	marker
suggesting	target	infection
suggesting	target	pneumonia
suggesting	target	super-transmission events
suggests	subject	COVID-19 cases
suggests	subject	difference
suggests	subject	estimation
suggests	target	SARS-CoV-2
suggests	target	decrease
suggests	target	may be
suggests	target	serial intervals estimates
suggests	target	will result
super-transmission events	in-context	COVID-19 transmission
superspreading	entails	control
superspreading	has-property	unlikely
support	has-property	adequate
support	in-context	hemodynamic
supporting	has-property	strongly
supporting	subject	evidence
supporting	subject	results
supporting	target	action
supporting	target	role
supports	subject	This
supports	target	robustness
suppress	in-context	clear
suppress	subject	primers
suppress	target	formation
suppressed	target	host gene expression
suppression	has-property	immune
suppression	has-property	innate
surveillance	has-property	essential
surveillance	in-context	clinical description
surveillance	in-context	swabbing
surveillance	in-context	swabbing GPs
surveillance	in-time	period
surveillance	target	SARS-CoV-2
survival	in-context	patients
survival	subject	viruses
survival time	has-property	under various environmental conditions
survival time	has-property	up to 4 days
survival time	subject	makes
survive	in-context	low temperatures
susceptibility	causes	number
susceptibility	has-property	disparities
susceptibility	has-property	less
susceptibility	in-context	MERS-Cov
susceptibility	in-context	SARS-Cov
susceptible	has-property	more
susceptible	in-context	SARS-CoV-2
susceptible	in-context	female
susceptible	in-context	immunity
susceptible	in-context	underlying disease
susceptible	subject	Children
susceptible	subject	male
susceptible	target	SARS-CoV-2
susceptible	target	female
suspected	has-property	21.1%
suspected	in-context	COVID-19
suspected	in-context	patients
suspected	subject	mothers
suspected	target	pneumonia
swab	has-property	nasopharyngeal
swab	has-property	positive
swab	in-context	309 COVID-19
swab	in-context	RT-PCR
swab	in-context	specimens
swab	is-a	RT-PCR
swab specimens	in-place	nasopharyngeal
swabbing	in-context	GPs
swabs	has-property	pharyngeal
swabs	in-context	four
switch	causes	genome
switch	in-time	after the oriI locus
switch	target	acceptor
symptom	has-property	co-existed
symptom	has-property	onset
symptom	in-context	patients
symptom onset	in-time	t-th day
symptomatic	entails	load
symptomatic	is-a	infections
symptoms	has-property	associated
symptoms	has-property	common
symptoms	has-property	depressive
symptoms	has-property	dominant
symptoms	has-property	existing
symptoms	has-property	lower
symptoms	has-property	mild
symptoms	has-property	obvious
symptoms	has-property	psychiatric
symptoms	has-property	resolved
symptoms	has-property	respiratory
symptoms	has-property	systemic
symptoms	has-property	typical
symptoms	in-context	COVID-19
symptoms	in-context	adults
symptoms	in-context	members
symptoms	in-context	only
symptoms	in-time	initially
symptoms	is-a	common
symptoms	is-a	cough
symptoms	is-a	fever
symptoms	is-a	manifestations
symptoms	target	disease
syndrome	has-property	acute
syndrome	has-property	respiratory
syndrome	has-property	severe
syndrome	in-context	coronavirus
syndrome	in-context	distress
syndrome	same-as	ARDS
synonymous mutations	in-context	RaTG13
synonymous mutations	in-context	SARS-CoV-2
synonymous substitution	in-context	RaTG13
synonymous substitution	in-context	SARS-CoV-2
synthesis	causes	persistence
synthesis	in-context	excessive
synthesis	target	IL-6
system	entails	addition
system	entails	fluid exchange
system	has-property	full
tachycardia	is-a	factors
tachycardia	is-a	high risk factors
tail fiber	in-context	T3 phage
taken	entails	delay
taken	entails	reduce
taken	in-context	CML
taken	target	measures
target	has-property	attractive
target	has-property	effectively
target	in-context	IAV
target	in-context	SARS-CoV-2
target	in-context	drug development
target	subject	Prophylactic Antiviral CRISPR
target	subject	Prophylactic Antiviral CRISPR in huMAN cells (PAC-MAN)
target	target	IAV
target	target	SARS-CoV-2
target	target	all sequenced coronaviruses
target	target	sequenced coronaviruses
target RNA	has-property	low as 0.1 aM
target RNA	is-a	0.1 aM
target and cleave	in-context	lung epithelial cell
target and cleave	subject	Cas13d-based genetic
target and cleave	target	IAV
target and cleave	target	RNA sequences
targeted	subject	antibodies
targeted	subject	drugs
targeted	subject	heat shock protein 90 alpha family class A member 1
targeted	subject	tumor necrosis factor
targeted	target	AIPs
targeted	target	RBD
targeting	entails	cleave
targeting	entails	target
targeting	in-context	validation
targeting	subject	Gemcitabine
targeting	target	SARS-CoV
targeting	target	population
targeting	target	vulnerable
taxol	causes	attachments
temperature	entails	relationship
temperature	in-context	Absolute
tends	subject	cases
tends	target	use
tens of thousands	in-context	cases
testing	has-property	rapid
testing	in-context	2019-nCoV
testing	in-context	COVID-19
testing	in-context	detection
testing	in-context	populations
testing	is-a	measures
testing	target	populations
tests	has-property	positive
tests	has-property	screening
tests	in-context	SARS-CoV-2
tests	in-context	acid
tests	in-context	reverse transcription polymerase chain reaction
tests	is-a	Diagnosis criteria
tests	subject	nucleic acid
tetraplex qPCR assay set n°1	entails	detection
tetraplex qPCR assay set n°1	entails	identification
than	has-property	higher
than	in-context	SARS-CoV S
than	in-context	controls
that	has-part	CVL218
that	has-property	olaparib
that	in-place	CVL218
the risk	has-property	death
the risk	in-context	infected
the scope of pathogens	in-context	detectable
therapeutic effect	in-context	COVID-19
therapeutic effect	in-context	SARS-CoV-2
therapeutic effect	in-context	coronavirus disease
therapy	causes	recurrence
therapy	has-property	antimicrobial
therapy	has-property	antivirus
therapy	has-property	imperfect
therapy	in-context	antivirus
there are	in-context	COVID-19
there are	in-context	acuteness
there are	target	treatments
there are	target	types
there are	target	vaccines
there is	target	significance
there were	subject	February 11, 2020
there were	target	72314
these	has-part	proteins
these	in-context	conformations
these	in-context	strains
these	in-context	two
these	is-a	coronaviruses
these	is-a	distributions
these	is-a	patients
these	is-a	requirements
these	same-as	values
they	has-property	potential
they	same-as	patients
thiohemiketal	has-property	R configuration
thiohemiketal	has-property	S configuration
third	in-context	virus
this	has-property	novel
this	in-context	coronavirus
this	is-a	pathogen
those	has-property	efficient
those	has-property	infected
those	has-property	using metapopulations
those	has-property	without
those	in-context	COVID-19 patients
those	in-context	ICU
those	in-context	patients
those	is-a	models
those	is-a	patients
threat	has-property	serious
threat	in-context	COVID-19
threat	in-context	global health
threat	in-context	public health
threat	subject	outbreak
threat	target	health
three	in-context	subspecies
three-stemmed	has-property	structurally
threshold	has-property	0.5%
threshold	in-context	fermentation
throat	in-time	11
through	subject	infectiousness
through	target	contact
through	target	droplets
thumb	in-place	domain
thumb	is-a	finger
time	causes	accumulation
time	has-property	long
time	has-property	longer
time	has-property	more
time	has-property	potentially
time	in-context	conditions
time	in-context	critical
time	in-context	death
time	in-context	discharge
time	in-context	infection
time	in-context	severe
time	in-time	infection
time delay	in-context	dailyobserved
time delay	in-context	dynamic
time delay	target	dynamic
time-consuming	in-context	processing steps
time-lapse	has-property	measurement
times	has-property	working
timing	in-context	transmission
timing	is-a	aspects
tissues	in-place	lung
titer	has-property	SARS-CoV
titer	has-property	low
titer	in-place	lung
to	subject	infected
to	target	February 11, 2020
to	target	other
to	target	uninfected
to achieve	target	immunity
to be elucidated	target	function(s)
to know	has-property	essential
to know	target	period
to occur	target	infections
to provide	subject	efforts
to provide	target	diagnostic method
to stabilize	subject	interactions
to stabilize	target	spike
to study	subject	tools
to study	target	law
took	in-place	patient
took	subject	DeCoV-Net
took	target	patient
took	target	volume
tools	has-property	best-known
tools	has-property	mathematical
tools	has-property	oldest
tourism	has-property	history
tourism history	in-place	epidemic areas
toxin	has-property	Killer
traced	target	cases
tracing	target	cases
tracing	target	contact
tract	has-property	respiratory
tract	has-property	upper
trajectory	has-property	100ns MD
trajectory	has-property	simulation
transcript	has-property	abundance
transcript	has-property	decay-induced
transcript	in-context	viral
transcriptomic signature	entails	differences
transfer	has-property	horizontal
transfer	in-context	Phage-mediated
transfer	in-context	gene
transfer	target	gene
transition	has-property	state
transition	subject	nucleotides
transitions	subject	coexistence
transitions	subject	dominance
transitions	target	coexistence
translate	in-context	into
translate	subject	These
translate	target	shifts
translated	has-property	efficiently
translated	in-context	relative
translated	subject	nucleocapsid (N) protein
translated	subject	pathway
translated	target	toxin
transmissibility	has-property	consistent
transmissibility	has-property	higher
transmissibility	has-property	human-to-human
transmissibility	has-property	similar
transmissibility	has-property	unknown
transmissibility	in-context	SARS-CoV-2
transmissibility	in-context	human-to-human
transmissibility	in-place	carriers
transmissibility	same-as	transmissibility
transmissibility	subject	SARS-CoV-2
transmissibility reduction	in-context	50%
transmission	causes	infection
transmission	causes	pneumonia
transmission	has-property	asymptomatic
transmission	has-property	human-to-human
transmission	has-property	patterns
transmission	has-property	potentia
transmission	has-property	presymptomatic
transmission	has-property	primary
transmission	has-property	rapid
transmission	has-property	risk
transmission	has-property	sustained
transmission	has-property	typical
transmission	has-property	widespread
transmission	in-context	COVID-19
transmission	in-context	Hospital-related
transmission	in-context	members
transmission	in-context	over 1,000
transmission	in-place	China
transmission	in-place	country
transmission	in-time	currently
transmission	subject	COVID-19
transmission	subject	SARS-CoV-2
transmission	subject	human
transmission	subject	pathogen
transmission	subject	person
transmission	target	-human
transmission	target	COVID-19
transmission	target	SARS-CoV-2
transmission	target	dengue
transmission	target	droplet
transmission	target	malaria
transmission	target	members
transmission	target	pathogen
transmission	target	person
transmission	target	person-to-person
transmission	target	rate
transmission approaches	in-context	SARS-CoV-2
transmission mode	has-property	primary
transmission route	in-context	SARS-CoV-2
transmission route	in-time	Currently
transmitted	entails	leading
transmitted	entails	spreading
transmitted	in-context	Comparing
transmitted	in-context	sex
transmitted	in-context	sexual transmission
transmitted	in-context	vaginal sex
transmitted	in-place	human
transmitted	subject	SARS-CoV
transmitted	subject	human
transmitted	target	2019-nCoV
transmitted	target	SARS-CoV-2
transmitted	target	human
transmitted	target	sexual transmission
transport	in-context	transporter
transportation	causes	82%
transportation	is-a	factors
transporter	in-context	peptides
transporter	same-as	TAP
transporter	target	antigenic peptides
travel	has-property	intercity
treat	target	COVID-19
treating	subject	Gemcitabine
treating	target	types
treatment	causes	improve
treatment	has-property	early
treatment	has-property	psychological
treatment	has-property	related
treatment	in-context	COVID-19
treatment	in-context	convalescent
treatment	in-context	plasma
treatment	in-context	renal replacement
treatment	in-context	replacement
treatment	in-place	convalescent
treatment	in-time	To-date
treatment	subject	CVL218
treatment	target	COVID-19
treatment	target	SARS-CoV-2
treatment	target	patients
treatment	target	respiratory pathogen
treatments	has-property	specific
treatments	in-context	COVID-19
treatments	in-time	Currently
trend	has-property	similar
trend	target	distribution
triggered	subject	virus infection
triggered	target	type 1 inflammatory cues
triggers	subject	SARS-CoV-2
triggers	target	release
tumor	has-property	chronic
tumor	has-property	hematologic
tumor necrosis factor	is-a	AIPs
tumor necrosis factor	is-a	drugs
tumor necrosis factor	same-as	TNF
two	in-context	specimens
two	in-context	subspecies
two	in-context	variables
two	in-context	viruses
two	is-a	variables
two batches	in-context	samples
type	has-property	wild
type	in-context	infection
type	is-a	cells
types	has-property	certain
types	in-context	COVID-19
types	in-context	HLA
types	in-context	acuteness
types	in-context	cancers
ubiquitinated	in-context	when not required
ubiquitinated	in-time	required
ubiquitinated	subject	proteasome
ubiquitinated	target	PARP2
ubiquitinated	target	genomic stability
ultrasound	has-property	serial
underlying	in-place	COPD
underlying	subject	mechanisms
underlying	target	exacerbations
underlying disease	causes	susceptible
understanding	has-property	good
understanding	has-property	overall
understanding	subject	epidemic dynamic
understanding	target	dynamic
understanding	target	evolution
understanding	target	origin
understanding	target	transmission
understood	has-property	poorly
unidentified	in-time	previously
unique world	in-context	yeast cytoplasmically
uniting	has-property	phylogenetic
uniting	in-context	related
unlikely	entails	control
up to	subject	number
up to	target	3.28
up to 4 days	has-property	lack of treatment
up to 4 days	has-property	under various environmental conditions
update	target	views
usable	in-context	load
usable	subject	assays
usable	target	screening tests
usable	target	tests
usage	target	amino acid
use	has-property	widespread
use	in-context	feeding
use	in-context	mothers
use	in-context	tests
use	in-place	assays
use	in-place	face
use	is-a	measures
use	subject	cases
use	subject	high-resolution homology modeling method
use	target	breastmilk
use	target	face mask
use	target	information
use	target	mask
use	target	predict
use	target	primers
use	target	specimens
use	target	swab specimens
used	has-property	laborious
used	has-property	time-consuming
used	in-context	diagnosis
used	subject	RT-PCR-based
used	subject	data
used	target	diagnosis
used	target	generate
used	target	methods
used to induce	entails	exhibited
used to induce	subject	STLC
used to induce	subject	taxol
used to induce	target	erroneous attachments
useful	in-context	identifying
uses	has-property	new
uses	has-property	similar
uses	in-context	drugs
uses	in-context	similar
uses	subject	SARS-CoV-2
uses	target	angiotensin converting enzyme 2 (ACE2)
uses	target	canonical TRS-mediated
uses	target	canonical TRS-mediated 144 mechanism
uses	target	cell entry receptor,
using	is-a	P-type transistor
using	target	GROMACS
using	target	estimates
using	target	field
utilizes	subject	SARS-CoV
utilizes	subject	it
utilizes	target	mRNA pseudoknot
utilizes	target	pseudoknot
vaccine	has-property	sufficient
vaccine	in-context	flu
vaccines	in-context	COVID-19
vaccines	in-time	Currently
validation	target	previous
value	has-property	large
value	in-context	Ab test
value	in-context	diagnosis
value	in-context	screening
value	in-context	testing
values	entails	retain
values	has-property	high
values	has-property	median
values	has-property	similar
values	in-context	DTR
values	in-context	fraction
values	in-context	median
values	in-context	s
values	in-context	two
values	in-context	κ
variation	in-context	betacoronaviruses
variation	in-context	fiber
variation	in-context	seasonal
variation	in-place	residues
variation	target	SARS-CoV-2
varied	has-property	nucleosome density
varied	has-property	remodeler-specific
varied	has-property	way
varied	in-context	nucleosome density
varied	subject	distance
varied	subject	distance of arrays to the barrier Reb1
varied	subject	global spread
varied	subject	lengths
varied	subject	linker lengths
varied	target	amino acid sequence
ventilation	has-property	CFR
ventilation	has-property	mechanical
ventilation	has-property	non-invasive
ventilatory support	in-context	patients
verified	entails	applied
verified	in-context	clinical trials
verified	target	safety
very cautious	entails	helpful
very cautious	in-context	sex behavior
vesicular stomatitis virus	is-a	virus
vesicular stomatitis virus	is-a	viruses
vesicular stomatitis virus	same-as	VSV
viral	has-property	new
viral	in-context	CoViD-19
viral	is-a	pathogens
viral 112 transcripts	in-time	expression
viral entry	causes	SARS-CoV-2 infection
viral entry	has-property	Receptor-dependent
viral existence	in-context	COVID-19
viral genomes	has-property	entire
viral genomics	has-part	studies
viral growth	subject	CoViD-19
viral infection	in-time	cytokines
viral load	causes	organ injury
viral load	causes	pathogenesis
viral load	in-context	SARS-CoV-2 infection
viral load	in-context	immunity
viral load	in-context	infection
viral pathogen	has-property	new
viral pathogens	in-context	new
viral pathogens	in-context	potential
viral real-time reverse transcription polymerase chain reaction (RT-PCR) test	causes	result
viral strains	has-property	novel
viral strains	in-context	novel
virtual elimination	has-part	HCoV-HKU1
virtual elimination	has-part	HCoV-OC43
virulence	has-property	unique capacities
virulence	in-context	SARS-CoV-2
virus	causes	murine hepatitis
virus	has-property	dependent
virus	has-property	functional
virus	has-property	infection
virus	has-property	killer
virus	has-property	related
virus	has-property	similar
virus	has-property	strain-3
virus	has-property	third
virus	in-context	COVID-19
virus	in-context	WU polyoma virus
virus	is-a	SARS-CoV-1
virus	is-a	satellite
virus	is-a	satellite RNA
virus genome sequence	has-property	original
virus infection	target	type 1 inflammatory cues
viruses	has-part	V1691R 553 substitution
viruses	has-part	sequences
viruses	has-property	mutant
viruses	has-property	wildtype
viruses	in-context	DUB-negative
viruses	in-context	all known
volume	in-context	CT-Mask
volume	in-context	input
vulnerable	has-property	least
was	subject	availability
was	subject	prevalence of COVID-19
was	target	23.9% (21/88)
was	target	factor
was found	in-place	Wuhan, China
was found	in-time	December 2019
was found	subject	Novel coronaviruses (COVID-19)
was identified	subject	HCOV-229E
was identified	target	patients
water	causes	pursued
water	same-as	starvation
way	has-property	remodeler-specific
wearing	has-property	cost-effective
wearing	in-context	prevent
wearing	is-a	measures
wearing	target	facemask
weights	has-property	negative
were found	in-place	SARS-CoV
were found	subject	changes
were included	subject	age
were included	subject	respiratory symptoms
were included	target	EWS
white matter	has-part	inferior fronto-occipital fasciculus
white matter	has-part	inferior longitudinal fasciculus
white matter	has-part	superior longitudinal fasciculus
white matter	in-place	angular gyrus
white matter	is-a	regions
who lived	in-place	areas
wide-range	has-part	elderly
wide-range	has-part	youth
widespread	in-context	infected
widespread	subject	Fever
width	in-context	CTT
will exist	in-context	COVID-19 patients
will exist	subject	role
will peak	in-context	absence
will peak	in-context	interventions
will peak	in-place	England
will peak	in-place	Wales
will peak	in-time	following
will peak	in-time	start
will peak	subject	disease
will peak	target	133 days
will peak	target	median
will result	subject	using
will result	target	overestimation
wind	has-property	speeds
window	has-property	long
window for diagnosis	has-property	long
window for diagnosis	in-context	COVID-19
with	subject	women
with	target	COVID-19
within	in-context	infrared
within	target	profile
without	in-context	LRTI pathogens
women	has-property	symptomatic
women	in-context	COVID-19
work	has-property	previous
work	in-place	sub-cellualr
work	in-place	sub-cellualr level
work	subject	contraction
work	subject	principle
worker	in-context	healthcare
working times	causes	contacting with
working times	has-property	Longer
worsen	in-place	adults
worsen	subject	death rate
worsen	subject	transmission
worsen	target	symptoms
would be possible	is-a	70% cross immunity
would be possible	subject	induced
would be possible	target	virtual elimination
wt	in-place	MRC5
wt	is-a	virus
yeast	has-property	wild
yeast linear pGKL plasmids	is-a	example
yeast linear pGKL plasmids	is-a	model
yeasts	has-property	wild
yield	has-property	false positives
yield	in-context	not targeted
yield	in-context	targeted specifically to SARS-CoV-2
yield	in-context	virus
yield	subject	SARS-CoV-2 assays
yield	target	false positive
yielded	subject	Absolute humidity
yielded	subject	temperature
yielded	target	relationship
~15%	in-context	patients
~7%	in-context	S -gene sites
θ = R	same-as	matches
κ-values	in-context	median
κ-values	in-context	residues
≥50%	in-context	chance
≥50% chance	in-context	having
≥65	in-context	years old
